-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Cgb0tne7gJQY3cn9Ty79EgtdSMakvuAAlA9gHQIF9oUtOgWEh34/T9RG3IshcEFc gA3KB369sGKj/G7Pg3L5ow== 0000930413-07-002538.txt : 20070320 0000930413-07-002538.hdr.sgml : 20070320 20070320172340 ACCESSION NUMBER: 0000930413-07-002538 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20061231 FILED AS OF DATE: 20070320 DATE AS OF CHANGE: 20070320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENTEK INC CENTRAL INDEX KEY: 0001077552 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 020505547 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14789 FILM NUMBER: 07707277 BUSINESS ADDRESS: STREET 1: C/O GENTEK INC STREET 2: 90 EAST HALSEY ROAD CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 9738846952 MAIL ADDRESS: STREET 1: C/O GENTEK INC STREET 2: 90 EAST HALSEY ROAD CITY: PARSIPPANY STATE: NJ ZIP: 07054 10-K 1 c47397_10-k.htm

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K


 

 

(Mark One)

 

x

ANNUAL REPORT UNDER SECTION 13 OR 15(d)

 

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2006

 

OR

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

 

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission File Number 001-14789

 

GENTEK INC.

 

(Exact name of Registrant as specified in its charter)


 

 

 

Delaware

 

02-0505547

(State of other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification Number)

90 East Halsey Road

 

 

Parsippany, New Jersey

 

07054

(Address of principal executive offices)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code: (973) 515-3221

Securities registered pursuant to Section 12(b) of the Act:

None

Securities registered pursuant to Section 12(g) of the Act:

Common stock, no par value

(Title of class)

          Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes o      No x

          Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes o      No x

          Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x      No o

          Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in the definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x

          Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer (as defined in Rule 12b-2 of the Act).
Large Accelerated Filer o      Accelerated Filer x      Non-accelerated Filer o

          Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o      No x

          State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter: $ 257,598,497.

          Applicable to issuers involved in bankruptcy proceedings during the preceding five years:
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.
Yes x      No o

          The number of outstanding shares of the Registrant’s Common Stock as of February 28, 2007 was 10,362,748.

Documents Incorporated by Reference:

          Portions of the Registrant’s definitive Proxy Statement for the Annual Meeting of Stockholders to be held on May 17, 2007, to be filed within 120 days after the close of the Registrant’s fiscal year, are incorporated by reference into Part III of this Annual Report on Form 10-K.



PART I

Item 1. Business.

Overview

          GenTek Inc. (the “Company” or “GenTek”) is a holding company whose subsidiaries manufacture industrial components and performance chemicals. GenTek’s subsidiaries operate through two primary business segments: manufacturing and performance chemicals. The manufacturing segment provides a broad range of engineered components and services to two principal markets: automotive and industrial. The performance chemicals segment provides value-added chemical products and services to four principal markets: water treatment, chemical processing, pharmaceutical and personal care, and technology. The Company’s products are frequently highly engineered and are important components of, or provide critical attributes to, its customers’ end products or operations. The Company operates over 50 manufacturing and production facilities located primarily in the U.S. and Canada. GenTek has no independent operations and, therefore, is dependent upon cash flow from its subsidiaries to meet its obligations.

Acquisitions

          On February 6, 2007, the Company acquired the assets of Chalum, Inc. The acquisition included the manufacturing facility in Sacaton, Arizona. Chalum produces aluminum sulfate for the greater Phoenix, Arizona municipal water treatment market. The purchase price was $3 million.

          On September 21, 2006, the Company acquired the assets of GAC MidAmerica, Inc. The acquisition included manufacturing facilities in Toledo, Ohio, Indianapolis, Indiana, and Saukville, Wisconsin. GAC produces aluminum sulfate and bleach, as well as distributing specialty water treatment chemicals, sulfuric acid and caustic soda. The purchase price of the transaction was $8 million.

          On July 31, 2006, the Company acquired the assets of Precision Engine Products Corp., a wholly owned subsidiary of Stanadyne Corporation. Precision Engine Products is dedicated principally to the manufacturing of hydraulic lash adjusters and die cast aluminum rocker arm assemblies utilized in valve train systems for both OEM and after market applications to the global automotive and light truck markets. Precision Engine Products has manufacturing facilities in Tallahassee, Florida and Curitiba, Brazil. The purchase price of the transaction was $26 million in cash, plus the potential of an earn out for Stanadyne of up to $10 million, payable, if at all, based on certain performance metrics being achieved during the twelve months following the closing date.

          On July 27, 2006, the Company acquired the assets of Repauno Products, LLC. The acquisition included the manufacturing facility in Gibbstown, New Jersey. Repauno Products manufactures sodium nitrite which is used in a wide range of industries including metal finishing, heat transfer salts, rubber processing, meat curing, odor control and inks and dyes. The purchase price of the transaction was $6 million.

Discontinued Operations

          On February 16, 2007, the Company completed the sale of its Noma wire and cable harness assembly business. The net proceeds from the transaction were used to repay outstanding debt. During April 2006, the Company completed the sale of its cable and wire manufacturing business

-1-


in Stouffville, Canada. Proceeds from the transaction were used to repay $22 million of the Company’s second lien term loan. Accordingly, these businesses have been classified as discontinued operations.

          During the second quarter of 2005, the Company ceased operations of its printing plate business. The business had become unprofitable as it had experienced severe competitive pressures over the last several years and had been hurt by a continued shift in technology in the printing plate market. Accordingly, all financial information included herein has been reclassified to reflect the business as discontinued operations.

Products and Services by Segment

          The following table sets forth the Company’s sales by segment:

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 


 

 

 

2006

 

2005

 

2004

 

 

 


 


 


 

 

 

(In millions)

 

Manufacturing

 

$

238,021

 

$

222,384

 

$

214,550

 

Performance Chemicals

 

 

373,347

 

 

334,113

 

 

316,573

 

 

 



 



 



 

 

 

$

611,368

 

$

556,497

 

$

531,123

 

 

 



 



 



 

Manufacturing Segment

          The manufacturing segment provides a broad range of engineered components, wiring products and services to two principal markets: automotive and industrial.The Company’s products for these markets are described below:

          Automotive. For the automotive market, the Company provides:

 

 

 

 

precision-engineered components for valve-train systems, including stamped and machined rocker and roller-rocker arms, cam follower rollers, cam follower roller axles, antifriction needle roller bearings, hydraulic lash adjusters, hydraulic flat and roller lifters, mechanical roller tappets and other hardened/machined components;

 

 

 

 

computer-aided and mechanical vehicle and component testing services for the transportation industry; and

 

 

 

 

fluid transport and handling equipment for automotive service applications.

          The Company’s precision-engineered stamped and machined engine components for valve-train systems improve engine efficiency by reducing engine friction and component mass. These components are used both in traditional overhead valve and in the increasingly popular single and double overhead cam engines which power cars, light trucks and sport utility vehicles. Over the last several years, the Company has benefited from the design transition of overhead valve engines to overhead cam engines providing a strong position with which to participate in the industry’s latest efforts to improve fuel efficiency and power. Increased design use of additional valves per cylinder to improve fuel/air throughput have resulted in volume growth on specific engine applications. The majority of the Company’s valve-train production is sold to U.S. automobile and diesel engine manufacturers and their Tier 1 suppliers.

          Through its automotive testing offerings, the Company provides mechanical testing services and computer-aided design, engineering and simulation services for automotive structural and mechanical systems to OEMs and Tier 1 suppliers. The Company provides a wide range of testing services for

-2-


automotive components and systems from single sub-systems, such as chassis, suspension, seats and seating assemblies, to entire vehicles. The Company’s engineering and simulation services provide customers with finite element modeling, kinematics, and crash and variation simulation analyses, and allow its customers to test their automotive products for durability, stress, noise, vibration and environmental considerations.

          Automotive and diesel engine manufacturers generally award business to their suppliers by individual engine line for the life of the engine. The loss of any single engine line contract would not be material to the Company. However, an economic downturn in the automotive industry as a whole or other events (e.g., labor disruptions) resulting in significantly reduced operations of DaimlerChrysler or Ford could have a material adverse impact on the results of the Company’s manufacturing segment. Neither of these customers accounted for 10 percent or more of the Company’s revenues in 2006.

          Industrial. For the industrial market, the Company manufactures wire and cable for a broad range of applications in the electronic, appliance, automotive and consumer electrical markets. These products are sold to OEM’s throughout North America.

          The Company produces a broad product line of single and multi conductor wire and cable. The Company’s wire jacketing expertise includes the use of polyvinyl chloride (PVC), thermoplastic elastomer (TPE) and ethylene vinyl acetate (EVA) engineered materials.

Performance Chemicals Segment

          The Company’s performance chemicals segment provides value-added products and services to four principal markets: (i)water treatment; (ii)chemical processing; (iii)pharmaceutical and personal care; and (iv)technology. The Company’s products and services for these markets are described below.

          Water Treatment. With a network of 35 water treatment chemical plants located throughout the United States and Canada, the Company is the largest North American producer of aluminum sulfate, or “alum”, which is used as a coagulant in potable water and waste water treatment applications, and a leading supplier of ferric sulfate and other specialty flocculents (polymer-based materials used for settling and/or separating solids from liquids) and sodium nitrate. The Company’s water treatment products are designed to address the important environmental issues confronting its customers. These value-added products provide cleaner drinking water, restore algae-infested lakes, reduce damaging phosphorus runoff from agricultural operations, and significantly reduce pollution from industrial waste water.

          Chemical Processing. The Company operates three sulfuric acid production facilities which produce various grades of sulfuric acid which is used in the manufacture of titanium pigments, fertilizers, synthetic fibers, steel, petroleum and paper, as well as many other products. In addition, the Company provides sulfuric acid regeneration services to the refining and chemical industries, and pollution abatement and sulfur recovery services to selected refinery customers. Refineries use sulfuric acid as a catalyst in the production of alkylate, a gasoline blending component with favorable performance and environmental properties. The alkylation process contaminates and dilutes the sulfuric acid, thereby creating the need to dispose of or regenerate the contaminated acid. The Company transports the contaminated acid back to the Company’s facilities for recycling and redelivers the fresh, recycled acid back to customers. This “closed loop” process offers customers significant savings versus alternative disposal methods and also benefits the environment by significantly reducing refineries’ waste streams.

-3-


          Pharmaceutical and Personal Care. The Company is a leading supplier of the active chemical ingredients used in the manufacture of antiperspirants, and also supplies ingredients used in prescription pharmaceuticals, nutritional supplements, veterinary health products and other personal care products. The customer base includes many of the world’s leading personal care companies, and the Company is favorably positioned with both North American and European sourcing capabilities.

          Technology. The Company provides ultrahigh-purity electronic chemicals for the semiconductor and disk drive industries. The Company’s electronic chemicals include ultrahigh-purity acids, caustics, solvents, etchants and formulated photo ancillaries for use in the manufacture of semiconductor processing chips and computer disk drives.

Competition

          Competition in the manufacturing segment’s markets is based upon a number of factors including design and engineering capabilities, quality, price and the ability to meet customer delivery requirements. In the automotive market, the Company competes with, among others, Delphi, Eaton, INA, Timken, and captive OEMs. In the industrial markets, the Company competes with Copperfield, General Cable and Southwire, among others.

          Although the Company’s performance chemicals segment generally has significant market share positions in the product areas in which it competes, most of its end markets are highly competitive. In the pharmaceuticals and personal care market, the Company’s major competitors include BK Giulini Corp. and Summit Research Labs as well as the captive production facilities of certain personal care companies. The Company’s competitors in the chemical processing market include the refineries that perform their own sulfuric acid regeneration, as well as DuPont, Marsulex, Chemtrade Logistics, PVS and Rhodia, which also have sulfuric acid regeneration facilities that are generally located near their major customers. In water treatment the Company competes with Geo Specialty Chemicals, Kemiron Companies Inc., U.S. Aluminates and other regional players. Competitors in the technology market include Air Products, Honeywell Electronic Materials and Tyco/Mallinckrodt-Baker.

Suppliers; Availability of Raw Materials

          The Company purchases a variety of raw materials for its businesses. The primary raw materials used by the manufacturing segment are copper and steel. The Company’s performance chemicals segment’s competitive cost position is, in part, attributable to its sourcing relationships for certain raw materials that serve as the feedstock for many of its products. Consequently, major raw material purchases are limited primarily to sulfuric acid where it is uneconomical for the Company to supply itself due to distribution costs, bauxite and aluminum tri-hydrate (for the manufacture of alum), zirconium based products (for the manufacture of antiperspirant active ingredients), sulfur (for the manufacture of sulfuric acid), and soda ash (for the manufacture of sodium nitrite).

          The Company purchases raw materials from a number of suppliers and, in most cases, believes that alternative sources are available to fulfill its needs. A number of the raw materials the Company will purchase are subject to cyclical price movements. In the performance chemicals segment, the Company is able to pass through all or a portion of raw material price increases, but often on a lagged basis. While the Company has been able to pass through a significant portion of copper raw material price increases, it has had limited success in doing so with steel cost increases in its automotive business. The Company continues its efforts to ensure it has sufficient access to required raw materials at competitive prices and to pass along raw material price increases where possible.

-4-


Sales and Distribution

          The Company’s manufacturing segment has approximately 50 sales, marketing, engineering and customer service personnel. Generally, the Company markets its products directly to its customers, but in certain industrial markets a distribution network is used. The manufacturing segment’s technical and engineering staff is an integral part of the segment’s sales and distribution effort. Since many of the Company’s products are precision-engineered and custom-designed to customer specifications, the Company’s sales force and engineers work closely with its customers in designing, producing, testing and improving its products.

          In the Company’s performance chemicals segment, the Company employs approximately 70 sales, marketing, distribution and customer service personnel. The sales force is divided into several specialized groups which focus on specific products, end-users and geographic regions. This targeted approach provides the Company with insight into emerging industry trends and creates opportunities for product development.

Seasonality; Backlog

          The business of the manufacturing segment is generally not seasonal. Within the performance chemicals segment, the water treatment and sulfur products businesses have higher volumes in the second and third quarters of the year, owing to (i) higher spring and summer demand for sulfuric acid regeneration services from gasoline refinery customers to meet peak summer driving season demand and (ii) higher spring and summer demand from water treatment chemical customers to manage seasonally high and low water conditions. The other markets that the performance chemicals segment serves are generally not seasonal. Due to the nature of the Company’s businesses, there are no significant backlogs.

Environmental Matters

          The Company’s various manufacturing operations, which have been conducted at a number of facilities for many years, are subject to numerous laws and regulations relating to the protection of human health and the environment in the U.S., Canada and other countries. The Company believes that it is in substantial compliance with such laws and regulations. However, as a result of its operations, the Company is involved from time to time in administrative and judicial proceedings and inquiries relating to environmental matters. Based on information available at this time with respect to potential liability involving these facilities, the Company believes that any such liability will not have a material adverse effect on its financial condition, cash flows or results of operations. However, modifications of existing laws and regulations or the adoption of new laws and regulations in the future, particularly with respect to environmental and safety standards, or the discovery of additional or unknown environmental contamination of any of the Company’s current or former facilities, could require the Company to make expenditures which may be material or otherwise adversely impact the Company’s operations.

          The Company maintains a program to manage its facilities’ compliance with environmental laws and regulations. Expenditures for 2006 approximated $8 million (of which approximately $1 million represented capital expenditures and approximately $7 million related to ongoing operations and the management and remediation of potential environmental contamination from prior operations). Expenditures for 2005 approximated $9 million (of which approximately $2 million represented capital expenditures and approximately $7 million related to ongoing operations and the management and remediation of potential environmental contamination from prior operations). The Company expects expenditures similar to 2006 levels in 2007. In addition, if environmental laws and regulations affecting

-5-


the Company’s operations become more stringent, costs for environmental compliance may increase above historical levels.

          The Comprehensive Environmental Response Compensation and Liability Act of 1980 (“CERCLA”) and similar statutes, have been construed as imposing joint and several liability, under certain circumstances, on present and former owners and operators of contaminated sites, and transporters and generators of hazardous substances, regardless of fault. The Company’s facilities have been operated for many years by the Company or its prior owners and operators, and adverse environmental conditions of which the Company is not aware may exist. Modifications of existing laws and regulations and discovery of additional or unknown environmental contamination at any of the Company’s current or former facilities could have a material adverse effect on the Company’s financial condition, cash flows and/or results of operations. In addition, the Company has received written notice from the Environmental Protection Agency that it has been identified as a “potentially responsible party” under CERCLA at two third-party sites. The Company does not believe that its liability, if any, for these sites will be material to its results of operations, cash flows or financial condition.

          At any time, the Company may be involved in proceedings with various regulatory authorities which could require the Company to pay various fines and penalties due to violations of environmental laws and regulations at its sites, remediate contamination at some of these sites, comply with applicable standards or other requirements, or incur capital expenditures to modify certain pollution control equipment or processes at its sites. Again, although the amount of any liability that could arise with respect to these matters cannot be accurately predicted, the Company believes that the ultimate resolution of these matters will have no material adverse effect on its results of operations, cash flows or financial condition.

          Avtex Site at Front Royal, Virginia. On March 22, 1990, the Environmental Protection Agency (the “EPA”) issued to the Company a Notice of Potential Liability pursuant to Section 107(a) of CERCLA with respect to a site located in Front Royal, Virginia, owned at the time by Avtex Fibers Front Royal, Inc., (“Avtex”) which filed for bankruptcy. A sulfuric acid plant adjacent to the main Avtex site was previously owned and operated by the Company. The Company reacquired the sulfuric acid plant site through the bankruptcy in order to control the required investigation and, if necessary, remediation. On September 30, 1998, the EPA issued an administrative order under Section 106 of CERCLA, which requires the Company, through its predecessor, AlliedSignal Inc. (now Honeywell Inc.) and Avtex to undertake certain removal actions at the acid plant. On October 19, 1998, the Company delivered to the EPA written notice of its intention to comply with that order, subject to numerous defenses. The Company investigated potential soil and groundwater contamination and decommissioned the site. As a result of the Company’s bankruptcy filing, the Company entered into an agreement with Honeywell, the previous owner and operator, whereby Honeywell agreed to take back all environmental liability at the site, past, present and future, and took back ownership of the site. Although the EPA refused to formally drop the Company from the administrative order, the EPA signed a letter acknowledging Honeywell’s agreement to be responsible for all liability at the site and agreed to seek recourse against Honeywell for such liability and only look to the Company in the event of a default by Honeywell. The Company believes that there is a strong likelihood that no further costs will be incurred at this site.

          Delaware Valley Facility. On September 7, 2000, the EPA issued to the Company an Initial Administrative Order (an “IAO”) pursuant to Section 3008(h) of the Resource Conservation and Recovery Act (“RCRA”), which requires that the Company conduct an environmental investigation of the Company’s Delaware Valley facility (the “Facility”) and, if necessary, propose and implement corrective measures to address any historical environmental contamination at the Facility. Over the past six years,

-6-


the Company has been working cooperatively with the EPA and Honeywell, a prior owner of the Facility and current owner of a plant adjacent to the Facility, to implement the actions required under the IAO. The Company conducted the first investigatory steps required by the IAO, the evaluation of potential soil and groundwater contamination, in both the North Plant (the area of the facility north of US Route 18) and the South Plant (the area south of US Route 18) that borders the Delaware River. As a result of the Company’s bankruptcy filing, the Company entered into an agreement with Honeywell dated April 30, 2004 in which Honeywell agreed to take back all environmental liability at the North Plant, past, present and future, as well as ownership of the North Plant. In addition, Honeywell took responsibility for the cost to address groundwater contamination at the South Plant. The Company remains responsible only for soil contamination at the South Plant. Although the EPA refused to formally drop the Company from the IAO, the EPA signed a letter acknowledging Honeywell’s agreement to be responsible for all liability at the North Plant and for groundwater contamination at the South Plant and to seek recourse against Honeywell for those liabilities and only look to the Company in the event of a default by Honeywell. The remaining requirements of the IAO will be performed over the course of the next several years. The Company closed the South Plant operations of its Delaware Valley facility on November 10, 2003. This closure resulted in an expansion of the investigation to be performed under the IAO. Depending on the results of that additional investigation, additional remedial activity may be required for soils in the South Plant. The Company has provided for the estimated costs of $2 million for compliance with the IAO in its accrual for environmental liabilities. As such, the Company believes that compliance with the IAO will not have a material effect on its results of operations or financial condition.

Employees/Labor Relations

          At December 31, 2006, the Company had approximately 1,525 employees, of whom approximately 560 were full-time salaried employees, approximately 590 were full-time hourly employees (represented by 8 different unions) and approximately 375 were hourly employees working in nonunion facilities.

          The Company’s union contracts have durations which vary from two to four years. The Company’s relationships with its unions are generally good.

Executive Officers and Key Employees

          Set forth below is information with respect to each of the Company’s executive officers and/or key employees.

          William E. Redmond, Jr., 47, President and Chief Executive Officer of the Company since May, 2005 and a Director of the Company since November 2003. Since 2005, Mr. Redmond has served as Chairman and a Director of Maxim Crane Works and as Chairman and a Director of Citation Corporation. From 1996 until 2003, Mr. Redmond held the position of Chairman, President and Chief Executive Officer of Garden Way Incorporated.

          George G. Gilbert, 58, Vice President and General Manager – Valve Train Group since 2001. From 1997 to 2001, Mr. Gilbert held the position of Vice President Technical Services/Strategic Development, for Simpson Industries.

          Douglas J. Grierson, 42, Vice President and Controller since April 2005. Mr. Grierson served as Director of Accounting and Assistant Controller from June 1999 to April 2005.

-7-


          James Imbriaco, 54, Vice President, General Counsel and Secretary since July 2005. From May 2004 to June 2005, Mr. Imbriaco held the position of Consulting Corporate Counsel with Bowne & Co., Inc. From October 2000 to August 2003, Mr. Imbriaco held the position of Vice President, General Counsel and Secretary with Agency.com, Ltd.

          Robert D. Novo, 49, Vice President of Human Resources and Environmental Health and Safety since August 2004. Mr. Novo served as the Vice President of Human Resources from July 2003 to August 2004. Prior to July 2003, Mr. Novo held various senior level human resource positions with Honeywell International since 1995.

          Vincent J. Opalewski, 44, Vice President and General Manager – Performance Chemicals Group since September 2006. Mr. Opalewski served as Vice President - Sales and Marketing, for the Performance Chemicals Group from July 2005 to September 2006. He previously served as General Manager of the Sulfur Products Group from January 2000 to July 2005.

          Thomas B. Testa, 45, Vice President and Chief Financial Officer since September 2006. Mr. Testa served as Vice President and General Manager – Performance Chemicals Group since August 2004. From April 2002 to August 2004, Mr. Testa served as Vice President – Operations for the Performance Chemicals Group. He previously served as General Manager of the Electronic Chemicals business group from October 1997 to April 2002.

Corporate Governance and Internet Address

          The Company emphasizes the importance of professional business conduct and ethics through its corporate governance initiatives. The Company’s board of directors has adopted a code of business conduct and ethics that applies to all employees, directors and officers, including the Company’s principal executive officer, principal financial officer and principal accounting officer. The Company’s board of directors consists of a majority of independent directors.

          The Company’s internet address is www.gentek-global.com. The Company makes available, free of charge through a link on its site, the annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to such reports, if any, as filed with the SEC as soon as reasonably practicable after such filing. The site also contains the Company’s code of business conduct and ethics and the charters of the audit committee, corporate governance and nominating committee and compensation committee of its board of directors. The Company’s principal executive offices are located at 90 East Halsey Road, Parsippany, New Jersey 07054, and its telephone number is (973) 515-3221.

Item 1A. Risk Factors.

          The following is a discussion of certain factors that currently impact or may impact the Company’s business, operating results and/or financial condition. An investment in the Company’s common stock involves a high degree of risk. You should carefully consider the risks described below before deciding to invest in its common stock. In assessing these risks, you should also refer to the other information in this Annual Report on Form 10-K, including the Company’s financial statements and the related notes. Various statements in this Annual Report on Form 10-K, including some of the following risk factors, constitute forward-looking statements.

Risks Related to the Company’s Capital Structure

-8-


The Company’s ability to make payments on its debt will be contingent on GenTek’s future operating performance, which will depend on a number of factors that are outside of its control.

          The Company’s debt service obligations are estimated to be approximately $28 million to $30 million in 2007, including approximately $5 million of principal repayments. This debt service may have an adverse impact on the Company’s earnings and cash flow, which could in turn negatively impact GenTek’s stock price.

          The Company’s ability to make principal and interest payments on its debt is contingent on its future operating performance, which will depend on a number of factors, many of which are outside of its control. The degree to which GenTek is leveraged could have other important negative consequences, including the following:

 

 

 

 

the Company must dedicate a substantial portion of its cash flows from operations to the payment of its indebtedness, reducing the funds available for future working capital requirements, capital expenditures, acquisitions or other general corporate requirements;

 

 

 

 

a significant portion of its borrowings are, and will continue to be, at variable rates of interest, which may result in higher interest expense in the event of increases in interest rates;

 

 

 

 

the Company may be more vulnerable to a downturn in the industries in which it operates or a downturn in the economy in general;

 

 

 

 

the Company may be limited in its flexibility to plan for, or react to, changes in its businesses and the industries in which it operates;

 

 

 

 

the Company may be placed at a competitive disadvantage compared to its competitors that have less debt;

 

 

 

 

the Company may be limited in its ability to react to unforeseen increases in certain costs and obligations arising in its businesses, including environmental, pension and tax liabilities;

 

 

 

 

the Company may determine it to be necessary to dispose of certain assets or one or more of its businesses to reduce its debt; and

 

 

 

 

the Company’s ability to borrow additional funds may be limited.

          The Company can provide no assurance that its businesses will generate sufficient cash flow from operations or that future borrowings will be available in amounts sufficient to enable the Company to pay its indebtedness or to fund its other liquidity needs. Moreover, the Company may need to refinance all or a portion of its indebtedness on or before maturity. In such a case, the Company cannot make assurances that it will be able to refinance any of its indebtedness on commercially reasonable terms or at all. If the Company is unable to make scheduled debt payments or comply with the other provisions of its debt instruments, the Company’s various lenders may be permitted under certain circumstances to accelerate the maturity of the indebtedness owed to them and exercise other remedies provided for in those instruments and under applicable law.

The Company is subject to restrictive debt covenants pursuant to its indebtedness. These covenants may restrict its ability to finance its business and, if the Company does not comply with the covenants or otherwise default under them, the Company may not have the funds necessary to pay all amounts that could become due and the lenders could foreclose on substantially all of its assets.

          The Company’s indebtedness contains covenants that, among other things, significantly restricts and, in some cases, effectively eliminates the Company’s ability and the ability of most of its subsidiaries to:

-9-



 

 

 

 

incur additional debt;

 

 

 

 

create or incur liens;

 

 

 

 

pay dividends or make other equity distributions to the Company’s shareholders;

 

 

 

 

purchase or redeem share capital;

 

 

 

 

make investments;

 

 

 

 

sell assets;

 

 

 

 

issue or sell share capital of certain subsidiaries;

 

 

 

 

engage in transactions with affiliates;

 

 

 

 

issue or become liable on a guarantee;

 

 

 

 

voluntarily prepay, repurchase or redeem debt;

 

 

 

 

create or acquire new subsidiaries; and

 

 

 

 

effect a merger or consolidation of, or sell all or substantially all of its assets.

          In addition, the Company and its subsidiaries must comply with certain financial covenants. In the event the Company was to fail to meet any of such covenants and were unable to cure such breach or otherwise renegotiate such covenants, the Company’s lenders would have significant rights to deny future access to liquidity and/or seize control of substantially all of its assets. The material financial covenants with which the Company must comply include total leverage, total interest coverage, and maximum capital expenditures.

          The covenants contained in the Company’s indebtedness and any credit agreement governing future debt may significantly restrict its future operations. Furthermore, upon the occurrence of any event of default, the Company’s lenders could elect to declare all amounts outstanding under such agreements, together with accrued interest, to be immediately due and payable. If those lenders were to accelerate the payment of those amounts, the Company cannot assure you that its assets and the assets of its subsidiaries would be sufficient to repay those amounts in full.

          The Company is also subject to interest rate risk due to its indebtedness at variable interest rates, based on a base rate or LIBOR plus an applicable margin. The Company cannot assure you that shifts in interest rates will not have a material adverse effect on it.

The Company may be required to prepay its indebtedness prior to its stated maturity, which may limit its ability to pursue business opportunities.

          Pursuant to the terms of certain of the Company’s indebtedness, in certain instances it is required to prepay outstanding indebtedness prior to its stated maturity date. Specifically, if certain tests are not met, a portion of excess cash flow, as defined in the credit agreement, and certain non-recurring cash inflows such as proceeds from asset sales, insurance recoveries, and equity offerings must be used to pay down indebtedness and may not be reborrowed. These prepayment provisions may limit the Company’s ability to utilize this excess cash flow to pursue business opportunities.

The Company’s business is capital intensive. It cannot assure you that it will have sufficient liquidity to fund its working capital and capital expenditures and to meet its obligations under existing debt instruments.

          The Company’s business is capital intensive and it cannot be certain that it will achieve sufficient cash flow in the future. Failure to maintain profitability and generate sufficient cash flow could diminish its ability to sustain operations, meet financial covenants, obtain additional required funds and make

-10-


required payments on any indebtedness it may have incurred or may incur in the future. If the Company does not comply with the covenants in its credit agreements or otherwise default under them, it may not have access to borrowings under its $60 million revolving credit facility or the funds necessary to pay amounts that become due.

          Although the Company believes that its current levels of cash and cash equivalents, along with available borrowings on its revolving credit facility, will be sufficient for its cash requirements during the next twelve months, it is possible that these sources of cash will be insufficient, resulting in the Company having to raise additional funds for liquidity. There can be no assurance the Company will have access to additional funding should the need arise.

The Company is a holding company that is dependent upon cash flow from its subsidiaries to meet its financial obligations; its ability to access that cash flow may be limited in some circumstances.

          The Company is a holding company with no independent operations or significant operating assets other than its investments in, and advances to, its subsidiaries. The Company depends upon the receipt of sufficient funds from its subsidiaries through its centralized cash management system from its domestic subsidiaries and through dividends, loans or other distributions from its foreign subsidiaries to meet its financial obligations. In addition, the terms of the Company and its subsidiaries’ existing indebtedness, and the laws of the jurisdictions under which it and its subsidiaries are organized, limit the payment of dividends, loan repayments and other distributions by its subsidiaries to the Company under some circumstances. Any indebtedness that it, or its subsidiaries, may incur in the future may contain similar restrictions.

Risks Related to the Company’s Operations

The industries in which the Company operates are highly competitive. This competition may prevent it from raising prices at the same pace as its costs increase, making it difficult for the Company to maintain existing business and win new business.

          The Company faces significant competition in most of its businesses. Certain of its competitors have large market shares and substantially greater financial and technical resources than it does. The Company may be required to reduce prices if its competitors reduce prices, or as a result of any other downward pressure on prices for its products and services, which could have an adverse effect on the Company.

          In each of its business segments, the Company operates in competitive markets. Its manufacturing segment competes with numerous international and North American companies, including various captive operations of automotive original equipment manufacturers (OEMs) and Tier 1 suppliers to automotive manufacturers. Competition in the manufacturing segment’s markets is based on a number of factors, including design and engineering capabilities, price, quality and the ability to meet customer delivery requirements. Due to the level of competition, its customers have regularly requested price decreases and maintaining or raising prices has been difficult over the past several years and will likely continue to be so in the near future. Most of the markets in which its performance chemicals segment does business are highly competitive, with competitors typically segregated by end market. Competition in the performance chemicals segment’s markets is based on a number of factors, including price, freight economics, product quality and technical support. If the Company is unable to compete successfully, its financial condition and results of operations could be adversely affected.

-11-


The industries the Company competes in are subject to economic downturns.

          An economic downturn in the automotive industry as a whole or other events (e.g., labor disruptions) resulting in significantly reduced operations at DaimlerChrysler or Ford, or at certain of its manufacturing plants, could have a material adverse impact on the results of its manufacturing segment. In addition, in the industrial markets, risks include loss of market share by its major customers and continued price pressure from major customers. For the Company’s performance chemicals business, weakness in the pulp and paper, electronics or petroleum refining industries could have an adverse effect on its results of operations.

The Company may experience increased costs and production delays if suppliers fail to deliver materials to the Company or if prices increase for raw materials and other goods and services that it purchases from third parties.

          The Company purchases raw materials from a number of domestic and foreign suppliers. Although it believes that the raw materials it requires will be available in sufficient supply on a competitive basis for the foreseeable future, continued increases in the cost of raw materials, including energy and other inputs used to make the Company’s products, could affect future sales volumes, prices and margins for its products. If a supplier should cease to deliver goods or services to the Company, it would probably find other sources, however, such a disruption could result in added cost and manufacturing delays. In addition, political instability, war, terrorism and other disruptions to international transit routes control could adversely impact its ability to obtain key raw materials in a timely fashion, or at all.

The Company’s revenues are dependent on the continued operation of its manufacturing facilities, and breakdowns or other problems in its operations could adversely affect its results of operations.

          The Company’s revenues are dependent on the continued operation of its various manufacturing facilities. In particular, the operation of chemical manufacturing plants involves many risks, including the breakdown, failure or substandard performance of equipment, natural disasters, acts of terrorism, power outages, the need to comply with directives of government agencies, and dependence on the ability of railroads and other shippers to transport raw materials and finished products in a timely manner. The occurrence of material operational problems, including but not limited to the foregoing events, at one or more of the Company’s facilities could have a material adverse effect on its results of operations or financial condition. Certain facilities within each of its business segments account for a significant share of its profits. Disruption to operations at one of these facilities could have a material adverse impact on segment financial performance and its overall financial condition. In addition, in certain circumstances the Company could also be materially affected by a disruption or closure of a customer’s plant or facility to which it supplies its products.

A significant portion of the Company’s revenue and operating income from its manufacturing segment has been, and is expected to continue to be, concentrated in a small number of customers.

          The Company derives and is expected to continue to derive significant portions of its revenues and operating income in its manufacturing segment from sales of products to Ford and DaimlerChrysler. As a result, the loss of, or reduced demand from these customers could adversely effect the Company’s revenues and operating income.

-12-


Material changes in pension and other post-retirement benefit costs may occur in the future. In addition, investment returns on pension assets may be lower than assumed, which could result in larger cash funding requirements for the Company’s pension plans, which could have an adverse impact on it.

          The Company maintains several defined benefit pension plans covering certain employees in Canada and the United States. It records pension and post-retirement benefit costs in amounts developed from actuarial valuations. Inherent in these valuations are key assumptions including the discount rate and expected long-term rate of return on plan assets. Material changes in pension and other post-retirement benefit costs may occur in the future due to changes in these assumptions, differences between actual experience and the assumptions used, and changes in the benefit plans. Amounts required to be funded are also dependent upon interest rates. Due to current interest rates and investment returns, some of the plans are underfunded. The Company is required to rectify this underfunding in accordance with federal guidelines. The Company expects to be required to make substantial cash contributions beginning in 2008 and continuing beyond such time. Moreover, if investment returns on pension assets are lower than assumed, it may have substantially larger cash funding requirements for its pension plans, which may have a material adverse impact on its liquidity.

The Company’s principal businesses are subject to government regulation, including environmental regulation, and changes in current regulations may adversely affect it.

          The Company’s principal business activities are regulated and supervised by various governmental bodies. Changes in laws, regulations or governmental policy or the interpretations of those laws or regulations affecting its activities and those of its competitors could have a material adverse effect on it.

          For example, the Company’s various manufacturing operations, which have been conducted at a number of facilities for many years, are subject to numerous laws and regulations relating to the protection of human health and the environment in the U.S., Canada and other countries. The Company believes that it is in substantial compliance with such laws and regulations. However, as a result of its operations, from time to time it is involved in administrative and judicial proceedings and inquiries relating to environmental matters. Based on information available to it at this time with respect to potential liability involving these facilities, the Company believes that any such liability will not have a material adverse effect on its financial condition, cash flows or results of operations. However, modifications to existing laws and regulations or the adoption of new laws and regulations in the future, particularly with respect to environmental and safety standards, could require it to make expenditures which may be material or may otherwise adversely impact its operations.

The production of chemicals is associated with a variety of hazards, which could create significant liabilities or cause the Company’s facilities to suspend its operations.

          The Company’s operations are subject to various hazards incident to the production of chemicals, including the use, handling, processing, storage and transportation of certain hazardous materials. These hazards, which include the risk of explosions, fires and chemical spills or releases, can cause personal injury and loss of life, severe damage to and destruction of property and equipment, environmental damage, suspension of operations and potentially subject us to lawsuits relating to personal injury and property damages. Any such event or circumstance could have a material adverse effect on its results of operations or financial condition.

-13-


          The Company’s facilities have been operated for many years by it or prior owners and operators, and adverse environmental conditions of which it is not aware may exist. The discovery of additional or unknown environmental contamination at any of its current or former facilities could have a material adverse effect on its financial condition, cash flows and/or results of operations.

The seasonal nature of the water treatment and chemical processing businesses could increase the Company’s costs or have other negative effects.

          Within its performance chemicals segment, the water treatment and chemical processing businesses have higher volumes in the second and third quarters of the year, owing to higher spring and summer demand for sulfuric acid regeneration services from gasoline refinery customers to meet peak summer driving season demand and higher spring and summer demand from water treatment chemical customers to manage seasonally high and low water conditions. The degree of seasonal peaks and declines in the volumes of its business could increase its costs, negatively impact its manufacturing efficiency, or have other negative effects on its operations or financial performance.

The Company may not be able to obtain insurance at its historical rates and its insurance coverage may not cover all claims and losses.

          The Company maintains insurance coverage on its properties, machines, supplies and other elements integral to its business and against certain third party litigation, environmental matters and similar events. Due to recent changes in market conditions in the insurance industry and other factors, the Company may not be able to secure insurance at a similar cost to what it may have previously paid, if at all. In addition, there are certain types of losses, such as earthquakes, floods, hurricanes, terrorism, acts of war or product warranty, that may be uninsurable or not economically insurable. Inflation, changes in building codes and ordinances, environmental considerations, and other factors, including terrorism or acts of war, also may make insurance proceeds insufficient to repair or replace a property if it is damaged or destroyed.

The Company is dependent upon many critical systems and processes, many of which are dependent upon hardware that is concentrated in a limited number of locations. If a catastrophe were to occur at one or more of those locations, it could have a material adverse effect on its business.

          The business is dependent on certain critical systems, which support various aspects of its operations, from its computer network to its billing and customer service systems. The hardware supporting a large number of such systems is housed in a small number of locations. If one or more of these locations were to be subject to fire, natural disaster, terrorism, power loss, or other catastrophe, it could have a material adverse effect on its business. While the Company believes that it maintains reasonable disaster recovery programs, there can be no assurance that, despite these efforts, any disaster recovery, security and service continuity protection measures it may have or may take in the future will be sufficient.

          In addition, computer viruses, electronic break-ins or other similar disruptive technological problems could also adversely affect its operations. The Company’s insurance policies may not adequately compensate it for any losses that may occur due to any failures or interruptions in its computer systems.

The Company cannot predict the impact of any asset or business disposition.

-14-


          From time to time the Company considers dispositions of assets or businesses. The Company cannot predict the types of dispositions that may be undertaken in the future or the financial impact of such actions. For example, after-tax cash proceeds received in connection with any disposition would be dependent on levels of interest from potential purchasers and the tax and other structuring elements of such transaction. As a result, there can be no assurance as to the terms of any such disposition, the level of any disruption to the operations of the Company caused by such transaction, or the long-term effect of such transaction on the Company’s financial condition.

The Company has recently completed several acquisitions and may continue to pursue new acquisitions or joint ventures, and any such transaction could adversely affect operating results or result in increased costs or other operating or management problems. The Company remains subject to the ongoing risks of successfully integrating and managing the acquisitions and joint ventures that have been completed.

          The Company has recently completed several acquisitions. These transactions expose the Company to the risk of successfully integrating those acquisitions. Such integration could impact various areas of the Company’s business, including, but not limited to, its workforce, management, production facilities, information systems, accounting and financial reporting, and customer service. Disruption to any of these areas could materially harm the Company’s financial condition or results of operations.

          The Company may continue to pursue new acquisitions or joint ventures in the future, a pursuit which could consume substantial time and resources. The successful implementation of the Company’s operating strategy in current and future acquisitions and joint ventures may require substantial attention from its management team, which could divert management attention from existing businesses. The businesses acquired, or the joint ventures entered into, may not generate the cash flow and earnings, or yield the other benefits anticipated at the time of their acquisition or formation. The risks inherent in any such strategy could have an adverse impact on the Company’s results of operation or financial condition.

The Company may be unable to identify liabilities associated with the properties that may be acquired or obtain protection from sellers against them.

          The acquisition of properties requires assessment of a number of factors, including physical condition and potential environmental and other liabilities. Such assessments are inexact and inherently uncertain. The assessments made result from a due diligence review of the subject properties, but such a review will not reveal all existing or potential problems. The Company may not be able to obtain contractual indemnities from the seller for liabilities that it created or that were created by any predecessor of the seller. The Company may be required to assume the risk of the physical or environmental condition of the properties in addition to the risk that the properties may not perform in accordance with expectations.

Risks Related to The Company’s Common Stock

The market price of the Company’s common stock is subject to volatility.

          The market price of the Company’s common stock could be subject to wide fluctuations in response to numerous factors, many of which are beyond its control. These factors include, among other things, actual or anticipated variations in its operating results and cash flow, the nature and content of its earnings releases and its competitors’ earnings releases, announcements of technological innovations that impact its products, customers, competitors or markets, changes in financial estimates by securities analysts, business conditions in its markets and the general state of the securities markets and the market

-15-


for similar stocks, changes in capital markets that affect the perceived availability of capital to companies in its industries, governmental legislation or regulation, as well as general economic and market conditions, such as recessions.

         Sales of large amounts of the Company’s common stock, or the perception that large sales could occur, may cause volatility in its stock price. In connection with GenTek’s emergence from bankruptcy protection on November 10, 2003, the Company issued an aggregate of 10,000,000 shares of its common stock to former holders of its debt securities and other claimants. This relatively small float of shares available for purchase/sale may result in share price volatility in cases where an investor seeks, or is perceived to be seeking, to acquire or divest a large block of shares in the public market.

The exercise of the Company’s Tranche B and Tranche C warrants could create substantial dilution, or there may be other events which would have a dilutive effect on its common stock.

          The Company currently has options and warrants outstanding covering the purchase of approximately 3 million shares of common stock. If options or warrants to purchase the Company’s common stock are exercised, or other equity interests are granted under its management and directors incentive plan or under other plans adopted in the future, such equity interests will have a dilutive effect on its common stock. The Company cannot predict the effect any such dilution may have on the price of its common stock.

Item 1B. Unresolved Staff Comments.

          None

Item 2. Properties.

          The Company operates over 50 manufacturing and production facilities located primarily in the United States and Canada. The Company’s headquarters are located in Parsippany, New Jersey.

          Set forth below are the locations and uses of the Company’s major properties:

 

 

 

 

 

Location

 

Use

 


 


 

 

 

 

 

Manufacturing Segment

 

 

 

Tallahassee, Florida

 

Production Facility

 

Troy, Michigan(1)

 

Production Facility and Offices

 

Westland, Michigan(1)

 

Production Facility, R&D Center and Offices

 

Weaverville, North Carolina(2)

 

Production Facility and Offices

 

Toledo, Ohio

 

Production Facility

 

Defiance, Ohio(2)

 

Production Facility

 

Perrysburg, Ohio(2)

 

Production Facility

 

Mineral Wells, Texas

 

Production Facility and Offices

 

Curitiba, Brazil

 

Production Facility

 

 

 

 

 

Performance Chemicals Segment

 

 

 

Hollister, California(2)

 

Production Facility and Offices

 

Pittsburg, California(2)

 

Production Facility

 

Richmond, California(2)

 

Production Facility

 

Augusta, Georgia

 

Production Facility

-16-


 

 

 

 

 

East St. Louis, Illinois

 

Production Facility

 

Berkeley Heights, New Jersey(2)

 

Production Facility, Offices and Warehouse

 

Solvay, New York

 

Production Facility

 

Celina, Texas

 

Production Facility

 

Midlothian, Texas

 

Production Facility

 

Anacortes, Washington

 

Production Facility

 

Thorold, Ontario

 

Production Facility

 

Valleyfield, Quebec

 

Production Facility

 

 

 

 

 

Offices

 

 

 

Parsippany, New Jersey(1)

 

Headquarters


 

 


(1)

Leased.

 

 

(2)

Mortgaged as security under the Company’s debt facilities.

Item 3. Legal Proceedings.

          The Company is involved in claims, litigation, administrative proceedings and investigations of various types, including the Richmond litigation discussed below, and certain environmental proceedings previously discussed. See “Item 1. Business - Environmental Matters” above. Although the amount of any liability that could arise with respect to these actions cannot be accurately predicted, the opinion of management based upon currently-available information is that any such liability not covered by insurance will have no material adverse effect on the Company’s results of operations, cash flows or financial condition.

          Richmond Litigation. Prior to October 2002, lawyers claiming to represent more than 47,000 persons filed approximately 24 lawsuits in several counties in California state court (Alameda, Contra Costa, San Francisco superior courts), making claims against General Chemical Corporation and, in some cases, a third party arising out of May 1, 2001 and/or November 29, 2001 releases of sulfur dioxide and/or sulfur trioxide from the Company’s Richmond, California sulfuric acid facility.

          The first case was filed in 2001 and subsequent cases were filed from March through July 2002. On May 1, 2002, a class action lawsuit arising out of the same facts was also filed. The lawsuits claim various damages for alleged injuries, including, without limitation, claims for personal injury, emotional distress, medical monitoring, nuisance, loss of consortium and punitive damages. The Company filed a petition for coordination to consolidate the state court cases before a single judge. The petition for coordination was granted and follow-on petitions to add additional cases to the coordinated proceedings were also granted. The state court cases were stayed as a result of the Company’s bankruptcy filing. Approximately 73,000 proofs of claim were submitted in the bankruptcy proceedings on behalf of the Richmond claimants, seeking damages for the May 1, 2001 and/or November 29, 2001 releases. A preliminary review of the claimant list indicated that the claimants included most of the plaintiffs in the state court cases, plus several thousand duplicates and some additional claimants. In addition, one class proof of claim was submitted. A motion for class certification was filed but the motion was later withdrawn subject to being re-filed in state court. The Company filed a motion to lift the automatic stay and discharge injunction to allow liquidation of the claims to proceed in California State Court. That motion was granted upon stipulation of the parties, and the action is proceeding in California State Court.

          On April 20, 2005 an order was entered substantially granting the Company’s motion to dismiss approximately 36,000 of the original 73,000 proofs of claim. As a result of further stipulations and orders

-17-


dismissing an additional 6,000 proofs of claim, there were approximately 30,000 claims remaining at the time that the litigation was stayed for settlement purposes (see below). There were approximately an additional 6,000 claims as to which further dismissal motions were contemplated at the time the stay went into effect. In addition to the claims against the Company and others seeking damages allegedly arising from chemical releases from the Company’s Richmond facility in 2001, certain Richmond claimants also commenced a class action in California State Court against third parties that the Richmond claimants alleged to have received fraudulent transfers of the Company’s assets or aided in such transfers. The Company believed that the fraudulent transfer claims and causes of action asserted in the state law complaint were foreclosed by the Company’s plan of reorganization and certain bankruptcy court orders, including the order confirming the plan of reorganization. Accordingly, the Company filed a motion with the bankruptcy court, which was heard May 18, 2005, seeking to enforce the plan of reorganization and bankruptcy court orders to preclude the continued prosecution of the asserted fraudulent transfer claims. That motion was granted in significant part in August 2005. On December 16, 2005, the California State Court granted preliminary approval to the proposed class action settlement agreement totaling $6,250,000 and resolving all claims asserted in the litigation and granted final approval of the settlement agreement on May 25, 2006. On October 26, 2006, in accordance with the terms and conditions of the finally approved settlement agreement, the Court entered an Order of Dismissal with prejudice dismissing the entire action. The portion of the settlement that will be the Company’s responsibility has been fully accrued for.

Item 4. Submission of Matters to a Vote of Security Holders.

          No items were submitted to a vote of security holders of the Company, through the solicitation of proxies or otherwise, during the fourth quarter of fiscal 2006.

-18-


PART II

Item 5. Market for Registrant’s Common Equity and Related Stockholder Matters.

Market Information

          The common stock is quoted on the NASDAQ National Market under the symbol “GETI”. The following table sets forth, for the period indicated, the high and low sale prices in dollars as quoted on the NASDAQ National Market for its common stock.

 

 

 

 

 

 

 

 

 

 

High

 

Low

 

 

 


 


 

2005

 

 

 

 

 

 

 

First Quarter

 

$

51.44

 

$

15.30

 

Second Quarter

 

$

16.50

 

$

9.51

 

Third Quarter

 

$

15.60

 

$

9.63

 

Fourth Quarter

 

$

18.43

 

$

12.05

 

 

 

 

 

 

 

 

 

2006

 

 

 

 

 

 

 

First Quarter

 

$

20.96

 

$

17.77

 

Second Quarter

 

$

29.04

 

$

22.60

 

Third Quarter

 

$

30.47

 

$

26.57

 

Fourth Quarter

 

$

36.15

 

$

27.46

 

          As of March 13, 2007, there were 2,953 stockholders of record of the Company’s common stock.

Dividends

          The Company paid a special dividend of $31.00 per share on March 16, 2005. The Company currently intends to retain its earnings for use in the operation and expansion of its business and for debt service and, therefore, it does not anticipate paying regular cash dividends in the foreseeable future. Additionally, the Company’s credit facilities directly limit the ability of the Company to pay cash dividends.

-19-


Equity Compensation Plan Information

          The following table gives information about its existing Common Stock that may be issued upon the exercise of options, warrants and rights under its 2003 Management and Directors Incentive Plan as of December 31, 2006.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity Compensation Plan Information

 





Plan Category

 

Number of Securities
to be issued upon
exercise of outstanding
options, warrants and
rights

(a)

 

Weighted average
exercise price of
outstanding options,
warrants and rights

(b)

 

Number of Securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a))

(c)

 









Equity compensation plans approved by security holders

 

 

0

 

 

 

N/A

 

 

 

0

 

 















Equity compensation plans not approved by security holders

 

 

366,848

 

 

$

15.28

 

 

 

283,960

(1)

 















Total

 

 

366,848

 

 

$

15.28

 

 

 

283,960

 

 
















 

 

(1)

Available for issuance under the 2003 Management and Directors Incentive Plan. This plan was approved by the bankruptcy court and became effective on November 10, 2003 concurrent with the effective date of the plan of reorganization.

2003 Management and Directors Incentive Plan

          Pursuant to the Company’s 2003 Management and Directors Incentive Plan, employees and directors of the Company and its subsidiaries may be granted stock options, restricted stock, stock appreciation rights, performance share awards, dividend equivalent rights or any other stock-based awards. The compensation committee of the Board has the authority to select participants and determine grants of awards. The maximum number of shares with respect to which any awards may be granted during a calendar year to any participant is 100,000. Upon a “change in control” of the Company, unless otherwise determined by the compensation committee, each outstanding award shall automatically become fully exercisable. The Board may, at any time, amend or discontinue the plan and the compensation committee may, at any time, amend or cancel any outstanding award or provide substitute awards in accordance with the plan, provided that such action does not adversely affect the participant. The term of the Plan is 10 years.

Performance Graph

          In accordance with the rules of the SEC, this section entitled “Performance Graph” shall not be incorporated by reference into any of our future filings under the Securities Act or the Exchange Act, and shall not be deemed to be soliciting material or to be filed under the Securities Act or the Exchange Act.

-20-


The following graph illustrates the cumulative total stockholder return that would have been realized (assuming reinvestment of dividends) by an investor who invested $100 on November 11, 2003 (the first trading day of the Company’s Common Stock following the Effective Date) in each of: (i) GenTek Inc. Common Stock, (ii) the Russell 2000 Index, (iii) the Standard & Poor’s MidCap Auto Components Index, and (iv) the Standard & Poor’s SmallCap Chemicals Index.

GenTek Indexed Performance

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11/11/2003

 

12/31/2003

 

12/31/2004

 

12/31/2005

 

12/31/2006

 

 

 


 


 


 


 


 

GenTek (GETI)

 

100.00

 

 

99.72

 

 

147.02

 

 

159.94

 

 

309.41

 

 

Russell 2000 Index

 

100.00

 

 

105.57

 

 

125.03

 

 

130.81

 

 

154.94

 

 

S&P MidCap Auto Components Index

 

100.00

 

 

111.27

 

 

112.82

 

 

95.30

 

 

92.47

 

 

S&P SmallCap Chemicals Index

 

100.00

 

 

114.69

 

 

138.00

 

 

108.48

 

 

132.10

 

 

-21-


Item 6. Selected Financial Data.

          The following selected consolidated financial data of the Company have been derived from and should be read in conjunction with the Company’s Consolidated Financial Statements. In connection with its emergence from bankruptcy on November 10, 2003, the Company has adopted fresh-start reporting in accordance with Statement of Position 90-7, Financial Reporting by Entities in Reorganization Under the Bankruptcy Code. Accordingly, the Company’s post-emergence financial statements (“Successor”) will not be comparable with its pre-emergence financial statements (“Predecessor”).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Successor

 

Predecessor

 

 

 


 


 

 

 

Years Ended December 31,

 

Period Ended

 

Period Ended

 

Year Ended

 

 

 


 

December 31,

 

November 10,

 

December 31,

 

 

 

2006

 

2005

 

2004

 

2003

 

2003

 

2002

 

 

 


 


 


 


 


 


 

 

 

(In thousands, except per share data)

 

 

 

 

 

Statement of Operations Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

611,368

 

$

556,497

 

$

531,123

 

$

65,310

 

$

475,693

 

$

664,608

 

Restructuring and impairment charges

 

 

2,974

 

 

6,989

 

 

8,934

 

 

293

 

 

24,597

 

 

 

Operating profit (loss)

 

 

53,709

 

 

39,231

 

 

32,058

 

 

3,395

 

 

11,494

 

 

45,937

 

Interest expense

 

 

29,137

 

 

24,736

 

 

7,938

 

 

2,430

 

 

865

 

 

52,364

 

Income (loss) from continuing operations(1)(2)

 

 

15,449

 

 

9,123

 

 

16,097

 

 

1,564

 

 

441,607

 

 

(106,019

)

Income (loss) from discontinued operations

 

 

(17,552

)

 

(9,945

)

 

179,221

 

 

(472

)

 

52,785

 

 

(93,505

)

Net income (loss)(1)(2)

 

$

(2,103

)

$

(822

)

$

195,318

 

$

1,092

 

$

494,392

 

$

(360,649

)(3)

 

Per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from continuing operations—
basic(1)(2)

 

$

1.52

 

$

0.91

 

$

1.61

 

$

0.16

 

$

17.27

 

$

(4.15

)

Income (loss) from continuing operations— diluted(1)(2)

 

 

1.41

 

 

0.90

 

 

1.61

 

 

0.16

 

 

17.27

 

 

(4.15

)

Income (loss) from discontinued operations— basic

 

 

(1.73

)

 

(0.99

)

 

17.92

 

 

(0.05

)

 

2.06

 

 

(3.66

)

Income (loss) from discontinued operations— diluted

 

 

(1.60

)

 

(0.98

)

 

17.87

 

 

(0.05

)

 

2.06

 

 

(3.66

)

Net income (loss)—basic(1)(2)

 

 

(0.21

)

 

(0.08

)

 

19.53

 

 

0.11

 

 

19.34

 

 

(14.13

)(3)

Net income (loss)—diluted(1)(2)

 

 

(0.19

)

 

(0.08

)

 

19.48

 

 

0.11

 

 

19.34

 

 

(14.13

)(3)

Dividends(4)

 

 

 

 

31.00

 

 

7.00

 

 

 

 

 

 

 

 

Balance Sheet Data (at end of period):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

730,206

 

$

761,075

 

$

755,519

 

$

1,067,534

 

 

 

 

$

959,391

 

Long-term debt (including current portion)

 

 

345,299

 

 

360,269

 

 

11,793

 

 

251,188

 

 

 

 

 

922,683

 

 

Total equity (deficit)

 

 

95,933

 

 

85,375

 

 

400,427

 

 

278,787

 

 

 

 

 

(510,321

)


 

 

(1)

Includes a decrease to the deferred tax asset valuation allowance of $98.5 million ($3.85 per share) in 2003, and an increase to the deferred tax asset valuation allowance of $97.7 million ($3.83 per share) in 2002 to record a valuation allowance for the Company’s net domestic deferred tax assets.

 

 

(2)

Includes reorganization items of $397.0 million ($15.53 per share) of income for the period ended November 10, 2003 and $11.7 million ($0.46 per share) of expense in 2002.

 

 

(3)

Includes the cumulative effect of a change in accounting principle of $161.1 million ($6.31 per share).

 

 

(4)

During 2005 and 2004, the Company paid special dividends of $31.00 and $7.00 per share, respectively.

-22-


Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

          The following section should be read in conjunction with the consolidated financial statements and the notes indicated elsewhere in this Annual Report. This Annual Report on Form 10-K includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements, other than statements of historical facts, included in this Annual Report may constitute forward-looking statements. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “may,” “will,” “should,” “potential,” “intend,” “expect,” “endeavor,” “seek,” “anticipate,” “estimate,” “overestimate,” “underestimate,” “believe,” “could,” “project,” “predict,” “continue” or other similar words or expressions. The Company has based these forward-looking statements on its current expectations and projections about future events. Although the Company believes that its assumptions made in connection with the forward-looking statements are reasonable, there can be no assurances that these assumptions and expectations will prove to have been correct. Important factors that could cause actual results to differ from these expectations are disclosed in this Annual Report and include various risks, uncertainties and assumptions. Such factors include, but are not limited to, those set forth in the section of this annual report captioned “Business – Risk Factors”.

          The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this Annual Report might not occur.

Acquisitions

          On September 21, 2006, the Company acquired the assets of GAC MidAmerica, Inc. The acquisition included manufacturing facilities in Toledo, Ohio, Indianapolis, Indiana, and Saukville, Wisconsin. GAC produces aluminum sulfate and bleach, as well as distributing specialty water treatment chemicals, sulfuric acid and caustic soda. The purchase price of the transaction was $8 million.

          On July 31, 2006, the Company acquired the assets of Precision Engine Products Corp., a wholly owned subsidiary of Stanadyne Corporation. Precision Engine Products is dedicated principally to the manufacturing of hydraulic lash adjusters and die cast aluminum rocker arm assemblies utilized in valve train systems for both OEM and after market applications to the global automotive and light truck markets. Precision Engine Products has manufacturing facilities in Tallahassee, Florida and Curitiba, Brazil. The purchase price of the transaction was $26 million in cash, plus the potential of an earn out for Stanadyne of up to $10 million, payable, if at all, based on certain performance metrics being achieved during the twelve months following the closing date.

          On July 27, 2006, the Company acquired the assets of Repauno Products, LLC. The acquisition included the manufacturing facility in Gibbstown, New Jersey. Repauno Products manufactures sodium nitrite which is used in a wide range of industries including metal finishing, heat transfer salts, rubber processing, meat curing, odor control and inks and dyes. The purchase price of the transaction was $6 million.

Discontinued Operations

          On February 16, 2007, the Company completed the sale of its Noma wire and cable harness assembly business. The net proceeds from the transaction were used to repay outstanding debt. During April 2006, the Company completed the sale of its cable and wire manufacturing business

-23-


in Stouffville, Canada. Proceeds from the transaction were used to repay $22 million of the Company’s second lien term loan. Accordingly, these businesses have been classified as discontinued operations.

          During the second quarter of 2005, the Company ceased operations of its printing plate business. The business had become unprofitable as it has experienced severe competitive pressures over the last several years and has been hurt by a continued shift in technology in the printing plate market. Accordingly, all financial information included herein has been reclassified to reflect the business as discontinued operations.

          On May 18, 2004, the Company sold its KRONE communications business to ADC Telecommunications, Inc. (ADC). Accordingly, all financial information included herein has been reclassified to reflect the KRONE communications business as discontinued operations. Net proceeds from the transaction of approximately $291 million were used to repay the Company’s then-outstanding Senior Term Loan Agreement in full, and the related loan agreement was terminated. Consummation of this transaction triggered the contingent redemption feature of the Company’s tranche A warrants. The Company made the required payment of $8.4 million ($7.13 per warrant) on June 30, 2004, and the tranche A warrants expired.

Overview

          The Company is a holding company whose subsidiaries manufacture industrial components and performance chemicals. It operates through two primary business segments: manufacturing and performance chemicals. Its products are frequently highly engineered and are important components of, or provide critical attributes to, its customers’ end products or operations. The Company operates over 50 manufacturing and production facilities located primarily in the U.S. and Canada. GenTek has no independent operations and, therefore, is dependent upon cash flow from its subsidiaries to meet its obligations.

Manufacturing

          The manufacturing segment provides a broad range of engineered components and services to two principal markets: automotive and industrial. Over the last several years the Company’s automotive sales and operating profits have been adversely impacted by industry conditions affecting its major customers’ operations. Volume reductions and pricing pressure by auto manufacturers and Tier 1 suppliers has resulted in lower volumes and selling prices. Sales to the automotive market, which accounted for approximately 74 percent of the manufacturing segment’s revenue in 2006, declined approximately 2 percent during the past year, due in large part to industry issues discussed above. The Company expects that revenues from the full year impact of the Precison Engine Products acquisition will more than offset weakness in the Company’s historic North American customer base in 2007. In response to competitive pressures from offshore suppliers in the automotive markets, the manufacturing segment has taken aggressive action to improve its cost position. The Company has closed certain facilities, reduced headcount and other operating expenses, and outsourced production of certain less complex components to lower cost, third party manufacturers in Asia. Sales to the industrial market, which accounted for approximately 26 percent of the manufacturing segment’s revenues in 2006, have increased from 22 percent last year principally due to the impact of the pass through of higher raw material prices for copper.

          Due to the Company’s dependence on the North American automotive market, production levels of the automotive OEMs influence the manufacturing segment’s sales and profitability. The North

-24-


American automobile and light truck “build rate” is one commonly used indicator of such production levels. More specifically, though, the production levels of the individual engine programs that it supplies impact its sales and profitability in the automotive market. The Company’s revenues in this market are also influenced, to a lesser degree, by the North American “class 8” heavy duty diesel truck build rate.

          Profitability in the Company’s manufacturing segment can be influenced by a number of factors, including: production levels at its individual manufacturing facilities, as well as the volume and consistency of production levels at its customers’ manufacturing facilities; demands from its customers to reduce the prices of its products; the prices it pays for key raw materials and transportation costs.

Performance Chemicals

          The performance chemicals segment provides a broad range of value-added chemical products and services to four principal markets: water treatment, chemical processing, pharmaceutical and personal care, and technology. Sales to the water treatment and chemical processing markets, which account for approximately 65 percent of the performance chemicals segment’s revenues, have increased approximately 14 percent over the last year. This increase is principally due to price increases as well as the impact of the acquisitions of GAC and Repauno. The Company anticipates that sales to the water treatment market will grow in 2007 primarily due to the full year impact of the acquisitions. Sales to the pharmaceutical and personal care market, which account for approximately 20 percent of the performance chemicals segment’s revenue, increased by approximately 8 percent over the last year primarily due to price increases. The Company anticipates sales to this market in the year 2007 will be flat year over year. Sales to the technology market, which account for approximately 15 percent of the performance chemicals segment’s revenues, have increased 12 percent over the last year. The Company anticipates that sales into this market will be flat year over year. Operating efficiency and price improvement offsetting raw material and other cost increases are expected to maintain the performance chemicals segment’s profitability in 2007.

          In the chemical processing market, its revenues are derived principally from the sale of sulfuric acid regeneration services to large oil refineries on the West Coast of the United States and from the sale of sulfuric acid which is used in the manufacture of synthetic fibers, paper, fertilizers as well as many other products. In the water treatment chemicals market its revenues are derived from the sale of water treatment chemicals to large municipal treatment facilities and pulp and paper operations. In the pharmaceutical and personal care market, GenTek’s revenues and profitability are driven by sales of active ingredients to manufacturers of antiperspirants, with such manufacturers’ production levels influenced by antiperspirant market share trends and new product introductions. The Company’s sales in the technology market are influenced by North American production levels of semiconductor devices.

          Profitability in its performance chemicals segment can be influenced by a number of factors, including: competitive market conditions; production levels at its individual manufacturing facilities; energy costs, including the prices of natural gas and electricity; the prices it pays for its key raw materials, including sulfur, bauxite, aluminum tri-hydrate and zirconium-based products; and transportation costs.

Results of Operations

          The following table sets forth certain line items from its Consolidated Statements of Operations for the three years ended December 31, 2006 and the corresponding percentage of net revenues for the relevant periods presented as a percentage of revenue for the periods indicated.

-25-


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 


 

 

 

2006

 

2005

 

2004

 

 

 


 


 


 

 

 

(In millions)

 

Net revenues

 

$

611.4

 

 

100

%

$

556.5

 

 

100

%

$

531.1

 

 

100

%

Cost of sales

 

 

503.8

 

 

82

 

 

452.8

 

 

81

 

 

438.8

 

 

83

 

Selling, general and administrative expense

 

 

51.5

 

 

8

 

 

56.8

 

 

10

 

 

64.8

 

 

12

 

Restructuring and impairment charges

 

 

3.0

 

 

 

 

7.0

 

 

1

 

 

8.9

 

 

2

 

Pension curtailment and settlement (gains) losses

 

 

(0.6

)

 

 

 

0.6

 

 

 

 

(13.4

)

 

(3

)

 

 



 



 



 



 



 



 

Operating profit

 

 

53.7

 

 

9

 

 

39.2

 

 

7

 

 

32.1

 

 

6

 

Interest expense

 

 

29.1

 

 

5

 

 

24.7

 

 

4

 

 

7.9

 

 

1

 

Interest income

 

 

0.6

 

 

 

 

0.6

 

 

 

 

0.6

 

 

 

Other (income) expense, net

 

 

0.3

 

 

 

 

(2.3

)

 

 

 

(3.1

)

 

(1

)

Income tax provision (benefit)

 

 

9.4

 

 

2

 

 

8.2

 

 

1

 

 

11.8

 

 

2

 

 

 



 



 



 



 



 



 

Income from continuing operations

 

$

15.4

 

 

2

%

$

9.1

 

 

2

%

$

16.1

 

 

3

%

 

 



 



 



 



 



 



 

2006 Compared with 2005

          Net revenues were $611 million for the year 2006 compared with $557 million for the prior year. This increase was due to higher sales of $39 million in the performance chemicals segment and $16 million in the manufacturing segment. The increase in the performance chemicals segment is due to broad based strength across all market segments as well as the impact of the acquisitions of GAC and Repauno. The increase in the manufacturing segment is primarily the result of higher sales revenues in the industrial market. Reduced sales in the automotive base business were offset by the favorable impact of the acquisition of Precision Engine Products.

          Gross profit was $108 million for the year 2006 as compared with $104 million for 2005. This reflects higher gross profit in performance chemicals and lower gross profit in manufacturing of $10 million and $6 million, respectively. The increase in the performance chemicals segment gross profit was driven primarily by the strong revenue performance. The decrease in gross profit in the manufacturing segment is principally due to reduced volumes and unfavorable product mix in the automotive market.

          Selling, general and administrative expense was $52 million for the year ended December 31, 2006 as compared with $57 million in the prior year. This reduction is primarily attributable to the Company’s cost reduction efforts. In addition, 2005 was adversely impacted by a $2 million charge relating to the former Chief Executive Officer’s separation from the Company.

          Restructuring and impairment charges were $3 million for the year ended December 31, 2006 as compared with charges of $7 million for the prior year ended December 31, 2005. During 2006, impairment charges of $1 million were recorded relating to machinery and equipment for a discontinued product line. Restructuring charges recorded in 2006 included $1 million associated with the closure of two production facilities and $1 million for continuing costs from activities initiated during prior years. The Company expects that the reduction in costs from the current year restructuring actions will be approximately offset by the resulting reductions in revenues. Revenues from the affected products were approximately $6 million in 2006, and were discontinued in December, 2006. The Company expects to substantially complete implementation of the current year restructuring actions during 2007. Restructuring actions initiated in prior years have been substantially completed. The Company will continue to review its operations, and may record additional restructuring charges to tailor its cost

-26-


structure to current economic conditions.

          During 2006, the Company adopted plan amendments that froze pension plan benefit accruals for hourly employees covered by certain collective bargaining agreements, and announced the closure of one of its manufacturing facilities. These actions resulted in a net curtailment gain of $0.6 million. During 2005, the Company terminated its two defined benefit pension plans relating to former employees of the Company’s personal care chemicals manufacturing operations in Ireland, which were closed in 2004. As a result of this action, a settlement loss of $0.6 million was recorded.

          Operating profit was $54 million for the year 2006 as compared with $39 million for the prior year. The higher operating profit is the result of higher gross margin and lower selling, general and administrative expense plus the reduction in restructuring costs as compared with 2005.

          Interest expense was $29 million for the year 2006 as compared to $25 million for the prior year. The increase in interest expense is the result of higher average principal balances and higher interest rates during 2006 as compared to the prior year.

          Income tax expense for the year 2006 was $9 million as compared to $8 million for the year 2005. In both years, the effective tax rate was negatively affected by the impact of the Company’s foreign operations. During 2006, this impact was partially offset by a one-time benefit related to the payment of dividends on restricted stock.

          Loss from discontinued operations was $18 million versus $10 million in 2005. Included in loss from discontinued operations in 2006 are impairment charges of $2 million related to the Canadian wire and cable business and $12 million related to the Noma wire and cable harness assembly business. Included in loss from discontinued operations in 2005 is an impairment charge of $7 million relating to the Canadian wire and cable business.

2005 Compared with 2004

          Net revenues were $556 million for the year 2005 compared with $531 million for the prior year. This increase was due to higher sales of $18 million in the performance chemicals segment and $7 million in the manufacturing segment. The increase in the performance chemicals segment is due to increased sales across the water treatment, chemical processing and the company’s pharmaceutical and personal care product lines partially offset by lost revenues attributable to closed facilities. The increase in the manufacturing segment is the result of higher sales to the industrial market partially offset by a decrease in sales in the automotive market. The increase in revenues in the industrial market is primarily due to strong volumes in the industrial wire market compounded by the impact of the pass through of higher raw material prices for copper. The decrease in sales in the automotive market is due to lower sales volumes to the Company’s North American automotive customer base.

          Gross profit was $104 million for the year 2005 as compared with $92 million for 2004. This reflects higher gross profit in performance chemicals and manufacturing of $11 million and $1 million, respectively. The increase in the performance chemicals segment gross profit includes an insurance recovery related to the Company’s closed Delaware Valley Works South Plant, the increased volumes discussed above, as well as plant cost savings net of lost revenue due to the closure of the North Plant of the Delaware Valley Works in January 2005. The increase in gross profit in the manufacturing segment is principally due to the performance of the industrial wire business.

-27-


          Selling, general and administrative expense was $57 million for the year ended December 31, 2005 as compared with $65 million in the prior year. This reduction is primarily attributable to the Company’s cost reduction efforts and lower pension and other postretirement benefits expense, partially offset by a $2 million charge relating to the former Chief Executive Officer’s separation from the Company.

          Restructuring and impairment charges were $7 million for the year ended December 31, 2005 as compared with charges of $9 million for the prior year ended December 31, 2004. During 2005, impairment charges of $2 million were recorded relating to closed facilities. Restructuring charges recorded in 2005 included $3 million associated with the closure of three production facilities and headcount reductions and $2 million for continuing costs from activities initiated during prior years. The charges recorded in the prior year were associated with the closure of four production facilities.

           During 2005, the Company terminated its two defined benefit pension plans relating to former employees of the Company’s personal care chemicals manufacturing operations in Ireland, which were closed in 2004. As a result of this action, a settlement loss of $0.6 million was recorded. During 2004, the Company notified its employees that benefit accruals in defined benefit pension plans covering domestic salaried and certain hourly employees would be frozen effective April 1, 2004. As a result, a curtailment gain of approximately $13 million was recognized in 2004.

           Operating profit was $39 million for the year 2005 as compared with $32 million for the prior year. The improvement in operating profit in 2005 reflects higher gross margin and lower selling, general and administrative expense in 2005 partly offset by a pension curtailment gain in 2004.

          Interest expense was $25 million for the year 2005 as compared to $8 million for the prior year. Interest expense for the year 2005 consisted principally of interest expense on the Company’s new credit facilities and a charge of $3 million to write-off deferred financing costs as a result of the recapitalization.

          Income tax expense for the year 2005 was $8 million as compared to $12 million for the year 2004. The principal reason that income tax expense was significantly higher than the US federal statutory rate was due to the impact of the Company’s foreign operations and state and local taxes.

          Loss from discontinued operations was $10 million in 2005 as compared with income from discontinued operations of $179 million in 2004. Included in loss from discontinued operations in 2005 is an impairment charge of $7 million relating to the Canadian wire and cable business. Included in income from discontinued operations in 2004 is a gain on the sale of the KRONE communications business of $185 million.

Results of Operations by Segment

2006 Compared with 2005

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 

 

 


 

 

 

 

 

2006

 

2005

 

Change

 

 

 


 


 


 

 

 

(In millions)

 

 

 

 

 

Net Revenues:

 

 

 

 

 

 

 

 

 

 

Manufacturing

 

$

238.0

 

$

222.4

 

$

15.6

 

Performance chemicals

 

 

373.4

 

 

334.1

 

 

39.3

 

 

 



 



 



 

Total

 

$

611.4

 

$

556.5

 

$

54.9

 

 

 



 



 



 

-28-


 

 

 

 

 

 

 

 

 

 

 

Operating Profit (Loss):

 

 

 

 

 

 

 

 

 

 

Manufacturing

 

$

15.1

 

$

20.7

 

$

(5.6

)

Performance chemicals

 

 

44.7

 

 

29.3

 

 

15.4

 

Corporate

 

 

(6.1

)

 

(10.8

)

 

4.7

 

 

 



 



 



 

Total

 

$

53.7

 

$

39.2

 

$

14.5

 

 

 



 



 



 

Manufacturing Segment

          Net revenues for the manufacturing segment were $238 million for the year 2006 as compared to $222 million for 2005. This increase is the result of higher sales in the both the industrial and automotive markets of $13 million and $3 million, respectively. The increase in the revenues in the industrial market is primarily due to the impact of the pass through of higher raw material prices for copper. The increase in sales in the automotive market is due to lower sales volumes to the Company’s existing North American automotive customer base of $17 million which were more than offset by revenue resulting from the acquisition of Precision Engine Products of $20 million. Gross profit was $37 million for the year 2006 as compared to $42 million for 2005. This decrease is principally due to reduced volumes and unfavorable product mix in the automotive market. Selling, general and administrative expense was $19 million for 2006 which was flat with 2005. Restructuring and impairment charges were $2 million for 2006 and $3 million for 2005. Operating profit for 2006 was $15 million as compared with $21 million for 2005. This decrease is the result of the above-mentioned lower gross profit and the slightly higher restructuring charges.

Performance Chemicals Segment

          Net revenues were $373 million for the year 2006 as compared with $334 million for the comparable prior year period. This was due to higher sales in the Company’s water treatment, chemical processing, technology, and pharmaceutical and personal care product lines of $22 million, $6 million, $5 million, and $5 million, respectively. The increase in sales was due to increased pricing of $24 million which was primarily the result of the pass through of higher raw material costs, increased volumes in the sulfur products and technology markets of $8 million as well $7 million attributable to the acquisition of the assets of Repauno and GAC during 2006. Gross profit was $71 million as compared with $61 million for the prior year. The increase in gross profit is primarily attributable to the increase in revenues. Reduced environmental remediation costs of $3 million vs. the prior period were offset by an insurance recovery of $3 million in 2005 related to the Company’s closed Delaware Valley Works South Plant. Selling, general and administrative expense was $26 million for the year 2006 as compared with $29 million for 2005. This decrease was primarily due to cost reduction efforts. There were no net restructuring and pension curtailment charges in 2006 as compared with $3 million of charges recorded during 2005. Operating profit for 2006 was $45 million as compared with $29 million for 2004. The increase is principally due to the increased gross profit, lower selling, general and administrative expense and increased operating efficiencies.

2005 Compared with 2004

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 

 

 

 


 

 

 

 

 

 

2005

 

2004

 

Change

 

 

 


 


 


 

 

 

(In millions)

 

 

 

 

 

Net Revenues:

 

 

 

 

 

 

 

 

 

 

Manufacturing

 

$

222.4

 

$

214.5

 

$

7.9

 

-29-


 

 

 

 

 

 

 

 

 

 

 

Performance chemicals

 

 

334.1

 

 

316.6

 

 

17.5

 

 

 



 



 



 

Total

 

$

556.5

 

$

531.1

 

$

25.4

 

 

 



 



 



 

Operating Profit (Loss):

 

 

 

 

 

 

 

 

 

 

Manufacturing

 

$

20.7

 

$

22.2

 

$

(1.5

)

Performance chemicals

 

 

29.3

 

 

21.3

 

 

8.0

 

Corporate

 

 

(10.8

)

 

(11.4

)

 

0.6

 

 

 



 



 



 

Total

 

$

39.2

 

$

32.1

 

$

7.1

 

 

 



 



 



 

Manufacturing Segment

          Net revenues for the manufacturing segment were $222 million for the year 2005 as compared to $215 million for 2004. This increase is primarily the result of higher sales to the industrial markets of $8 million partly offset by lower sales to the automotive markets of $1 million. The increase in revenues in the industrial market is primarily due to strong wire sales volumes compounded by the impact of the pass through of higher raw material prices for copper. The decrease in sales in the automotive market is due to lower sales to the Company’s North American automotive testing customer base. Gross profit was $42 million for the year 2005 which was flat with 2004. Selling, general and administrative expense was $19 million for 2005 as compared with $22 million for 2004. This decrease was principally due to cost reduction programs, and lower sales commissions. Restructuring and impairment charges were $3 million for 2005, there were no restructuring charges for 2004. Operating profit for 2005 was $21 million as compared with $22 million for 2004, primarily as a result of the restructuring charges incurred in 2005, partially offset by the reduction in selling, general and administrative spending.

Performance Chemicals Segment

           Net revenues were $334 million for the year 2005 as compared with $317 million for the prior year. This increase was principally the result of higher sales in the Company’s water treatment, chemical processing and pharmaceutical personal care product line of $19 million, $4 million and $7 million, respectively, partially offset by lost revenues of $11 million attributable to closed facilities. The increase was primarily the result of the pass through of higher raw material prices and freight costs as well as higher volumes in the environmental and personal care product lines. Gross profit for 2005 was $61 million as compared to $50 million for the prior year. The increase was principally the result of the increased volumes and the pass through of previously incurred raw material price increases discussed above, an insurance recovery of $3 million related to the Company’s closed Delaware Valley Works South Plant, and plant cost savings net of lost revenue of $2 million due to the closure of the North Plant of the Delaware Valley Works in January 2005. Selling, general and administrative expense was $29 million for the year 2005 as compared with $31 million for 2004. The decrease was principally due to lower pension expense and lower salaries and other cost reductions. Restructuring and impairment charges were $3 million for the year 2005 as compared with a $9 million charge recorded during 2004. Operating income for 2005 was $29 million as compared with $21 million for 2004. The increase is principally due to the increased gross profit, lower selling, general and administrative expense and increased operating efficiencies.

Liquidity and Capital Resources

          Cash and cash equivalents were $6 million at December 31, 2006, compared with $12 million at December 31, 2005. Significant cash flows during 2006 included acquisitions of $40 million, capital expenditures of $22 million, and net debt payments of $14 million offset by proceeds from asset sales of $29 million and cash provided by operations of $42 million. The Company had working capital (current

-30-


assets minus current liabilities) of $148 million at December 31, 2006 as compared with working capital of $193 million at December 31, 2005. This decrease is primarily a result of a decrease in receivables and assets held for sale, in connection with the sale of the Company’s Canadian wire and cable manufacturing business, partially offset by an increase in inventory.

          Cash payments for employee termination costs and facility exit costs totaled $1 million in the year ended December 31, 2006. Management expects that cash outlays of approximately $2 million related to these actions will be substantially completed by the end of 2007. Management intends to fund these cash outlays from existing cash balances and cash flow generated by operations.

           In February, 2005, the Company closed on a secured financing consisting of $370 million of term loans and a $60 million revolving credit facility (the “Credit Facilities”). The term loans included a $235 million first lien loan due on February 28, 2011 and a $135 million second lien loan due on February 28, 2012. The first lien term loan is subject to amortization of $2 million per year for five years, with the remainder payable in the sixth year. There is no amortization over the term of the second lien loan. The $60 million revolving credit facility matures on February 28, 2010 and carries an interest rate of LIBOR plus 2.50 percent subject to rate changes under a pricing grid if the Company’s leverage ratio changes. In April, 2006, the Company entered into amendments to its first and second term loan agreements which reduced the interest rate margins to LIBOR plus 2.25 percent or base rate plus 1.25 pecent on the first lien loan and LIBOR plus 4.25 percent on the second lien loan. In addition, the debt holders agreed to allow a partial redemption of the second lien term loan. On May 1, 2006, the Company repaid $22 million of its second lien term loan. This redemption was sourced from proceeds of the Company’s sale of its Canadian wire and cable business. In September, 2006, the first lien interest rate margin was reduced by an additional 0.25 percent when Moody’s Investor Services upgraded the rating on that loan to B1. The Credit Facilities are secured by liens on substantially all of the personal property and certain real property of the Company and its domestic subsidiaries. The Credit Facilities contain covenants which impose certain restrictions on the Company’s ability to, among other things, incur additional debt, pay dividends, make investments or sell assets. Additionally, if certain tests are not met, a portion of excess cash flow, as defined in the Credit Facilities, and certain non-recurring cash inflows such as proceeds from asset sales, insurance recoveries, and equity offerings must be used to pay down indebtedness and may not be reborrowed. In addition, the Credit Facilities contain certain financial covenants which include a maximum leverage ratio, minimum interest coverage ratio and maximum annual capital expenditures. At December 31, 2006, the Company was in compliance with the covenants in the Credit Facilities.

          On March 19, 2007, the Company completed an amendment to its credit facilities which enabled it to increase borrowings under the first lien term loan by $50 million and to use these borrowings and the net proceeds from the Noma wire and cable harness assembly business sale to redeem the entire second lien term loan.

          In April 2005, the Company entered into two no-cost interest rate collar agreements, effectively hedging $185 million of its LIBOR-based floating rate term debt for five years. As a result of entering into the agreements, the interest rate to be paid by the Company relating to the hedged portion of its debt will be based on a minimum three-month LIBOR rate of 4.05 percent on average and a maximum three-month LIBOR rate of 5.00 percent.

          During 2006, the Company made $22 million of capital expenditures. Capital expenditures are expected to be approximately $35 to $40 million in 2007. Contributions to pension plan trusts are expected to be approximately $1 million in 2007.

          Management believes that the Company’s cash flow from operations and availability under its revolving credit facility will be sufficient to cover debt service requirements, capital expenditures, and working capital requirements during 2007.

Off-Balance Sheet Agreements

-31-


          The Company has approximately $10 million of standby letters of credit outstanding as of December 31, 2006.

Contractual Obligations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments Due by Period

 

 

 


 

 

 

(In thousands)

 

 

 

Less than
1 Year

 

1-3 Years

 

4-5 Years

 

After
5 Years

 

Total

 

 

 


 


 


 


 


 

Long-term debt(1)

 

$

4,612

 

$

5,025

 

$

222,501

 

$

113,161

 

$

345,299

 

Interest on outstanding debt(2)

 

 

27,854

 

 

54,998

 

 

35,208

 

 

1,812

 

 

119,872

 

Operating leases

 

 

3,882

 

 

5,717

 

 

2,815

 

 

403

 

 

12,817

 

Purchase obligations

 

 

4,827

 

 

 

 

 

 

 

 

4,827

 

 

 



 



 



 



 



 

Total contractual obligations

 

$

41,175

 

$

65,740

 

$

260,524

 

$

115,376

 

$

482,815

 

 

 



 



 



 



 



 



(1)   On March 19, 2007, the Company repaid the entire second lien term loan balance of $113 million, which is included in this table with payments due after five years, and borrowed $50 million of additional first lien term loan debt, with payments due of $0.4 million in less than one year, $1 million in one to three years, and $48.6 million in four to five years.
(2)   Reflects interest on debt balances outstanding at year end using interest rates in effect at December 31, 2006. Interest is calculated based on contractual maturity dates and does not reflect any prepayments.

Environmental Matters

          The Company’s various manufacturing operations, which have been conducted at a number of facilities for many years, are subject to numerous laws and regulations relating to the protection of human health and the environment in the U.S., Canada and other countries. The Company believes that it is in substantial compliance with such laws and regulations. However, as a result of its operations, the Company is involved from time to time in administrative and judicial proceedings and inquiries relating to environmental matters. Based on information available at this time with respect to potential liability involving these facilities, the Company believes that any such liability will not have a material adverse effect on its financial condition, cash flows or results of operations. However, modifications of existing laws and regulations or the adoption of new laws and regulations in the future, particularly with respect to environmental and safety standards, could require the Company to make expenditures which may be material or otherwise adversely impact the Company’s operations. See also Item 1. “Business - Environmental Matters.”

          The Company’s accruals for environmental liabilities are recorded based on current interpretation of environmental laws and regulations when it is probable that a liability has been incurred and the amount of such liability can be reasonably estimated. At December 31, 2006, accruals for environmental matters were $25 million. The Company maintains a comprehensive insurance program, including customary comprehensive general liability insurance for bodily injury and property damage caused by various activities and occurrences and significant excess coverage to insure against catastrophic occurrences. However, the Company generally does not maintain insurance other than as described above for potential liabilities related specifically to remediation of existing environmental contamination or future environmental contamination, if any.

          The Company maintains a program to manage its facilities’ compliance with environmental laws and regulations. Expenditures for 2006 approximated $8 million (of which approximately $1 million represented capital expenditures and approximately $7 million related to ongoing operations and the management and remediation of potential environmental contamination from prior operations). Expenditures for 2005 approximated $9 million (of which approximately $2 million represented capital expenditures and approximately $7 million related to ongoing operations and the management and remediation of potential environmental contamination from prior operations). The Company expects expenditures similar to 2006 levels in 2007. In addition, if environmental laws and regulations affecting the Company’s operations become more stringent, costs for environmental compliance may increase above historical levels.

-32-


Recent Accounting Pronouncements

          In December 2004, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 123R, Share-Based Payment (Revised 2004) (“SFAS 123R”). This statement addresses the accounting for share-based payment transactions in which a company receives employee services in exchange for the company’s equity instruments or liabilities that are based on the fair value of the company’s equity securities or may be settled by the issuance of these securities. SFAS No. 123R eliminates the ability to account for share-based compensation using the intrinsic value method and generally requires that such transactions be accounted for using a fair value method. The Company adopted SFAS 123R using the modified prospective transition method. Under this method, compensation cost is recognized for the unvested portion of share-based payments granted prior to January 1, 2006 and all share-based payments granted subsequent to December 31, 2005 over the related vesting period. Prior to January 1, 2006, the Company applied the intrinsic value method prescribed in APB Opinion No. 25 in accounting for employee stock based compensation. Prior period results have not been restated.

          In June 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, an Interpretation of FASB Statement No. 109 (“FIN 48”). FIN 48 clarifies the accounting for uncertainty in income taxes recognized in a company’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. The interpretation also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. FIN 48 will be effective for the Company beginning in the first quarter of 2007. The Company is currently evaluating the impact of adopting FIN 48.

          In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements, (“SFAS 157”), to define fair value, establish a framework for measuring fair value in accordance with generally accepted accounting principles and expand disclosures about fair value measurements. SFAS 157 requires quantitative disclosures using a tabular format in all periods (interim and annual) and qualitative disclosures about the valuation techniques used to measure fair value in all annual periods. The provisions of this Statement shall be effective for financial statements issued for fiscal years beginning after November 15, 2007 and interim periods within those fiscal years. The Company will be required to adopt the provisions of this statement as of January 1, 2008. The Company is currently evaluating the impact of adopting SFAS 157.

          In September 2006, the FASB issued SFAS No. 158, Employers’ Accounting for Defined Benefit Pensions and Other Postretirement Plans, (“SFAS 158”). SFAS 158 requires an employer to recognize the overfunded or underfunded status of a defined benefit postretirement plan (other than a multiemployer plan) as an asset or liability in its statement of financial position and to recognize changes in that funded status in the year in which the changes occur through comprehensive income. Employers are required to initially recognize the funded status and provide the required disclosures beginning for fiscal year ends after December 15, 2006. The net impact on the December 31, 2006 balance sheet is to decrease prepaid pension costs by $1.7 million, decrease other current liabilities by $0.9 million, reduce accrued pension and and postretirement benefit costs by $15.9 million and increase deferred tax liabilities by $6.0 million, with the offset increasing stockholders’ equity by $9.1 million. Additionally, for fiscal years ending after December 15, 2008, SFAS 158 will require employers to measure the plan assets and obligations as of the date of the employer’s fiscal year end. The Company currently utilizes a measurement date of October 31. The Company does not anticipate the change in the fiscal year end measurement date to have a material impact on the Company’s results of operations or financial condition.

-33-


          In September 2006, the Securities and Exchange Commission (“SEC”) issued Staff Accounting Bulletin No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements (“SAB 108”). SAB 108 requires the use of two alternative approaches in quantitatively evaluating materiality of misstatements. If the misstatement as quantified under either approach is material to the current year financial statements, the misstatement must be corrected. If the effect of correcting the prior year misstatements, if any, in the current year income statement is material, the prior year financial statements should be corrected. In the year of adoption, the misstatements may be corrected as an accounting change by adjusting the opening retained earnings rather than including the adjustment in the current year income statement. The Company has adopted the provisions of SAB 108 and there was no effect on its consolidated financial statements.

          In February 2007, the FASB issued SFAS No. 159 The Fair Value Option for Financial Assets and Financial Liabilities – including an Amendment of SFAS No. 115, (“SFAS No. 159”), which permits an entity to measure many financial assets and financial liabilities at fair value that are not currently required to be measured at fair value. Entities that elect the fair value option will report unrealized gains and losses in earnings at each subsequent reporting date. The fair value option may be elected on an instrument-by-instrument basis, with few exceptions. SFAS No. 159 amends previous guidance to extend the use of the fair value option to available-for-sale and held-to-maturity securities. The Statement also establishes presentation and disclosure requirements to help financial statement users understand the effect of the election. SFAS No. 159 is effective as of the beginning of the first fiscal year beginning after November 15, 2007. The Company is currently evaluating the impact of adopting SFAS No. 159.

Critical Accounting Policies and Estimates

          The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant accounting policies are described in Note 2 to the audited consolidated financial statements. The significant accounting policies which it believes are the most critical to the understanding of reported financial results include the following:

          Revenue Recognition – GenTek recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collectibility is reasonably assured. Revenue is recognized from product sales when title and risk of loss has passed to the customer consistent with the related shipping terms, generally at the time products are shipped. The Company records a provision for estimated sales returns and other allowances as a reduction of revenue at the time of revenue recognition. Provisions for sales returns and other allowances are determined using management’s judgments of required amounts, based upon the Company’s historical experience. Actual returns could differ from these estimates. However, if the total actual level of sales returns differed from management’s estimates by 10 percent, the effect would not be material.

          Accounts Receivable – GenTek maintains allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. Allowances are based upon historical experience and information available to management about the creditworthiness, financial condition and payment history of its customers. If the financial condition of the customers were to deteriorate, additional allowances may be required. To the extent that management’s estimate of the uncollectible amount of receivables differs from the amount the Company is ultimately not able to collect by 10 percent, its results would be impacted by approximately $1 million.

-34-


          Deferred Taxes – GenTek records a valuation allowance to reduce its deferred tax assets to the amount the Company believes is more likely than not to be realized based upon historical taxable income, projected future taxable income and available tax planning strategies. Its estimates of future taxable income are based upon its current operating forecast, which it believes to be reasonable. The Company will continue to monitor the likelihood of realizing its net deferred tax assets and future adjustments to the deferred tax asset valuation allowances will be recorded as necessary. However, different assumptions regarding its current operating forecast could materially effect its estimates.

          Purchase Accounting – GenTek applies the purchase method of accounting for acquisitions. Under this method, the purchase price, including any capitalized acquisition costs is allocated to the underlying tangible and intangible assets acquired and liabilities assumed based on their respective fair market values, with any excess recorded as goodwill. The Company determines the fair values of such assets and liabilities, generally in consultation with third-party valuation advisors. Such fair value assessments require significant judgments and estimates such as projected cash flows, discount rates, royalty rates, and remaining useful lives. The initial fair values assigned to certain of these acquisitions are preliminiary and may be revised prior to finalization, which is to be completed within a reasonable period, generally within one year of acquisition. Different assumptions and estimates that underlie the fair value assessments could materially affect its results.

          Impairment of Goodwill and Other Intangible Assets – GenTek records impairment losses on goodwill and indefinite lived intangible assets based upon an annual review of the value of the assets or when events and circumstances indicate that the asset might be impaired and when the recorded value of the asset is more than its fair value. Its estimates of fair value are based upon its current operating forecast, which it believes to be reasonable. Significant assumptions that underlie the fair value estimates include future growth rates and weighted average cost of capital rates. However, different assumptions regarding its current operating forecast could materially affect its results.

          Impairment of Long-Lived Assets – GenTek records impairment losses on long-lived assets when events and circumstances indicate that the assets might be impaired and the undiscounted cash flows estimated to be generated by those assets are less than their carrying amount. In this case, the Company records an impairment loss equal to the difference between the fair value of the long-lived assets and their carrying amount. Management’s estimates of fair value are based on discounted cash flow analyses and/or independent appraisals. Significant assumptions underlying these estimates include future growth rates and weighted average cost of capital rates. Its estimates of future cash flows are based upon its current operating forecast, which it believes to be reasonable. However, different assumptions regarding such cash flows or other assumptions that underlie its fair value estimates could materially affect its results.

          Pension and Other Post Retirement Benefits – GenTek records pension and other post retirement benefit costs based on amounts developed from actuarial valuations. Inherent in these valuations are key assumptions provided by the Company to its actuaries, including the discount rate and expected long-term rate of return on plan assets. For example, holding all other components of the calculations constant, a change in the assumed discount rate by ¼ percent would change 2006 pension and other post retirement benefit costs by approximately $0.1 million and the projected pension and other post retirement benefit obligations by approximately $7 million. A change in the expected long-term rate of return on plan assets of 1 percent would change 2006 pension cost by approximately $2 million. Material changes in pension and other post retirement benefit costs may occur in the future due to changes in these assumptions, differences between actual experience and the assumptions used and changes in the benefit plans.

-35-


          Environmental Liabilities – GenTek has recorded accruals for environmental liabilities based on current interpretation of environmental laws and regulations when it is probable that a liability has been incurred and the amount of such liability can be reasonably estimated. These estimates are established based upon information available to management to date, including the nature and extent of any environmental contamination, the available remedial alternatives, cost estimates obtained from outside consultants for the implementation of such remedial alternatives, the Company’s experience with similar activities undertaken at similar sites, and the legal and regulatory framework in the jurisdiction in which the liability arose. Differences between actual amounts incurred and its estimates or the receipt of new information with respect to these liabilities could have a material effect on its estimates and results of operations. In addition, discovery of unknown environmental contamination, the adoption of new laws or regulations or modifications or changes in enforcement of existing laws and regulations could require adjustments to these accruals.

          The impact and any associated risks related to these policies on its business operations is discussed throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations where such policies affect its reported and expected financial results.

-36-


Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

          The Company’s cash flows and earnings are subject to fluctuations resulting from changes in interest rates, foreign currency exchange rates and commodity prices and the Company selectively uses financial instruments to manage these risks. The Company’s objective in managing its exposure to changes in interest rates, foreign currency exchange rates and commodity prices is to reduce volatility on earnings and cash flow associated with such changes. The Company has not entered, and does not intend to enter, into financial instruments for speculation or trading purposes.

Interest rate risk

          At December 31, 2006, the Company’s debt financing consisted primarily of amounts outstanding under the Company’s credit facility. The borrowings outstanding under the Company’s credit facility are collateralized by substantially all of the personal property and certain real property of the Company and its domestic subsidiaries. Borrowings under the Company’s credit facility are sensitive to changes in interest rates. Given the existing level of borrowings under the credit facility of $342 million as of December 31, 2006, a ½ percent change in the weighted-average interest rate would have an interest impact of approximately $0.1 million each month.

 

 

 

 

 

 

 

 

 

 

 

Principal Balance

 

Fair Value

 

Weighted-Average Interest Rate at
December 31, 2006

 

Scheduled Maturity

 


 


 


 


 

$

219 million    

 

$

221 million  

 

7.36%

 

February 28, 2011

 

$

113 million    

 

$

115 million  

 

9.62%

 

February 28, 2012

 

$

10 million    

 

$

10 million  

 

7.85%

 

February 28, 2010

          The Company has two interest rate collar agreements in the aggregate notional amount of $185 million, in order to hedge against the effect that interest rate fluctuations may have on the Company’s floating rate debt. The interest rate to be paid is based on a minimum three-month LIBOR of 4.05 percent on average and a maximum three-month LIBOR of 5.00 percent. These interest rate collar agreements are scheduled to mature in 2010. The fair value of the agreements was $2 million at December 31, 2006.

Foreign currency exchange rate and commodity price risks

          The Company measures the market risk related to its holding of financial instruments based on changes in foreign currency rates and commodity prices using a sensitivity analysis. The sensitivity analysis measures the potential loss in fair values, cash flows and earnings based on a hypothetical 10 percent change in foreign currency exchange rates and commodity prices. Such analysis indicates that a hypothetical 10 percent change in foreign currency exchange rates or commodity prices would not have a material impact on the fair values, cash flows or earnings of the Company.

-37-


Item 8. Financial Statements and Supplementary Data.

Index

 

 

 

 

 

 

Page No.

 

 


 

 

 

 

Report of Independent Registered Public Accounting Firm

39

 

 

 

Consolidated Statements of Operations – Years Ended December 31, 2006, 2005 and 2004

40

 

 

 

Consolidated Balance Sheets – As of December 31, 2006 and 2005

41

 

 

 

Consolidated Statements of Cash Flows – Years Ended December 31, 2006, 2005 and 2004

42

 

 

 

Consolidated Statement of Changes in Equity – Years Ended December 31, 2006, 2005 and 2004

43

 

 

 

Notes to the Consolidated Financial Statements

44-69

 

-38-


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of
GenTek Inc.
Parsippany, New Jersey

          We have audited the accompanying consolidated balance sheets of GenTek Inc. and subsidiaries (the “Company”) as of December 31, 2006 and 2005, and the related consolidated statements of operations, changes in equity, and cash flows for each of the three years in the period ended December 31, 2006. Our audits also included the financial statement schedule listed in the Index at Item 15. These financial statements and financial statement schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on the financial statements and financial statement schedule based on our audits.

          We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

          In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of GenTek Inc. and subsidiaries at December 31, 2006 and 2005, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2006, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

          As discussed in Note 2 to the consolidated financial statements, the Company adopted Statement of Financial Accounting Standards No. 123(R), Share-Based Payment.

          As discussed in Note 2 to the consolidated financial statements, the Company adopted Statement of Financial Accounting Standards No. 158, Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans.

          As discussed in Note 16 to the consolidated financial statements, in December 2006 the Company entered into an agreement to sell its Noma wire and cable assembly business. The Company has classified the related operations as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets.

          We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the effectiveness of the Company’s internal control over financial reporting as of December 31, 2006, based on the criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated March 20, 2007 expressed an unqualified opinion on management’s assessment of the effectiveness of the Company’s internal control over financial reporting and an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

/s/ Deloitte & Touche LLP
Parsippany, New Jersey
March 20, 2007

-39-


GENTEK INC.
CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 


 

 

 

2006

 

2005

 

2004

 

 

 


 


 


 

Net revenues

 

$

611,368

 

$

556,497

 

$

531,123

 

Cost of sales

 

 

503,806

 

 

452,835

 

 

438,775

 

Selling, general and administrative expense

 

 

51,523

 

 

56,816

 

 

64,770

 

Restructuring and impairment charges

 

 

2,974

 

 

6,989

 

 

8,934

 

Pension curtailment and settlement (gains) losses

 

 

(644

)

 

626

 

 

(13,414

)

 

 



 



 



 

Operating profit

 

 

53,709

 

 

39,231

 

 

32,058

 

Interest expense

 

 

29,137

 

 

24,736

 

 

7,938

 

Interest income

 

 

645

 

 

579

 

 

592

 

Other (income) expense, net

 

 

343

 

 

(2,274

)

 

(3,120

)

 

 



 



 



 

Income from continuing operations before income taxes

 

 

24,874

 

 

17,348

 

 

27,832

 

Income tax provision

 

 

9,425

 

 

8,225

 

 

11,735

 

 

 



 



 



 

Income from continuing operations

 

 

15,449

 

 

9,123

 

 

16,097

 

Income (loss) from discontinued operations (net of tax for the years ended December 31, 2006, 2005 and 2004 of $(8,121), $(5,356) and $89,745)

 

 

(17,552

)

 

(9,945

)

 

179,221

 

 

 



 



 



 

Net income (loss)

 

$

(2,103

)

$

(822

)

$

195,318

 

 

 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share – basic:

 

 

 

 

 

 

 

 

 

 

Income from continuing operations

 

$

1.52

 

$

0.91

 

$

1.61

 

Income (loss) from discontinued operations

 

 

(1.73

)

 

(0.99

)

 

17.92

 

 

 



 



 



 

Net income (loss)

 

$

(0.21

)

$

(0.08

)

$

19.53

 

 

 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share – assuming dilution:

 

 

 

 

 

 

 

 

 

 

Income from continuing operations

 

$

1.41

 

$

0.90

 

$

1.61

 

Income (loss) from discontinued operations

 

 

(1.60

)

 

(0.98

)

 

17.87

 

 

 



 



 



 

Net income (loss)

 

$

(0.19

)

$

(0.08

)

$

19.48

 

 

 



 



 



 

See the accompanying notes to the consolidated financial statements.

-40-


GENTEK INC.
CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 


 

 

 

2006

 

2005

 

 

 


 


 

ASSETS

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

5,715

 

$

11,645

 

Receivables, net

 

 

80,413

 

 

91,960

 

Inventories

 

 

46,885

 

 

35,843

 

Deferred income taxes

 

 

31,578

 

 

32,623

 

Assets held for sale

 

 

111,544

 

 

143,779

 

Other current assets

 

 

6,811

 

 

9,672

 

 

 



 



 

Total current assets

 

 

282,946

 

 

325,522

 

Property, plant and equipment, net

 

 

232,180

 

 

221,346

 

Goodwill

 

 

150,253

 

 

147,369

 

Intangible assets

 

 

56,703

 

 

53,664

 

Deferred income taxes

 

 

611

 

 

220

 

Other assets

 

 

7,513

 

 

12,954

 

 

 



 



 

Total assets

 

$

730,206

 

$

761,075

 

 

 



 



 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

43,026

 

$

36,017

 

Accrued liabilities

 

 

57,021

 

 

54,675

 

Current portion of long-term debt

 

 

4,612

 

 

3,840

 

Liabilities of businesses held for sale

 

 

30,516

 

 

38,220

 

 

 



 



 

Total current liabilities

 

 

135,175

 

 

132,752

 

Long-term debt

 

 

340,687

 

 

356,429

 

Pension and postretirement obligations

 

 

85,501

 

 

107,887

 

Other liabilities

 

 

72,910

 

 

78,632

 

 

 



 



 

Total liabilities

 

 

634,273

 

 

675,700

 

 

 



 



 

Equity:

 

 

 

 

 

 

 

Preferred stock, $.01 par value; authorized: 10,000,000 shares; none issued or outstanding

 

 

 

 

 

Common stock, no par value; authorized: 100,000,000 shares; issued: 10,359,716 and 10,194,571 shares at December 31, 2006 and 2005, respectively

 

 

83,516

 

 

81,395

 

Unearned compensation

 

 

 

 

(859

)

Warrants

 

 

8,355

 

 

8,361

 

Accumulated other comprehensive income (loss)

 

 

6,004

 

 

(3,861

)

Retained earnings (deficit)

 

 

(1,678

)

 

425

 

Treasury stock, at cost: 12,198 and 5,191 shares at December 31, 2006 and 2005, respectively

 

 

(264

)

 

(86

)

 

 



 



 

Total equity

 

 

95,933

 

 

85,375

 

 

 



 



 

Total liabilities and equity

 

$

730,206

 

$

761,075

 

 

 



 



 

See the accompanying notes to the consolidated financial statements.

-41-


GENTEK INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 


 

 

 

2006

 

2005

 

2004

 

 

 


 


 


 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(2,103

)

$

(822

)

$

195,318

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

Discontinued operations

 

 

15,423

 

 

9,945

 

 

(179,221

)

Pension curtailment gain

 

 

(644

)

 

 

 

(13,414

)

Depreciation and amortization

 

 

36,314

 

 

37,224

 

 

40,175

 

Asset impairment charges

 

 

1,231

 

 

1,852

 

 

 

Net (gain) loss on disposition of long-term assets

 

 

476

 

 

(1,622

)

 

(4,823

)

Long-term incentive plan costs, net

 

 

1,793

 

 

1,176

 

 

1,483

 

Excess tax benefit from stock option exercises

 

 

(318

)

 

 

 

 

(Increase) decrease in receivables

 

 

3,381

 

 

(7,328

)

 

(416

)

(Increase) decrease in inventories

 

 

(2,230

)

 

21

 

 

(2,248

)

(Increase) decrease in deferred tax assets

 

 

(5,055

)

 

(14,828

)

 

6,693

 

Increase (decrease) in accounts payable

 

 

5,549

 

 

(2,149

)

 

11,127

 

Increase (decrease) in accrued liabilities

 

 

3,899

 

 

(6,531

)

 

(38,883

)

Increase (decrease) in other liabilities and assets, net

 

 

3,750

 

 

(16,377

)

 

(5,171

)

 

 



 



 



 

Net cash provided by continuing operations

 

 

61,466

 

 

561

 

 

10,620

 

Net cash provided by (used for) discontinued operations

 

 

(19,434

)

 

3,164

 

 

37,543

 

 

 



 



 



 

Net cash provided by operating activities

 

 

42,032

 

 

3,725

 

 

48,163

 

 

 



 



 



 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

Capital expenditures

 

 

(22,409

)

 

(21,605

)

 

(25,040

)

Proceeds from sales or disposals of long-term assets

 

 

849

 

 

2,499

 

 

10,127

 

Purchase of short-term investments

 

 

2,367

 

 

(2,229

)

 

 

Acquisition of businesses net of cash acquired*

 

 

(40,119

)

 

 

 

(1,451

)

Other investing activities

 

 

 

 

 

 

(75

)

 

 



 



 



 

Net cash used for continuing operations

 

 

(59,312

)

 

(21,335

)

 

(16,439

)

Net cash provided by (used for) discontinued operations

 

 

28,489

 

 

(6,582

)

 

285,488

 

 

 



 



 



 

Net cash provided by (used for) investing activities

 

 

(30,823

)

 

(27,917

)

 

269,049

 

 

 



 



 



 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

Proceeds from long-term debt

 

 

15,533

 

 

400,767

 

 

18,131

 

Repayment of long-term debt

 

 

(29,589

)

 

(56,061

)

 

(268,336

)

Redemption of tranche A warrants

 

 

 

 

 

 

(8,365

)

Dividends

 

 

(2,367

)

 

(310,742

)

 

(70,690

)

Exercise of stock options and warrants

 

 

872

 

 

708

 

 

 

Excess tax benefit from stock option exercises

 

 

318

 

 

 

 

 

Payments to acquire treasury stock

 

 

(178

)

 

(86

)

 

 

 

 



 



 



 

Net cash provided by (used for) continuing operations

 

 

(15,411

)

 

34,586

 

 

(329,260

)

Net cash used for discontinued operations

 

 

(1,738

)

 

(7,319

)

 

(5,663

)

 

 



 



 



 

Net cash provided by (used for) financing activities

 

 

(17,149

)

 

27,267

 

 

(334,923

)

 

 



 



 



 

Effect of exchange rate changes on cash

 

 

10

 

 

(151

)

 

246

 

 

 



 



 



 

Increase (decrease) in cash and cash equivalents

 

 

(5,930

)

 

2,924

 

 

(17,465

)

Cash and cash equivalents at beginning of period

 

 

11,645

 

 

8,721

 

 

26,186

 

 

 



 



 



 

Cash and cash equivalents at end of period

 

$

5,715

 

$

11,645

 

$

8,721

 

 

 



 



 



 

Supplemental information:

 

 

 

 

 

 

 

 

 

 

Cash paid (refunded) for income taxes

 

$

(287

)

$

(283

)

$

13,282

 

 

 



 



 



 

Cash paid for interest

 

$

29,358

 

$

19,079

 

$

8,505

 

 

 



 



 



 

*Acquisition of businesses, net of cash acquired:

 

 

 

 

 

 

 

 

 

 

Working capital, other than cash

 

$

(10,771

)

$

 

$

(29

)

Property, plant and equipment

 

 

(21,647

)

 

 

 

(968

)

Other assets

 

 

(13,438

)

 

 

 

(454

)

Non-current laibilities

 

 

5,737

 

 

 

 

 

 

 



 



 



 

Total cash used to acquire businesses

 

$

(40,119

)

$

 

$

(1,451

)

 

 



 



 



 

See the accompanying notes to the consolidated financial statements.

-42-


GENTEK INC.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

For the Three Years Ended December 31, 2006
(In thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common
Stock

 

Unearned
Compensation

 

Warrants

 

Treasury
Stock

 

Accumulated
Other
Comprehensive
Income
(Loss
)

 

Retained
Earnings
(Deficit)

 

Total

 

 

 


 


 


 


 


 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2004

 

 $

268,084

 

 $

 

 $

8,361

 

 $

 

 $

1,250

 

 $

1,092

 

 $

278,787

 

Components of comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

195,318

 

 

195,318

 

Minimum pension liability adjustments (net of tax of $(1,010))

 

 

 

 

 

 

 

 

 

 

(1,543

)

 

 

 

(1,543

)

Foreign currency translation adjustments (net of tax of $(420))

 

 

 

 

 

 

 

 

 

 

(644

)

 

 

 

(644

)

Change in unrealized gain on derivative instruments (net of tax of $34)

 

 

 

 

 

 

 

 

 

 

51

 

 

 

 

51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

193,182

 

Long-term incentive plan grants, net

 

 

3,606

 

 

(2,123

)

 

 

 

 

 

 

 

 

 

1,483

 

Tranche A warrant payment

 

 

 

 

 

 

 

 

 

 

 

 

(2,335

)

 

(2,335

)

Dividends ($7.00 per share)

 

 

 

 

 

 

 

 

 

 

 

 

(70,690

)

 

(70,690

)

 

 



 



 



 



 



 



 



 

Balance at December 31, 2004

 

 

271,690

 

 

(2,123

)

 

8,361

 

 

 

 

(886

)

 

123,385

 

 

400,427

 

Components of comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

(822

)

 

(822

)

Minimum pension liability adjustments (net of tax of $(2,197))

 

 

 

 

 

 

 

 

 

 

(3,357

)

 

 

 

(3,357

)

Foreign currency translation adjustments (net of tax of $(95))

 

 

 

 

 

 

 

 

 

 

(145

)

 

 

 

(145

)

Change in unrealized gain on derivative instruments (net of tax of $345)

 

 

 

 

 

 

 

 

 

 

527

 

 

 

 

527

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,797

)

Long-term incentive plan grants, net

 

 

(88

)

 

1,264

 

 

 

 

 

 

 

 

 

 

1,176

 

Exercise of warrants

 

 

2

 

 

 

 

 

 

 

 

 

 

 

 

2

 

Dividends ($31.00 per share)

 

 

(190,917

)

 

 

 

 

 

 

 

 

 

(122,138

)

 

(313,055

)

Exercise of stock options

 

 

708

 

 

 

 

 

 

 

 

 

 

 

 

708

 

Acquisition of treasury stock

 

 

 

 

 

 

 

 

(86

)

 

 

 

 

 

(86

)

 

 



 



 



 



 



 



 



 

Balance at December 31, 2005

 

 

81,395

 

 

(859

)

 

8,361

 

 

(86

)

 

(3,861

)

 

425

 

 

85,375

 

Components of comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss)

 

 

 

 

 

 

 

 

 

 

 

 

(2,103

)

 

(2,103

)

Minimum pension liability adjustment (net of tax $(283))

 

 

 

 

 

 

 

 

 

 

432

 

 

 

 

432

 

Adjustment to initially apply FASB Statement No. 158 (net of tax of $(5,956))

 

 

 

 

 

 

 

 

 

 

9,102

 

 

 

 

9,102

 

Foreign currency translation adjustments (net of tax of $59)

 

 

 

 

 

 

 

 

 

 

92

 

 

 

 

92

 

Change in unrealized gain on derivative instruments (net of tax of $157)

 

 

 

 

 

 

 

 

 

 

239

 

 

 

 

239

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,762

 

Long-term incentive plan grants, net

 

 

1,243

 

 

859

 

 

 

 

 

 

 

 

 

 

2,102

 

Exercise of warrants

 

 

48

 

 

 

 

(6

)

 

 

 

 

 

 

 

42

 

Exercise of stock options

 

 

830

 

 

 

 

 

 

 

 

 

 

 

 

830

 

Acquisition of treasury stock

 

 

 

 

 

 

 

 

(178

)

 

 

 

 

 

(178

)

 

 



 



 



 



 



 



 



 

Balance at December 31, 2006

 

$

83,516

 

$

 

$

8,355

 

$

(264

)

$

6,004

 

$

(1.678

)

$

95,933

 

 

 



 



 



 



 



 



 



 

See the accompanying notes to the consolidated financial statements.

-43-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands, except per share data)

Note 1 – Basis of Presentation

          GenTek Inc. (“GenTek” or the “Company”) is a holding company with no independent operations and, therefore, is dependent upon cash flow from its subsidiaries to meet obligations. GenTek’s subsidiaries operate through two primary business segments: manufacturing and performance chemicals. The manufacturing segment provides a broad range of engineered components and services to two principal markets: automotive and industrial. The performance chemicals segment provides a broad range of value-added products and services to four principal markets: water treatment, chemical processing, pharmaceutical and personal care and technology. The Company operates over 50 manufacturing and production facilities located primarily in the U.S. and Canada.

          On May 18, 2004, the Company sold its KRONE communications business to ADC Telecommunications, Inc. During the second quarter of 2005, the Company ceased operations of its printing plate business. During April 2006, the Company completed the sale of its cable and wire manufacturing business in Stouffville, Canada. On February 16, 2007, the Company completed the sale of its Noma wire and cable harness assembly business. Accordingly, these businesses have been classified as discontinued operations. See Note 16.

Note 2 – Summary of Significant Accounting Policies

          The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

          The consolidated financial statements include the accounts of the Company and all of its majority owned subsidiaries. Investments in affiliates in which ownership is at least 20 percent, but less than a majority voting interest, are accounted for using the equity method. Investments in less than 20 percent owned affiliates are accounted for using the cost method. Intercompany balances and transactions are eliminated in consolidation.

          All highly liquid instruments purchased with a maturity of three months or less are considered to be cash equivalents.

          Inventories are valued at the lower of cost or market, using the last-in, first-out (“LIFO”) method for certain domestic production inventories and the first-in, first-out (“FIFO”) or average-cost method for all other inventories. Production inventory costs include material, labor and factory overhead.

          Property, plant and equipment are carried at cost and are depreciated principally using the straight-line method. Estimated lives range from five to 35 years for buildings and leasehold improvements and three to 15 years for machinery and equipment.

          Intangible assets that have finite lives are amortized using the straight-line method, over their estimated useful lives, which range from four to 15 years.

-44-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
(Dollars in thousands, except per share data)

          The Company reviews long-lived assets for impairment whenever events and circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by comparing the carrying amount of these assets against the estimated undiscounted future cash flows to be generated by the assets. At the time such evaluations indicate that the future cash flows are not sufficient to recover the carrying value of such assets, the carrying values are adjusted to their fair values, which have been determined on a discounted cash flow basis. Assets to be disposed of are reported at the lower of their carrying amount or fair value less costs to sell.

          The Company reviews goodwill and indefinite lived intangible assets for impairment annually and whenever events and circumstances indicate that the recorded value of the assets might be more than its fair value. Estimated fair values are determined based upon a number of factors, including independent appraisals and current operating forecasts.

          Accruals for product warranties are estimated based upon historical warranty experience and are recorded at the time revenue is recognized.

          Accruals for environmental liabilities are recorded based on current interpretations of environmental laws and regulations when it is probable that a liability has been incurred and the amount of such a liability can be reasonably estimated.

          Accruals for pension and other post-retirement benefit costs utilize a number of accounting mechanisms that reduce the volatility of reported costs. Differences between actuarial assumptions and actual plan results are deferred and are amortized into expense only when the accumulated differences exceed 10 percent of the greater of the projected benefit obligation or the market-related value of plan assets. If necessary, the excess is amortized over the average remaining service period of active employees. Additionally, the impact of asset performance on pension expense is recognized over a five-year phase-in period though a “market-related” value of assets calculation. Since the market-related value of assets recognizes investment gains or losses over a five-year period, the future value of assets will be impacted as previously deferred gains or losses are recognized.

          The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred, the amount is fixed or determinable, and collectibility is reasonably assured. Revenue is recognized from product sales when title and risk of loss has passed to the customer consistent with the related shipping terms, generally at the time products are shipped. The Company records a provision for estimated sales returns and other allowances as a reduction of revenue at the time of revenue recognition.

          Effective January 1, 2006, the Company adopted SFAS No. 123R, Share-Based Payment (Revised 2004) (“SFAS 123R”). This statement addresses the accounting for share-based payment transactions in which a company receives employee services in exchange for the company’s equity instruments or liabilities that are based on the fair value of the company’s equity securities or may be settled by the issuance of these securities. SFAS 123R eliminates the ability to account for share-based compensation using the intrinsic value method and generally requires that such transactions be accounted for using a fair value method. The Company adopted SFAS 123R using the modified prospective transition method. Under this method, compensation cost is recognized for the unvested portion of share-based payments granted prior to January 1, 2006 and all share-based payments granted subsequent to

-45-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
(Dollars in thousands, except per share data)

December 31, 2005 over the related vesting period. Prior to January 1, 2006, the Company applied the intrinsic value method prescribed in APB Opinion No. 25 in accounting for employee stock based compensation. Prior period results have not been restated. Due to the adoption of SFAS 123R, the Company’s results for the year ended December 31, 2006 include incremental share-based compensation expense totaling $599.

          The following table illustrates the effect on net income and net income per share if the Company had applied the fair value based method to recognize stock-based employee compensation for the years ended December 31, 2005 and 2004:

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 


 

 

 

2005

 

2004

 

 

 


 


 

 

Net income (loss) as reported

 

$

(822

)

$

195,318

 

Add: Stock-based employee compensation expense included in net income determined under intrinsic value method, net of related tax effects

 

 

1,176

 

 

1,483

 

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects

 

 

(1,430

)

 

(1,776

)

 

 



 



 

Pro forma net income (loss)

 

$

(1,076

)

$

195,025

 

 

 



 



 

Earnings (loss) per share:

 

 

 

 

 

 

 

Basic – as reported

 

$

(0.08

)

$

19.53

 

 

 



 



 

Basic – pro forma

 

$

(0.11

)

$

19.50

 

 

 



 



 

Diluted – as reported

 

$

(0.08

)

$

19.48

 

 

 



 



 

Diluted – pro forma

 

$

(0.11

)

$

19.45

 

 

 



 



 

          For purposes of this calculation, the fair value of each option grant was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

2005

 

2004

 

 

 


 


 

Dividend yield

 

 

 

 

 

 

 

Expected volatility

 

 

22

%

 

 

50

%

 

Risk-free interest rate

 

 

3.97

%

 

 

2.32

%

 

Expected holding period (in years)

 

 

4

 

 

 

4

 

 

Weighted average fair value

 

$

2.94

 

 

$

14.82

 

 

          Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets if it is more likely than not that such assets will not be realized.

          The Company does not hold or issue financial instruments for trading purposes. The Company uses derivative financial instruments primarily for purposes of hedging exposures to fluctuations in

-46-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
(Dollars in thousands, except per share data)

interest rates and commodity prices. Gains and losses related to qualifying hedges of firm commitments or anticipated transactions are deferred and are recognized in earnings or as adjustments of carrying amounts when the hedged transaction occurs.

          The components of accumulated other comprehensive income (loss) are as follows:

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 


 

 

 

2006

 

2005

 

 

 


 


 

Foreign currency translation

 

$

552

 

$

460

 

Minimum pension liability adjustments

 

 

 

 

(4,900

)

Unrecognized pension and post retirement (costs) credits

 

 

4,634

 

 

 

Net unrealized gain on derivative instruments

 

 

818

 

 

579

 

 

 



 



 

Accumulated other comprehensive income (loss)

 

$

6,004

 

$

(3,861

)

 

 



 



 

          In June 2006, the Financial Accounting Standards Board (“FASB”) issued FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, an Interpretation of FASB Statement No. 109 (“FIN 48”). FIN 48 clarifies the accounting for uncertainty in income taxes recognized in a company’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. The interpretation also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. FIN 48 will be effective for the Company beginning in the first quarter of 2007. The Company is currently evaluating the impact of adopting FIN 48.

          In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements, (“SFAS 157”), to define fair value, establish a framework for measuring fair value in accordance with generally accepted accounting principles and expand disclosures about fair value measurements. SFAS 157 requires quantitative disclosures using a tabular format in all periods (interim and annual) and qualitative disclosures about the valuation techniques used to measure fair value in all annual periods. The provisions of this Statement shall be effective for financial statements issued for fiscal years beginning after November 15, 2007 and interim periods within those fiscal years. The Company will be required to adopt the provisions of this statement as of January 1, 2008. The Company is currently evaluating the impact of adopting SFAS 157.

          In September 2006, the FASB issued SFAS No. 158, Employers’ Accounting for Defined Benefit Pensions and Other Postretirement Plans, (“SFAS 158”). SFAS 158 requires an employer to recognize the overfunded or underfunded status of a defined benefit postretirement plan (other than a multiemployer plan) as an asset or liability in its statement of financial position and to recognize changes in that funded status in the year in which the changes occur through comprehensive income. Employers are required to initially recognize the funded status and provide the required disclosures beginning for fiscal year ends after December 15, 2006. The net impact on the December 31, 2006 balance sheet is to decrease prepaid pension costs by $1,749, decrease other current liabilities by $862, reduce accrued pension and postretirement benefit costs by $15,947 and increase deferred tax liabilities by $5,956, with the offset increasing stockholders’ equity by $9,102. Additionally, for fiscal years ending after December 15, 2008, SFAS 158 will require employers to measure the plan assets and obligations as of the date of the employer’s fiscal year end. The Company currently utilizes a measurement date of October 31. The Company does not anticipate the change in the fiscal year end measurement date to have a material

-47-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Continued)
(Dollars in thousands, except per share data)

impact on the Company’s results of operations or financial condition.

          In September 2006, the Securities and Exchange Commission (“SEC”) issued Staff Accounting Bulletin No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements (“SAB 108”). SAB 108 requires the use of two alternative approaches in quantitatively evaluating materiality of misstatements. If the misstatement as quantified under either approach is material to the current year financial statements, the misstatement must be corrected. If the effect of correcting the prior year misstatements, if any, in the current year income statement is material, the prior year financial statements should be corrected. In the year of adoption, the misstatements may be corrected as an accounting change by adjusting the opening retained earnings rather than including the adjustment in the current year income statement. The Company has adopted the provisions of SAB 108 and there was no effect on its consolidated financial statements.

          In February 2007, the FASB issued SFAS No. 159 The Fair Value Option for Financial Assets and Financial Liabilities – including an Amendment of SFAS No. 115, (“SFAS No. 159”), which permits an entity to measure many financial assets and financial liabilities at fair value that are not currently required to be measured at fair value. Entities that elect the fair value option will report unrealized gains and losses in earnings at each subsequent reporting date. The fair value option may be elected on an instrument-by-instrument basis, with few exceptions. SFAS No. 159 amends previous guidance to extend the use of the fair value option to available-for-sale and held-to-maturity securities. The Statement also establishes presentation and disclosure requirements to help financial statement users understand the effect of the election. SFAS No. 159 is effective as of the beginning of the first fiscal year beginning after November 15, 2007. The Company is currently evaluating the impact of adopting SFAS No. 159.

Note 3 – Acquisitions

          On September 21, 2006, the Company acquired the assets of GAC MidAmerica, Inc. (“GAC”). The acquisition included manufacturing facilities in Toledo, Ohio, Indianapolis, Indiana, and Saukville, Wisconsin. GAC produces aluminum sulfate and bleach, as well as distributing specialty water treatment chemicals, sulfuric acid and caustic soda. The total cost of the acquisition was $8,266.

          On July 31, 2006, the Company acquired the assets of Precision Engine Products Corp., a wholly owned subsidiary of Stanadyne Corporation. Precision Engine Products is dedicated principally to the manufacturing of hydraulic lash adjusters and die cast aluminum rocker arm assemblies utilized in valve train systems for both OEM and after market applications to the global automotive and light truck markets. Precision Engine Products has manufacturing facilities in Tallahassee, Florida and Curitiba, Brazil. The total cost of the acquisition was $26,262, plus the potential of an earn out for Stanadyne of up to $10,000, payable, if at all based on certain performance metrics being achieved during the twelve months following the closing date. Because of this contingent payment, the purchase price allocation includes a liability of $4,090, representing the excess of the values assigned to the assets purchased over the preliminary purchase price, which is subject to change based on the determination of the contingent consideration, if any. This determination is expected to be completed during the third quarter of 2007.

          On July 27, 2006, the Company acquired the assets of Repauno Products, LLC. The acquisition included the manufacturing facility in Gibbstown, New Jersey. Repauno Products manufactures sodium

-48-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

nitrite which is used in a wide range of industries including metal finishing, heat transfer salts, rubber processing, meat curing, odor control and inks and dyes. The total cost of the acquisition was $6,057.

          The allocation of the purchase price of the acquisitions is based on valuation information available to the Company which is subject to change as such information is finalized. The Company expects to finalize the purchase price allocations for these acquisitions by the third quarter of 2007. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:

 

 

 

 

 

 

 

 

 

 

 

 

 

GAC
MidAmerica, Inc.
Purchase Price
Allocation

 

Precision Engine
Products Corp.
Purchase Price
Allocation

 

Repauno
Products, LLC
Purchase Price
Allocation

 

 

 


 


 


 

 

Current assets

 

$

2,400

 

$

16,219

 

$

1,736

 

Propery, plant and equipment

 

 

4,407

 

 

15,990

 

 

1,250

 

Intangible assets

 

 

750

 

 

4,100

 

 

4,191

 

Goodwill

 

 

2,879

 

 

 

 

 

Other

 

 

 

 

1,518

 

 

 

 

 



 



 



 

Total assets acquired

 

 

10,436

 

 

37,827

 

 

7,177

 

 

Current liabilities

 

 

2,170

 

 

6,078

 

 

1,120

 

Other

 

 

 

 

5,487

 

 

 

 

 



 



 



 

Total liabilities assumed

 

 

2,170

 

 

11,565

 

 

1,120

 

 

Net assets acquired

 

$

8,266

 

$

26,262

 

$

6,057

 

 

 



 



 



 

          The acquired intangibles for GAC and Repauno Products were assigned to covenant not-to-compete and have a weighted-average useful life of 5 years. The acquired intangible in the Precision Engine Products acquisition was assigned to technology and has a useful life of 7 years.

          The $2,879 of goodwill was assigned to the performance chemicals segment, all of which is expected to be deductible for tax purposes. The GAC acquisition resulted in goodwill due to the synergies and cost reductions expected to be realized as GAC’s facilities and business are assimilated into the Company’s network of water treatment chemical production facilities.

          Operating results for the acquired entities have been reflected in the Company’s consolidated financial statements from date of acquisition. The following unaudited pro forma consolidated financial information has been prepared as if the acquisitions had taken place at the beginning of each fiscal year presented. The following unaudited pro forma information is not necessarily indicative of the results of operations in future periods or results that would have been achieved had the acquisitions taken place at the beginning of the periods presented.

-49-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 


 

 

 

2006

 

2005

 

 

 


 


 

 

Net revenues

 

$

665,771

 

$

649,780

 

Net (loss) income

 

 

(4,077

)

 

(8,227

)

Net (loss) income per share:

 

 

 

 

 

 

 

Basic

 

$

(0.40

)

$

(0.82

)

Diluted

 

 

(0.37

)

 

(0.81

)

Note 4 – Restructuring and Impairment Charges

Restructuring Actions – 2006

          During 2006, the Company initiated actions to close two manufacturing facilities in its performance chemicals segment. The Company expects to substantially complete implementation of these restructuring actions during 2007. The following tables summarize the Company’s expected costs and accruals for these restructuring actions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Manufacturing

 

Performance
Chemicals

 

Corporate

 

Total

 

 

 


 


 


 


 

Employee Termination Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs incurred in current period

 

$

 

$

390

 

$

 

$

390

 

Costs anticipated to be incurred in the future

 

 

 

 

208

 

 

 

 

208

 

 

 



 



 



 



 

Total costs expected to be incurred

 

$

 

$

598

 

$

 

$

598

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provisions

 

$

 

$

390

 

$

 

$

390

 

Amounts paid

 

 

 

 

 

 

 

 

 

 

 



 



 



 



 

Accrual balance at December 31, 2006

 

$

 

$

390

 

$

 

$

390

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Manufacturing

 

Performance
Chemicals

 

Corporate

 

Total

 

 

 


 


 


 


 

Facility Exit Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs incurred in current period

 

$

 

$

212

 

$

 

$

212

 

Costs anticipated to be incurred in the future

 

 

 

 

1,219

 

 

 

 

1,219

 

 

 



 



 



 



 

Total costs expected to be incurred

 

$

 

$

1,431

 

$

 

$

1,431

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provisions

 

$

 

$

212

 

$

 

$

212

 

Amounts paid

 

 

 

 

 

 

 

 

 

 

 



 



 



 



 

Accrual balance at December 31, 2006

 

$

 

$

212

 

$

 

$

212

 

 

 



 



 



 



 

Restructuring Actions – Prior to 2006

          During 2005, the Company initiated actions to close three manufacturing facilities in its manufacturing segment. In addition, the Company initiated a workforce reduction affecting corporate and performance chemicals employees. During 2004, the Company initiated actions to close two facilities in its performance chemicals segment. In addition, the Company initiated a workforce reduction affecting

-50-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

corporate employees. The Company’s restructuring actions during 2003 consist of two plant closures in its performance chemicals segment. These restructuring actions have been completed. The following tables summarize the Company’s costs and accruals for these restructuring actions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Manufacturing

 

Performance
Chemicals

 

Corporate

 

Total

 

 

 


 


 


 


 

Employee Termination Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

Cumulative costs incurred

 

$

675

 

$

8,584

 

$

2,145

 

$

11,404

 

Costs anticipated to be incurred in the future

 

 

 

 

 

 

 

 

 

 

 



 



 



 



 

Total costs incurred

 

$

675

 

$

8,584

 

$

2,145

 

$

11,404

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accrual balance at December 31, 2003

 

$

 

$

2,697

 

$

 

$

2,697

 

Provisions

 

 

 

 

1,381

 

 

132

 

 

1,513

 

Amounts paid

 

 

 

 

(3,134

)

 

(132

)

 

(3,266

)

 

 



 



 



 



 

Accrual balance at December 31, 2004

 

 

 

 

944

 

 

 

 

944

 

Provisions

 

 

338

 

 

219

 

 

2,013

 

 

2,570

 

Amounts paid

 

 

(249

)

 

(1,114

)

 

(2,013

)

 

(3,376

)

 

 



 



 



 



 

Accrual balance at December 31, 2005

 

 

89

 

 

49

 

 

 

 

138

 

Provisions

 

 

337

 

 

 

 

 

 

337

 

Amounts paid

 

 

(426

)

 

(49

)

 

 

 

(475

)

 

 



 



 



 



 

Accrual balance of December 31, 2006

 

$

 

$

 

$

 

$

 

 

 



 



 



 



 

          In the performance chemicals segment, included in costs incurred during 2004, but not in provisions in the accrual roll forward, is $1,130 of contractual termination pension benefits, which have been recorded in the pension liability.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Manufacturing

 

Performance
Chemicals

 

Corporate

 

Total

 

 

 


 


 


 


 

Facility Exit Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

Cumulative costs incurred

 

$

1,671

 

$

15,952

 

$

 

$

17,623

 

Costs anticipated to be incurred in the future

 

 

 

 

 

 

 

 

 

 

 



 



 



 



 

Total costs incurred

 

$

1,671

 

$

15,952

 

$

 

$

17,623

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accrual balance at December 31, 2003

 

$

 

$

5,651

 

$

 

$

5,651

 

Provisions

 

 

 

 

6,113

 

 

 

 

6,113

 

Amounts paid

 

 

 

 

(10,921

)

 

 

 

(10,921

)

 

 



 



 



 



 

Accrual balance at December 31, 2004

 

 

 

 

843

 

 

 

 

843

 

Provisions

 

 

1,169

 

 

1,397

 

 

 

 

2,566

 

Amounts paid

 

 

(1,035

)

 

(2,240

)

 

 

 

(3,275

)

 

 



 



 



 



 

Accrual balance at December 31, 2005

 

 

134

 

 

 

 

 

 

134

 

Provisions

 

 

502

 

 

302

 

 

 

 

804

 

Amounts paid

 

 

(636

)

 

(302

)

 

 

 

(938

)

 

 



 



 



 



 

Accrual balance at December 31, 2006

 

$

 

$

 

$

 

$

 

 

 



 



 



 



 

Impairment Charges

-51-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

          During the fourth quarter of 2006, the Company recorded an impairment charge of $728 to reflect revised fair values of machinery and equipment used for a discontinued product line in the manufacturing segment, based on its estimated salvage value.

          During the second quarter of 2006, the Company recorded an impairment charge of $503 to reflect revised estimated fair values of fixed assets at its facilities in Waterdown, Ontario, Canada and Guelph, Ontario, Canada, which were included in the manufacturing segment and had previously been closed. The revised estimates of fair values were determined based upon sales of and offers to purchase these assets.

          During December 2005, the Company announced its intention to close a facility in Waterdown, Ontario, Canada, which is included in the manufacturing segment. Accordingly, the long-lived assets at this facility were assessed for impairment. Based on the results of this assessment, the Company recorded a non-cash impairment charge of $453 to reduce the fixed assets at this facility to fair value, which was determined based upon market prices for similar assets.

          During August 2005, the Company closed a facility in Guelph, Ontario, Canada, which is included in the manufacturing segment. Accordingly, the long-lived assets at the facility were assessed for impairment. Based on the results of the assessment, the Company recorded a non-cash impairment charge of $642 to reduce the fixed assets at this facility to fair value, which was determined based upon market prices for similar assets.

          During July 2005, the Company closed a facility in Cleveland, Ohio, which is included in the performance chemicals segment. Accordingly, the long-lived assets at the facility were assessed for impairment. Based on the results of this assessment, the Company recorded a non-cash impairment charge of $758 to reduce the fixed assets at this facility to fair value, which was determined based on market transactions for similar assets.

          During December 2004, the Company closed a facility in Klamath Falls, Oregon, which is included in the performance chemicals segment. Accordingly, the Company assessed the long-lived assets at this facility for impairment. Based on the results of this assessment, the Company recorded a non-cash impairment charge of $178 to reduce the fixed assets to fair value, which was determined based on market transactions for similar assets.

Note 5 – Earnings Per Share

          The computation of basic earnings per share is based on the weighted average number of common shares outstanding during the period. The computation of diluted earnings per share assumes the foregoing and, in addition, the exercise of all warrants, stock options and restricted units, using the treasury stock method.

          The components of the denominator for basic earnings per common share and diluted earnings per common share are reconciled as follows:

-52-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

    Years Ended December 31,  
   
 

 

 

2006

 

2005

 

2004

 

 

 


 


 


 

Basic earnings per common share:

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

10,166,614

 

 

10,040,709

 

 

10,000,000

 

 

 



 



 



 

Diluted earnings per common share:

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

10,166,614

 

 

10,040,709

 

 

10,000,000

 

Options and restricted stock

 

 

808,566

 

 

72,243

 

 

27,500

 

 

 



 



 



 

Total

 

 

10,975,180

 

 

10,112,952

 

 

10,027,500

 

 

 



 



 



 

          For the year ended December 31, 2006, 2005 and 2004, there were potentially dilutive securities totaling 819,615, 3,035,877 and 1,067,973, respectively, which were not included in the computation of diluted earnings per common share due to their anti-dilutive effect.

Note 6 – Income Taxes

          Income from continuing operations before income taxes is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 


 

 

 

2006

 

2005

 

2004

 

 

 


 


 


 

United States

 

$

22,217

 

$

13,874

 

$

16,975

 

Foreign

 

 

2,657

 

 

3,474

 

10,858

 

 

 



 



 



 

Total

 

$

24,874

 

$

17,348

 

$

27,833

 

 

 



 



 



 

          The components of the income tax provision (benefit) are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 


 

 

 

2006

 

2005

 

2004

 

 

 


 


 


 

United States:

 

 

 

 

 

 

 

 

 

 

Current

 

$

689

 

$

1,461

$

(163

)

Deferred

 

 

7,016

 

 

5,395

 

 

9,940

 

Foreign:

 

 

  

 

 

 

 

 

 

 

Current

 

 

771

 

 

(7

)

 

858

 

Deferred

 

 

(461

)

 

357

 

(70

)

State:

 

 

 

 

 

 

 

 

 

 

Current

 

 

2,418

 

 

1,741

 

 

(797

)

Deferred

 

 

(1,008

)

 

(718

)

 

1,968

 

 

 



 



 



 

Total

 

$

9,425

 

$

8,229

 

$

11,736

 

 

 



 



 



 

          A summary of the components of deferred tax assets and liabilities is as follows:

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 


 

 

 

2006

 

2005

 

 

 


 


 

Net operating loss carry forwards

 

$

19,149

 

$

23,589

 

Postretirement benefits

 

 

37,161

 

 

35,983

 

Other accruals not currently deductible

 

 

33,018

 

 

30,199

 

Goodwill

 

 

19,291

 

 

21,956

 

-53-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

 

 

 

 

 

 

 

 

Foreign tax credits

 

 

19,705

 

 

19,705

 

 

 



 



 

Deferred tax assets

 

 

128,324

 

 

131,432

 

 

 



 



 

Intangibles

 

 

20,056

 

 

22,599

 

Property, plant and equipment

 

 

61,439

 

 

70,801

 

Basis differences in partnerships

 

 

8,592

 

 

8,592

 

Taxes on unremitted foreign earnings

 

 

5,657

 

 

3,178

 

Other

 

 

6,082

 

 

524

 

 

 



 



 

Deferred tax liabilities

 

 

101,826

 

 

105,694

 

Valuation allowance

 

 

20,694

 

 

20,112

 

 

 



 



 

Net deferred tax assets (liabilities)

 

$

5,804

 

$

5,626

 

 

 



 



 

          At December 31, 2006 and 2005, the Company had deferred tax assets of $19,705 and $19,705 related to foreign tax credits, for which a full valuation allowance had been provided. The increase to the valuation allowance during 2006 is primarily due to certain foreign operating loss carry forwards generated during the year for which the Company has concluded that it is more likely than not that the carry forwards will not be realized. Net operating loss carryforwards in the United States will expire in future years through 2025 and carryforwards in foreign countries expire in future years through 2015. The Company has an unrecognized deferred tax liability for a temporary difference related to an investment in a foreign subsidiary that is essentially permanent in duration. It is not currently practicable to determine the tax effect of this temporary difference. The Company will continue to monitor the likelihood of realizing its net deferred tax assets and future adjustments to the deferred tax asset valuation allowances will be recorded as necessary. The Company took advantage of the foreign earnings repatriation provision of the American Jobs Creation Act of 2004 for certain foreign earnings repatriated during 2004. The effect on tax expense of applying this provision to eligible dividends is approximately $771.

          Included in other liabilities on the balance sheet are deferred tax liabilities of $26,480 and 27,217 as of December 31, 2006 and 2005, respectively.

          The difference between the Company’s effective income tax rate and the United States statutory rate is reconciled below:

 

 

 

 

 

 

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 


 

 

 

2006

 

2005

 

2004

 

 

 


 


 


 

U.S. federal statutory rate

 

 

35.0

%

 

35.0

%

 

35.0

%

State income taxes, net of federal benefit

 

 

3.7

 

 

3.8

 

 

2.7

 

Tax effect of foreign operations

 

 

3.2

 

 

5.4

 

 

5.8

 

Benefit on restricted stock dividend payment

 

 

(3.2

)

 

 

 

 

Other

 

 

(0.8

)

 

3.2

 

 

(1.3

)

 

 



 



 



 

Total

 

 

37.9

%

 

47.4

%

 

42.2

%

 

 



 



 



 

Note 7 – Pension Plans and Other Postretirement Benefits

          The Company maintains several defined benefit pension plans covering certain employees in Canada and the United States. A participating employee’s annual postretirement pension benefit is determined by the employee’s credited service and, in most plans, final average annual earnings with the Company. Vesting requirements are from two to five years.

          The Company also sponsors several defined contribution pension plans covering certain employees in the United States. The Company’s contributions are based upon a formula utilizing an employee’s credited service and annual salary. Vesting requirements are from two to five years. The Company’s cost to provide this benefit was $0, $1,108 and $1,307 for the years ended December 31, 2006, 2005 and 2004, respectively.

-54-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

          The Company also maintains several plans providing postretirement benefits other than pensions covering certain hourly and salaried employees in Canada and the United States. The Company funds these benefits on a pay-as-you-go basis.

          Accruals for pension and other post-retirement benefit costs utilize a number of accounting mechanisms that reduce the volatility of reported costs. Differences between actuarial assumptions and actual plan results are deferred and are amortized into expense only when the accumulated differences exceed 10 percent of the greater of the projected benefit obligation or the market-related value of plan assets. If necessary, the excess is amortized over the average remaining service period of active employees. Additionally, the impact of asset performance on pension expense is recognized over a five-year phase-in period though a ‘market-related’ value of assets calculation. Since the market-related value of assets recognizes investment gains or losses over a five-year period, the future value of assets will be impacted as previously deferred gains or losses are recognized.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pension Benefits

 

Other Postretirement Benefits

 

 

 


 


 

 

 

Years Ended December 31,

 

Years Ended December 31,

 

 

 


 


 

 

 

2006

 

2005

 

2004

 

2006

 

2005

 

2004

 

 

 


 


 


 


 


 


 

Components of net periodic benefit cost:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service cost

 

$

1,613

 

$

1,540

 

$

2,636

 

$

1,343

 

$

1,164

 

$

1,189

 

Interest cost

 

 

13,417

 

 

13,094

 

 

13,869

 

 

2,674

 

 

2,551

 

 

3,587

 

Expected return on plan assets

 

 

(14,867

)

 

(14,226

)

 

(12,375

)

 

 

 

 

 

 

Amortization of net:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Prior service cost

 

 

135

 

 

74

 

 

56

 

 

(4,342

)

 

(3,672

)

 

(1,366

)

(Gain)/loss

 

 

92

 

 

5

 

 

 

 

105

 

 

(68

)

 

(163

)

 

 



 



 



 



 



 



 

Net periodic benefit cost (income)

 

$

390

 

$

487

 

$

4,186

 

$

(220

)

$

(25

)

$

3,247

 

 

 



 



 



 



 



 



 

          During 2006, the Company adopted plan amendments that froze pension plan benefit accruals for hourly employees covered by certain collective bargaining agreements, and announced the closure of one of its manufacturing facilities. These actions resulted in a net curtailment gain of $644.

          On August 31, 2005, the Company terminated and settled its two pension plans in Ireland, which resulted in a settlement loss of $626.

          During the first quarter of 2004, the Company notified its employees that benefit accruals in defined benefit pension plans covering domestic salaried and certain hourly employees would be frozen effective April 1, 2004. This action resulted in a curtailment gain of $13,414. During the second quarter of 2004, the Company accrued $1,130 of contractual termination pension benefits, related to the closure of a plant, which was recorded as a component of restructuring and impairment charges.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pension Benefits
December 31,

 

Other Postretirement Benefits
December 31,

 

 

 


 


 

 

 

2006

 

2005

 

2006

 

2005

 

 

 


 


 


 


 

Change in benefit obligation:

 

 

 

 

 

 

 

 

 

 

 

 

 

Benefit obligation at prior measurement date

 

$

240,045

 

$

240,609

 

$

48,281

 

$

50,916

 

Service cost

 

 

1,613

 

 

1,540

 

 

1,343

 

 

1,164

 

Interest cost

 

 

13,417

 

 

13,094

 

 

2,674

 

 

2,551

 

Actuarial (gain)/loss

 

 

418

 

 

10,947

 

 

3,552

 

 

6,179

 

-55-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation

 

 

17

 

 

(776

)

 

10

 

 

160

 

Benefits paid

 

 

(15,754

)

 

(15,053

)

 

(5,239

)

 

(4,959

)

Plan amendments

 

 

949

 

 

(102

)

 

 

 

(7,730

)

Settlements and curtailments

 

 

(466

)

 

(10,214

)

 

 

 

 

 

 



 



 



 



 

Benefit obligation at measurement date

 

$

240,239

 

$

240,045

 

$

50,621

 

$

48,281

 

 

 



 



 



 



 

Change in plan assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of assets at prior measurement date

 

$

191,608

 

$

168,108

 

$

 

$

 

Actual return on plan assets

 

 

25,260

 

 

11,764

 

 

 

 

 

Employer contributions

 

 

355

 

 

37,522

 

 

5,239

 

 

4,959

 

Foreign currency translation

 

 

88

 

 

(519

)

 

 

 

 

Benefits paid

 

 

(15,754

)

 

(15,053

)

 

(5,239

)

 

(4,959

)

Settlements

 

 

 

 

(10,214

)

 

 

 

 

 

 



 



 



 



 

Fair value of assets at measurement date

 

$

201,557

 

$

191,608

 

$

 

$

 

 

 



 



 



 



 

Funded status:

 

 

 

 

 

 

 

 

 

 

 

 

 

Funded status

 

$

(38,682

)

$

(48,437

)

$

(50,621

)

$

(48,281

)

Amounts recognized in the balance sheet:

 

 

 

 

 

 

 

 

 

 

 

 

 

Noncurrent assets

 

$

45

 

$

1,417

 

$

 

$

 

Current liabilities

 

 

 

 

 

 

(3,492

)

 

(4,338

)

Noncurrent liabilities

 

 

(38,727

)

 

(45,013

)

 

(47,110

)

 

(63,176

)

 

 



 



 



 



 

Net amount recognized

 

$

(38,682

)

$

(43,596

)

$

(50,602

)

$

(67,514

)

 

 



 



 



 



 

 

Amounts recognized in accumulated other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

Prior service cost (credit)

 

$

1,584

 

 

N/A

 

$

(16,515

)

 

N/A

 

Net actuarial loss

 

 

2,211

 

 

N/A

 

 

5,055

 

 

N/A

 

 

 



 

 

 

 



 

 

 

 

Net amount recognized

 

$

3,795

 

 

N/A

 

$

(11,460

)

 

N/A

 

 

 



 

 

 

 



 

 

 

 

 

Amounts expected to be recognized during the next fiscal year:

 

 

 

 

 

 

 

 

 

 

 

 

 

Prior service cost (credit)

 

$

137

 

 

N/A

 

$

(4,342

)

 

N/A

 

Actuarial loss

 

 

115

 

 

N/A

 

 

127

 

 

N/A

 

 

 



 

 

 

 



 

 

 

 

Total

 

$

252

 

 

 

 

$

(4,215

)

 

 

 

 

 



 

 

 

 



 

 

 

 

          During the third quarter of 2004, the Company adopted the provisions of FASB Staff Position No. FAS 106-2, “Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003” (FSP FAS 106-2). The effect of adopting FSP FAS 106-2 was a reduction to the accumulated postretirement benefit obligation of $8,220. This reduction will be amortized as a component of net periodic postretirement benefit cost over the average remaining service periods of active plan participants.

          Effective June 1, 2005, the Company implemented plan amendments to one of its postretirement medical plans which cap the Company’s cost for providing these benefits at current levels. The effect of these changes was a reduction to the accumulated postretirement benefit obligation of $7,730 which will be amortized as a component of net periodic postretirement benefit cost over the average remaining service period until full eligibility of active plan participants.

-56-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

          Additionally, effective July 1, 2004, the Company implemented plan amendments to certain postretirement medical plans, which cap the Company’s cost for providing these benefits at current levels. The effect of these changes was a reduction to the accumulated postretirement benefit obligation of $18,165 which will be amortized as a component of net periodic postretirement benefit cost over the average remaining service period until full eligibility of active plan participants.

          The accumulated benefit obligations for the defined benefit pension plans were $237,758 and $236,185 at December 31, 2006 and 2005, respectively. For pension plans included above with aggregate benefit obligations and accumulated benefit obligations in excess of plan assets, at December 31, 2006 and 2005, the projected benefit obligations were $236,639 and $236,828, respectively, the accumulated benefit obligations were $234,410 and $233,181, respectively, and the fair values of plan assets for these plans were $197,912 and $188,057, respectively.

          Gross benefits expected to be paid from the plans and Medicare Part D federal subsidy payments expected to be received are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pension
Benefits

 

Other
Postretirement
Benefits

 

Federal
Subsidies

 

 

 

 



 

 



 



 

2007

 

 

$

15,900

 

 

 

$

3,500

 

 

 

$

400

 

 

2008

 

 

 

15,700

 

 

 

 

3,500

 

 

 

 

500

 

 

2009

 

 

 

15,900

 

 

 

 

3,500

 

 

 

 

600

 

 

2010

 

 

 

16,000

 

 

 

 

3,600

 

 

 

 

600

 

 

2011

 

 

 

16,200

 

 

 

 

3,600

 

 

 

 

600

 

 

2012-2016

 

 

 

84,500

 

 

 

 

18,700

 

 

 

 

2,900

 

 

          The weighted-average assumptions used to determine benefit obligations for the plans were:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

2005

 

2004

 

 

 


 


 


 

Discount rate

 

 

%

 

 

%

 

 

%

 

Average rate of increase in employee compensation

 

 

4

%

 

 

4

%

 

 

4

%

 

          The weighted-average assumptions used to determine net periodic benefit cost for the plans were:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

2005

 

2004

 

 

 


 


 


 

Discount rate

 

 

%

 

 

%

 

 

6

%

 

Long-term rate of return on assets

 

 

8

%

 

 

8

%

 

 

8

%

 

Average rate of increase in employee compensation

 

 

4

%

 

 

4

%

 

 

5

%

 

          The health care cost trend rate used in accounting for the medical plans was eight percent in 2006 (decreasing to six percent in the year 2009 and beyond) and nine percent in 2005 (decreasing to six percent in the year 2009 and beyond). A one percent increase in the health care trend rate would increase the accumulated postretirement benefit obligation by $3,587 at year-end 2006 and the net periodic cost by $428 for the year. A one percent decrease in the health care trend rate would decrease the accumulated postretirement benefit obligation by $2,963 at year-end 2006 and the net periodic cost by $371 for the year.

-57-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

          The expected long-term rate of return on assets is developed based upon the expected future return of asset classes the plans invest in, along with the expected future mix of investments in the pension trusts. The Company considers historical returns of the pension assets, independent market forecasts and management estimates when developing the expected long-term rate of return on assets.

          The dates used to measure plan assets and liabilities were October 31, 2006 and 2005 for all plans.

          The pension trusts’ weighted-average asset allocations at October 31, 2006 and 2005 were:

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

 

2005

 

 

 

 



 

 



 

 

Asset Category

 

 

 

 

 

 

 

Cash and short-term investments

 

 

4

%

 

 

1

%

 

Debt securities

 

 

37

%

 

 

44

%

 

Equity securities

 

 

58

%

 

 

54

%

 

Real estate

 

 

1

%

 

 

1

%

 

 

 



 

 



 

 

 

 

 

100

%

 

 

100

%

 

 

 



 

 



 

 

          The Company’s investment policy for its pension trusts is to balance risk and return through a diversified portfolio of fixed income securities, equity securities and private equity investments. Maturities for fixed income securities are managed such that sufficient liquidity exists to meet near-term benefit payment obligations. In 2007, the Company expects to contribute approximately $1,312 to its pension plan trusts.

Note 8 – Commitments and Contingencies

          Future minimum rental payments for operating leases (primarily for transportation equipment, offices and warehouses) having initial or remaining noncancellable lease terms in excess of one year as of December 31, 2006 are as follows:

 

 

 

 

 

Years Ending December 31,

 

 

 

 


 

 

 

 

2007

 

$

3,882

 

2008

 

 

3,317

 

2009

 

 

2,400

 

2010

 

 

2,206

 

2011

 

 

609

 

thereafter

 

 

403

 

 

 



 

 

 

$

12,817

 

 

 



 

          Rental expense for the years ended December 31, 2006, 2005 and 2004 was $7,892, $7,703 and $8,334, respectively.

-58-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

Environmental Matters

          Accruals for environmental liabilities are recorded based on current interpretations of applicable environmental laws and regulations when it is probable that a liability has been incurred and the amount of such liability can be reasonably estimated. Estimates are established based upon information available to management to date, the nature and extent of the environmental liability, the Company’s experience with similar activities undertaken, estimates obtained from outside consultants and the legal and regulatory framework in the jurisdiction in which the liability arose. The potential costs related to environmental matters and their estimated impact on future operations are difficult to predict due to the uncertainties regarding the extent of any required remediation, the complexity and interpretation of applicable laws and regulations, possible modification of existing laws and regulations or the adoption of new laws or regulations in the future, and the numerous alternative remediation methods and their related varying costs. The material components of the Company’s environmental accruals include potential costs, as applicable, for investigation, monitoring, remediation and ongoing maintenance activities at any affected site. Accrued liabilities for environmental matters do not include third-party recoveries nor have they been discounted. The time frame over which these liabilities will be paid out is subject to significant uncertainties, and is not presently determinable. Activity in the aggregate accrued liability for environmental matters is summarized as follows:

 

 

 

 

 

 

 

 

 

 

2006

 

2005

 

 

 


 


 

Balance at beginning of period

 

$

27,325

 

$

34,532

 

Accruals, net

 

 

495

 

 

2,117

 

Payments

 

 

(2,808

)

 

(6,570

)

Transfer of liability

 

 

 

 

(2,765

)

Foreign exchange and other

 

 

2

 

 

11

 

 

 



 



 

Balance at end of period

 

$

25,014

 

$

27,325

 

 

 



 



 

          On April 30, 2004, the Company and Honeywell International Inc. entered into a settlement agreement relating to the Company’s proposed rejection in the Company’s bankruptcy proceedings of certain executory contracts dealing with environmental issues at sites formerly owned by Honeywell’s predecessor, along with certain other claims made by Honeywell. The settlement agreement provides, among other things, that the Company will transfer ownership of two sites to Honeywell in exchange for Honeywell assuming all environmental liabilities at these sites, along with any groundwater contamination at another site. In addition, Honeywell agreed to share with the Company the costs of certain environmental remediation at two other sites that will continue to be owned by GenTek. Accordingly, the Company recorded a receivable of $6,000, which represents amounts expected to be received over the next several years from Honeywell in accordance with the cost sharing provisions of the agreement. The balance remaining to be received at December 31, 2006 was $426.

Contingencies

          The Company is involved in various claims, litigation, administrative proceedings and investigations. Although the amount of any ultimate liability which could arise with respect to these matters cannot be accurately predicted, it is the opinion of management, based upon currently available information, that any such liability will have no material adverse effect on the Company’s financial condition, results of operations or cash flows.

-59-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

Note 9 – Additional Financial Information

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 


 

 

 

2006

 

2005

 

 

 


 


 

Receivables

 

 

 

 

 

 

 

Trade

 

$

82,430

 

$

88,678

 

Other

 

 

2,436

 

 

7,330

 

Allowance for doubtful accounts

 

 

(4,453

)

 

(4,048

)

 

 



 



 

 

 

$

80,413

 

$

91,960

 

 

 



 



 


 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 


 

 

 

2006

 

2005

 

 

 


 


 

Inventories

 

 

 

 

 

 

 

Raw materials

 

$

24,888

 

$

14,832

 

Work in process

 

 

6,389

 

 

6,341

 

Finished products

 

 

14,430

 

 

12,923

 

Supplies and containers

 

 

1,178

 

 

1,747

 

 

 



 



 

 

 

$

46,885

 

$

35,843

 

 

 



 



 

          Inventories valued at LIFO amounted to $14,376 and $11,247 at December 31, 2006 and 2005, respectively, which were below estimated replacement cost by $2,550 and $1,689, respectively. The impact of LIFO liquidations in 2006, 2005 and 2004 was not significant.

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 


 

 

 

2006

 

2005

 

 

 


 


 

Property, Plant and Equipment

 

 

 

 

 

 

 

Land and improvements

 

$

46,225

 

$

44,167

 

Machinery and equipment

 

 

217,303

 

 

189,361

 

Buildings and leasehold improvements

 

 

40,716

 

 

41,244

 

Construction in progress

 

 

18,985

 

 

15,103

 

 

 



 



 

 

 

 

323,229

 

 

289,875

 

Less: accumulated depreciation and amortization

 

 

(91,049

)

 

(68,529

)

 

 



 



 

 

 

$

232,180

 

$

221,346

 

 

 



 



 


 

 

 

 

 

 

 

 

 

 

 

 

 

Performance
Chemicals

 

Manufacturing

 

Total

 

 

 


 


 


 

Goodwill

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2005

 

 

12,127

 

 

135,201

 

 

147,328

 

Foreign currency translation

 

 

 

 

41

 

 

41

 

 

 


 


 


 

Balance at December 31, 2005

 

 

12,127

 

 

135,242

 

 

147,369

 

Foreign currency translation

 

 

 

 

5

 

 

5

 

Acquisitions

 

 

2,879

 

 

 

 

2,879

 

 

 


 


 


 

Balance at December 31, 2006

 

$

15,006

 

$

135,247

 

$

150,253

 

 

 


 


 


 


-60-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

 

 

December 31,

 

Weighted Average Life

 

 

 


 

 

 

 

2006

 

2005

 

 

 

 


 


 


 

Intangible Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Patents – gross

 

$

12,997

 

$

13,055

 

 

13 ½ years

 

Accumulated amortization

 

 

(3,003

)

 

(2,040

)

 

 

 

 

 



 



 

 

 

 

Patents – net

 

 

9,994

 

 

11,015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Customer related – gross

 

 

35,000

 

 

35,000

 

 

9 years

 

Accumulated amortization

 

 

(13,770

)

 

(9,351

)

 

 

 

 

 



 



 

 

 

 

Customer related – net

 

 

21,230

 

 

25,649

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Technology – gross

 

 

4,100

 

 

 

 

7 years

 

Accumulated amortization

 

 

(240

)

 

 

 

 

 

 

 



 



 

 

 

 

Technology – net

 

 

3,860

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-compete agreements – gross

 

 

4,941

 

 

 

 

5 years

 

Accumulated amortization

 

 

(322

)

 

 

 

 

 

 

 



 



 

 

 

 

Non-compete agreements – net

 

 

4,619

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trademarks – indefinite life

 

 

17,000

 

 

17,000

 

 

 

 

 

 



 



 

 

 

 

 

 

$

56,703

 

$

53,664

 

 

 

 

 

 



 



 

 

 

 

          During the years ended December 31, 2006, 2005 and 2004, the Company recognized $5,942, $5,382 and $5,372 of amortization expense, respectively. The estimated amortization expense for each of the next 5 years is $6,935, $6,239, $5,967, $4,819 and $4,560.

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 


 

 

 

2006

 

2005

 

 

 


 


 

Accrued Liabilities

 

 

 

 

 

 

 

Wages, salaries and benefits

 

$

20,818

 

$

21,058

 

Interest

 

 

4,559

 

 

4,760

 

Environmental

 

 

4,291

 

 

5,104

 

Dividends

 

 

 

 

2,354

 

Taxes, other than income taxes

 

 

3,558

 

 

4,433

 

Other

 

 

23,795

 

 

16,966

 

 

 


 


 

 

 

$

57,021

 

$

54,675

 

 

 


 


 

Note 10 – Long-Term Debt

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

 

 

 


 

 

 

 

 

 

2006

 

2005

 

 

 

 

 

 


 


 

Revolving credit facility – floating rates

 

 

2010

 

$

10,000

 

$

 

First lien term loan – floating rates

 

 

2011

 

 

219,053

 

 

221,283

 

Second lien term loan – floating rates

 

 

2012

 

 

113,000

 

 

135,000

 

Other debt – various rates

 

 

2006-2018

 

 

3,246

 

 

3,986

 

 

 

 

 

 



 



 

Total debt

 

 

 

 

 

345,299

 

 

360,269

 

Less: current portion

 

 

 

 

 

4,612

 

 

3,840

 

 

 

 

 

 



 



 

Net long-term debt

 

 

 

 

$

340,687

 

$

356,429

 

 

 

 

 

 



 



 

-61-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

          Aggregate maturities of long-term debt are as follows: 2007, $4,612; 2008, $2,538; 2009, $2,487; 2010, $169,483; 2011, $53,018; thereafter, $113,161.

          On February 28, 2005, the Company closed on a secured financing consisting of $370,000 of term loans and a $60,000 revolving credit facility (the “Credit Facilities”). In conjunction with securing the Credit Facilities, all amounts outstanding under the Company’s then-outstanding revolving credit facility were repaid and the underlying credit agreement was terminated, and the Company recorded a charge in interest expense of $3,030 to write-off the related deferred financing costs. The term loans include a $235,000 first lien loan due on February 28, 2011 with an initial interest rate of LIBOR plus 2.75 percent or base rate plus 1.75 percent, subject to a rate reduction of 0.25 percent if such term loan is rated B1 or better by Moody’s Investor Services, Inc. and a $135,000 second lien loan due on February 28, 2012 with an initial interest rate of LIBOR plus 5.75 percent or base rate plus 4.75 percent. On April 26, 2006, the Company entered into amendments of its first and second lien term loan agreements, which reduced the interest rate margins by 50 and 150 basis points, respectively. In addition, the debt holders agreed to allow a redemption of the second lien term loan. On May 1, 2006, the Company repaid $22,000 of its second lien term loan. In connection with the amendments, the Company recorded charges of $3,572 for certain costs related to the amendment and to write-off certain deferred financing costs. In September, 2006, Moody’s Investor Services upgraded the first lien loan to B1, which resulted in a 0.25 percent rate reduction. The interest rates in effect at December 31, 2005 were 7.1 percent and 9.9 percent on the first lien and second lien loans, respectively. The interest rates in effect at December 31, 2006 were 7.38 percent and 9.62 percent on the first and second lien loans, respectively. The first lien term loan is subject to amortization of $2,230 per year for five years, with the remainder payable over the sixth year. There is no amortization over the term of the second lien loan. The $60,000 revolving credit facility matures on February 28, 2010 and carried an initial interest rate of LIBOR plus 2.75 percent or base rate plus 1.75 percent, subject to rate reductions under a pricing grid if the Company’s leverage ratio decreases. In October, 2006, the interest rate on the revolving credit facility decreased 0.25 percent as a result of the Company’s improved leverage ratio. The interest rate in effect on the revolving credit facility at December 31, 2006 was 7.85 percent. There were no borrowings outstanding under the revolving credit facility at December 31, 2005. The Credit Facilities are secured by liens on substantially all of the personal property and certain real property of the Company and its domestic subsidiaries. The Credit Facilities contain covenants which impose certain restrictions on the Company’s ability to, among other things, incur additional debt, pay dividends, make investments or sell assets. Additionally, if certain tests are not met, a portion of excess cash flow, as defined in the Credit Facilities, and certain non-recurring cash inflows such as proceeds from asset sales, insurance recoveries, and equity offerings must be used to pay down indebtedness and may not be reborrowed. In addition, the Credit Facilities contain certain financial covenants which include a maximum leverage ratio, minimum interest coverage ratio and maximum annual capital expenditures.

          Commitment fees paid for the Company’s credit facilities were $212, $249 and $319 for the years ended December 31, 2006, 2005 and 2004, respectively. The unused letter of credit balance available under the Company’s credit facilities was $29,634 and $23,672 at December 31, 2006 and 2005, respectively.

Note 11 – Warrants

-62-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

          The Company has the following warrants outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2006

 

December 31, 2005

 

 

 

 

 

 


 


 

 

 

Expiration Date

 

Number of
shares covered

 

 

Strike Price

 

Number of
shares covered

 

Strike Price

 

 

 


 


 

 


 


 


 

Tranche B

 

 

November 10, 2008

 

 

1,996,735

 

$

19.98

 

 

1,998,091

 

$

19.98

 

Tranche C

 

 

November 10, 2010

 

 

975,147

 

$

22.03

 

 

975,831

 

$

22.03

 

          The terms of the warrants provide for the number of shares covered by the warrants and the strike price to be adjusted in the case of certain events, including dividends. During March 2005 and December 2004, the Company paid special dividends of $31.00 and $7.00 per share, respectively, and the number of shares covered by the warrants and their strike price was adjusted pursuant their terms.

          In addition, the Company formerly had 1,173,184 Tranche A warrants outstanding. The terms of the Tranche A warrants contained a contingent redemption feature, which was triggered by a sale of all or substantially all of the assets of the communications business. Accordingly, these warrants were classified as temporary equity. The sale of the KRONE communications business triggered the contingent redemption feature. The Company made the required payment of $8,365 ($7.13 per warrant) on June 30, 2004 and the Tranche A warrants expired. The difference between the amount paid and the carrying amount was treated as a reduction in stockholder’s equity.

          During 2006 and 2005, 2,037 and 91 shares of common stock were issued upon exercise of warrants.

Note 12 – Stock Incentive Plans

          The Company has an incentive plan under which stock options, restricted stock and other stock–based awards may be granted to employees, officers and directors. Grants under the plan generally vest over three years and options have a maximum term of ten years. Exercise prices for stock option grants are set at market value on the grant date. Compensation cost recorded for stock-based compensation under this plan was $1,793, $1,176 and $1,483 for the years ended December 31, 2006, 2005 and 2004, respectively. As of December 31, 2006, the total number of shares authorized for grant under this plan was 1,000,000 with 283,960 shares available for future grant.

          Information with respect to restricted stock is summarized below:

 

 

 

 

 

 

 

 

 

 

Shares

 

Weighted
Average
Grant-Date
Value

 

 

 


 


 

Outstanding at December 31, 2005

 

 

79,261

 

$

21.20

 

Granted

 

 

97,904

 

 

27.90

 

Vested

 

 

39,758

 

 

26.76

 

Forfeited

 

 

8,815

 

 

23.85

 

 

 



 

 

 

 

Outstanding at December 31, 2006

 

 

128,592

 

$

24.40

 

 

 



 

 

 

 

          Information with respect to stock options is summarized below:

-63-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options

 

Weighted Average Exercise Price

 

Weighted
Average
Remaining
Contractual Life

 

Aggregate
Intrinsic
Value

 

 

 

 


 


 


 


 

 

Outstanding at December 31, 2005

 

 

388,783

 

$

11.52

 

 

 

 

 

 

 

 

Granted

 

 

97,728

 

 

26.92

 

 

 

 

 

 

 

 

Exercised

 

 

74,019

 

 

11.23

 

 

 

 

 

 

 

 

Forfeited

 

 

45,644

 

 

14.71

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2006

 

 

366,848

 

$

15.28

 

 

8.3

 

$

6,388

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

Vested or expected to vest at December 31, 2006

 

 

329,193

 

$

15.04

 

 

8.3

 

$

5,842

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

Exercisable at December 31, 2006

 

 

110,252

 

$

11.31

 

 

7.8

 

$

2,566

 

 

 

 



 

 

 

 

 

 

 

 

 

 

          The fair value of each option grant was estimated using the Black-Scholes option pricing model that uses the assumptions noted in the following table. The expected term of the options was based on the contractual term of the option and expected employee exercise and post-vesting employment termination behavior. Expected volatility was calculated based on the historic volatility of the Company’s stock. The risk-free rate was based on U.S. Treasury issues with a remaining term equal to the expected term of the options at the grant date.

 

 

 

 

 

 

 

 

 

 

2006

 

 

 

 

 


 

 

 

Dividend yield

 

 

 

 

 

Expected volatility

 

 

31

%

 

 

Risk-free interest rate

 

 

5.02

%

 

 

Expected holding period (in years)

 

 

4

 

 

 

Weighted average fair value

 

$

8.74

 

 

          As a result of the special dividends of $31.00 per share and $7.00 per share in March 2005 and December 2004, respectively, outstanding stock options were modified pursuant to equitable adjustment calculations to maintain the aggregate amount of intrinsic value for the options and to ensure that the ratio of the exercise price per share to the market value per share was not reduced. The effect of this modification was to increase the number of options outstanding by 223,605 and 20,589 and reduce the exercise price of the options from $31.14 to $11.03 and from $36.00 to $31.14 in 2005 and 2004, respectively.

          The total intrinsic value of options exercised was $1,126, $241 and $0 during the years ended December 31, 2006, 2005 and 2004, respectively. The Company generally issues new shares upon the exercise of stock options. The total tax benefit realized as a result of stock option exercises was $445, $95 and $0 during the years ended December 31, 2006, 2005 and 2004, respectively.

          As of December 31, 2006, there was $2,061 of total unrecognized compensation cost that is expected to be recognized over a weighted average period of 1.9 years.

Note 13 – Financial Instruments

Interest Rate Collar Agreements

-64-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

          The Company periodically enters into derivative financial instruments to reduce the Company’s exposure to investments in variable interest rates on its outstanding debt. Derivative financial instruments are only entered into with strong creditworthy counterparties. In April, 2005, the Company entered into two no-cost interest rate collar agreements, effectively hedging $185 million of its LIBOR-based floating rate debt for five years. In September 2005, the Company designated these agreements as cash flow hedges. These instruments are 100 percent effective, and therefore there is no impact on earnings due to hedge ineffectiveness. As a result of entering into the agreements, the interest rate to be paid by the Company relating to the hedged portion of its debt will be based on a minimum three-month LIBOR rate of 4.05 percent on average and a maximum three-month LIBOR rate of 5.00 percent.

Fair Value of Financial Instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

 


 

 

 

 

2006

 

2005

 

 

 

 


 


 

 

 

 

Carrying
Amount

 

Fair Value

 

Carrying
Amount

 

Fair Value

 

 

 

 


 


 


 


 

 

Held to maturity securities

 

$

 

$

 

$

2,254

 

$

2,252

 

 

Long-term debt

 

$

345,299

 

$

348,236

 

$

360,269

 

$

361,810

 

 

Derivative instruments

 

$

1,614

 

$

1,614

 

$

1,160

 

$

1,160

 

          The fair values of cash and cash equivalents, receivables and payables approximate their carrying values due to the short-term nature of the instruments. Held to maturity securities represents U.S. Treasury securities maturing on February 28, 2006, whose fair value was based on quoted market prices. The fair value of the Company’s long-term debt was based on quoted market prices for traded debt and discounted cash flow analyses on its nontraded debt. The fair value of the Company’s interest rate collar agreements is the estimated amount the Company would pay or receive to terminate the collar agreements based upon quoted market prices as provided by financial institutions which are counterparties to the collar agreements.

Note 14 – Geographic and Industry Segment Information

          GenTek operates through two primary business segments: manufacturing and performance chemicals. The business segments were determined based on several factors including products and services provided and markets served. The manufacturing segment provides a broad range of engineered components and services to the automotive and industrial markets. The performance chemicals segment provides products and services to four principal markets: water treatment, chemical processing, pharmaceutical and personal care and technology. The accounting policies of the segments are the same as those described in the summary of significant accounting policies.

-65-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
(Dollars in thousands, except per share data)

          Industry segment information is summarized as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Net Revenues   Operating Profit (Loss)  
   
 
 
    Years Ended December 31,   Years Ended December 31,  
   
 
 

 

 

2006

 

2005

 

2004

 

2006

 

2005

 

2004

 

 

 


 


 


 


 


 


 

Manufacturing

 

$

238,021

 

$

222,384

 

$

214,550

 

$

15,112

 

$

20,693

 

$

22,214

 

Performance chemicals

 

 

373,347

 

 

334,113

 

 

316,573

 

 

44,710

 

 

29,377

 

 

21,257

 

Corporate

 

 

 

 

 

 

 

 

(6,113

)

 

(10,839

)

 

(11,413

)

 

 



 



 



 



 



 



 

Consolidated

 

$

611,368

 

$

556,497

 

$

531,123

 

 

53,709

 

 

39,231

 

 

32,058

 

 

 



 



 



 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

 

 

 

 

 

 

 

 

 

29,137

 

 

24,736

 

 

7,938

 

Other (income), expense net

 

 

 

 

 

 

 

 

 

 

 

(302

)

 

(2,853

)

 

(3,712

)

 

 

 

 

 

 

 

 

 

 

 



 



 



 

Consolidated income (loss) from continuing operations before income taxes

 

 

 

 

 

 

 

 

 

 

$

24,874

 

$

17,348

 

$

27,832

 

 

 

 

 

 

 

 

 

 

 

 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Expenditures

 

Depreciation and Amortization

 

 

 


 


 

 

 

Years Ended December 31,

 

Years Ended December 31,

 

 

 


 


 

 

 

2006

 

2005

 

2004

 

2006

 

2005

 

2004

 

 

 


 


 


 


 


 


 

Manufacturing

 

$

4,606

 

$

4,696

 

$

4,984

 

$

16,240

 

$

17,774

 

$

20,165

 

Performance chemicals

 

 

17,684

 

 

16,909

 

 

20,056

 

 

18,466

 

 

17,648

 

 

19,292

 

Corporate

 

 

119

 

 

 

 

 

 

1,608

 

 

1,802

 

 

718

 

 

 



 



 



 



 



 



 

Consolidated

 

$

22,409

 

$

21,605

 

$

25,040

 

$

36,314

 

$

37,224

 

$

40,175

 

 

 



 



 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Identifiable Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

2005

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 


 

 

Manufacturing

 

 

 

 

 

 

 

 

 

 

 

 

 

$

315,428

 

$

313,550

 

 

Performance chemicals(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

289,978

 

 

268,428

 

 

Corporate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13,256

 

 

35,318

 

 

Assets held for sale

 

 

 

 

 

 

 

 

 

 

 

 

 

 

111,544

 

 

143,779

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 



 

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

$

730,206

 

$

761,075

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 



 


 

 


(1)

Includes equity method investments of $288 and $273, respectively.

 

 

 

Geographic area information is summarized as follows:


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External Revenues(1)

 

Long-Lived Assets(2)

 

 

 

 

 

 


 


 

 

 

 

 

 

Year Ended December 31,

 

December 31,

 

 

 

 

 

 


 


 

 

 

 

 

 

2006

 

2005

 

2004

 

2006

 

2005

 

 

 

 

 

 


 


 


 


 


 

United States

 

 

 

 

$

505,648

 

$

456,590

 

$

438,831

 

$

231,203

 

$

223,568

 

Canada

 

 

 

 

 

50,240

 

 

55,296

 

 

51,713

 

 

6,603

 

 

10,299

 

Other foreign

 

 

 

 

 

55,480

 

 

44,611

 

 

40,579

 

 

1,887

 

 

433

 

 

 

 

 

 



 



 



 



 



 

Consolidated

 

 

 

 

$

611,368

 

$

556,497

 

$

531,123

 

$

239,693

 

$

234,300

 

 

 

 

 

 



 



 



 



 



 


 

 


(1)

Revenues are attributed to geographic areas based on the locations of customers.

 

 

(2)

Represents all non-current assets except deferred tax assets, goodwill and other intangible assets.

Note 15 – Related Party Transactions

Management Agreement

-66-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

          The Company was party to a management agreement with Latona Associates Inc., which is controlled by a former stockholder of the Company, under which the Company received corporate supervisory and administrative services and strategic guidance. The management agreement expired in November 2004. Pursuant to this agreement, the Company was charged $3,000 for the year ended December 31, 2004.

Other Transactions

          GenTek provides The General Chemical Group Inc. (“GCG”) with certain administrative services pursuant to a transition support agreement entered into in connection with the spinoff of GenTek from GCG in 1999. For the years ended December 31, 2006, 2005 and 2004, GenTek charged GCG $561, $842 and $1,214, respectively, related to this agreement. GCG supplies soda ash to GenTek. For the years ended December 31, 2006, 2005 and 2004, purchases from GCG amounted to $2,934, $2,386, and $2,675, respectively.

Note 16 – Discontinued Operations

          On March 25, 2004, the Company signed a definitive agreement to sell its KRONE communications business. The transaction was completed on May 18, 2004 and resulted in a gain of $185,044, net of a tax provision of $81,115 of which $5,560 represents the current or cash portion and $75,555 represents the deferred portion. The net gain is included in income from discontinued operations. This business was formerly reported as part of the communications segment, which is no longer a reportable segment.

          During the second quarter of 2005, the Company ceased operations of its printing plate business. The business had become unprofitable as it has experienced severe competitive pressures over the last several years and has been hurt by a continued shift in technology in the printing plate market. This business was formerly reported as part of the communications segment, which is no longer a reportable segment.

          During April 2006, the Company completed the sale of its cable and wire manufacturing business in Stouffville, Canada. All requirements for classifying this business as “held for sale” were met during the first quarter of 2006. Accordingly, the Company recorded an impairment charge of $2,458 in order to reflect assets to be sold at net realizable value, which has been included in income (loss) from discontinued operations, related to property, plant and equipment and goodwill allocated to the business. This business was formerly reported as part of the manufacturing segment.

          On December 22, 2006, the Company announced that it had signed a definitive agreement to sell its Noma wire and cable assembly business to Electrical Components International, Inc. Accordingly, the Company recorded an impairment charge of $11,907 in order to reflect the net assets to be sold at net realizable value, which has been included in income (loss) from discontinued operations, related to property, plant and equipment, goodwill and other intangible assets. This business was formerly reported as part of the manufacturing segment. GenTek’s wire and cable manufacturing business has and will continue to supply the Noma wire and cable assembly business with wire used as a raw material. These sales are expected to continue through 2007, after which time any future sales will be subject to open market bidding. The principal factors used to conclude that the expected continuing cash flows are not direct cash flows were the length of time the transactions are expected to continue and the magnitude of

-67-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Dollars in thousands, except per share data)

the expected transactions versus the expected amount of revenue for the Noma wire and cable assembly business. Based on the factors, the expected continuing cash flows are not expected to be significant. Revenues between the wire and cable manufacturing business and the Noma wire and cable assembly business that were previously eliminated in consolidation were $37,578, $28,886 and $16,282 for the years ended December 31, 2006, 2005 and 2004, respectively.

          Because the net proceeds of the Noma wire and cable assembly business sale are required to be used to repay certain outstanding indebtedness, interest expense of $5,380 and $3,660 for the years ending December 31, 2006 and 2005, respectively, has been allocated to discontinued operations. This allocation was performed using the estimated net proceeds of the sale and the interest costs incurred in the periods on the debt that requires the repayment.

         The components of assets held for sale were as follows:

 

 

 

 

 

 

 

 

 

 

December 31,

 

 
 

 

 

2006

 

2005

 

 

 


 


 

Accounts receivable

 

$

37,965

 

$

36,151

 

Inventories

 

 

40,686

 

 

41,520

 

Other current assets

 

 

2,389

 

 

1,699

 

Property, plant and equipment

 

 

23,008

 

 

47,103

 

Other assets

 

 

7,496

 

 

17,306

 

 

 



 



 

 

 

$

111,544

 

$

143,779

 

 

 



 



 

          The components of liabilities of businesses held for sale were as follows:

 

 

 

 

 

 

 

 

 

 

December 31,

 

   
 

 

 

2006

 

2005

 

 

 


 


 

Accounts payable

 

$

20,002

 

$

26,893

 

Accrued liabilities

 

 

9,468

 

 

9,863

 

Current portion of long-term debt

 

 

457

 

 

417

 

Long-term debt

 

 

589

 

 

1,047

 

 

 



 



 

 

 

$

30,516

 

$

38,220

 

 

 



 



 

          The businesses included in discontinued operations had revenues of $299,164, $367,471 and $443,754 and pretax profit (loss) of $(25,672), $(15,301) and $2,807 for the years ended December 31, 2006, 2005 and 2004, respectively.

-68-


GENTEK INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – (Concluded)
(Dollars in thousands, except per share data)

Note 17 – Unaudited Quarterly Information

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

 

 


 

 

 

First

 

Second

 

Third

 

Fourth

 

 

 


 


 


 


 

Net revenues(1)

 

$

143,413

 

$

153,434

 

$

163,122

 

$

151,399

 

Gross profit

 

 

26,874

 

 

29,887

 

 

28,425

 

 

22,376

 

Net income (loss)

 

 

3,387

(2)

 

4,153

(3)

 

2,882

(4)

 

(12,525

)(5)

 

 



 



 



 



 

Earnings (loss) per common share – basic:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

0.33

 

$

0.41

 

$

0.28

 

$

(1.23

)

 

 



 



 



 



 

Earnings (loss) per common share – diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

0.33

 

$

0.38

 

$

0.26

 

$

(1.09

)

 

 



 



 



 



 


 

 


(1)

Excludes revenues relating to discontinued operations of $107,274, $70,323, $61,822, and $59,745, respectively.

 

 

(2)

Includes restructuring charges of $501.

 

 

(3)

Includes restructuring charges of $851 and a pension curtailment gain of $635.

 

 

(4)

Includes restructuring charges of $246.

 

 

(5)

Includes restructuring and impairment charges of $1,376 and a pension curtailment gain of $9.


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2005

 

 

 


 

 

 

First

 

Second

 

Third

 

Fourth

 

 

 


 


 


 


 

Net revenues(1)

 

$

133,873

 

$

141,864

 

$

143,540

 

$

137,220

 

Gross profit

 

 

23,351

 

 

29,320

 

 

25,621

 

 

25,370

 

Net income (loss)

 

 

(1,027

)(2)

 

976

(3)

 

1,335

(4)

 

(2,106

)(5)

 

 



 



 



 



 

Earnings (loss) per common share – basic:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(0.10

)

$

0.10

 

$

0.13

 

$

(0.21

)

 

 



 



 



 



 

Earnings (loss) per common share – diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(0.10

)

$

0.10

 

$

0.13

 

$

(0.21

)

 

 



 



 



 



 


 

 


(1)

Excludes revenues relating to discontinued operations of $92,402, $84,716, $93,980 and $96,373, respectively.

 

 

(2)

Includes restructuring charges of $2,901.

 

 

(3)

Includes restructuring charges of $914.

 

 

(4)

Includes restructuring and impairment charges of $2,433 and a pension settlement loss of $626.

 

 

(5)

Includes restructuring and impairment charges of $741.

Note 18 – Subsequent Events

          On February 6, 2007, the Company acquired the assets of Chalum, Inc. for approximately $3,200. The acquisition included the manufacturing facility in Sacaton, Arizona. Chalum produces aluminum sulfate for the greater Phoenix, Arizona municipal water treatment market.

          On February 16, 2007, the Company completed the sale of its Noma wire and cable harness assembly business for $75,000, plus a working capital adjustment.

          On March 19, 2007, the Company completed an amendment to its credit facilities which enabled it to increase borrowings under the first lien term loan by $50,000 and to use these borrowings and the net proceeds from the Noma wire and cable harness assembly business sale to redeem the entire second lien term loan.

-69-


Item 9. – Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

          None.

Item 9A. – Controls and Procedures

Disclosure Controls and Procedures

          The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures are effective at the reasonable assurance level in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act.

Management’s Report On Internal Control Over Financial Reporting

          The management of GenTek Inc is responsible for establishing and maintaining adequate internal control over financial reporting for the Company, as such term is defined in Exchange Act Rules 13a-15(f). The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles.

          Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

          Under the supervision of its principal executive and principal financial officer and with the participation of its management, we conducted an evaluation of the effectiveness of its internal control over financial reporting based on the framework in the Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on its evaluation under the framework in the Internal Control – Integrated Framework issued by COSO, its management concluded that the Company’s internal control over financial reporting was effective at a reasonable assurance level as of December 31, 2006.

          GenTek Inc. acquired the assets of Precision Engine Products Corp. on July 31, 2006, and management’s conclusions about the effectiveness of its internal control over financial reporting does not extend to the internal controls of this business. This business had total assets of $37 million as of December 31, 2006 and total revenues of approximately $20 million for the five months ended December 31, 2006, which are included in our consolidated financial statements.

          GenTek’s independent registered public accounting firm, Deloitte & Touche LLP, has audited GenTek’s financial statements for the year ended December 31, 2006 included in this annual report on Form 10-K and, as part of that audit, have issued a report on management’s assessment of internal control over financial reporting, a copy of which is included in this annual report on Form 10-K.

-70-


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of
GenTek Inc.
Parsippany, New Jersey

          We have audited management’s assessment, included in the accompanying Management’s Report On Internal Control Over Financial Reporting, that GenTek Inc. and subsidiaries (the “Company”) maintained effective internal control over financial reporting as of December 31, 2006, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. As described in Management’s Report On Internal Control Over Financial Reporting, management excluded from its assessment the internal control over financial reporting at Precision Engine Products, which was acquired on July 31, 2006 and whose financial statements constitute 5 percent of total assets and 3 percent of revenues of the consolidated financial statement amounts as of and for the year ended December 31, 2006. Accordingly, our audit did not include the internal control over financial reporting at Precision Engine Products. The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express an opinion on management’s assessment and an opinion on the effectiveness of the Company’s internal control over financial reporting based on our audit.

          We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinions.

          A company’s internal control over financial reporting is a process designed by, or under the supervision of, the company’s principal executive and principal financial officers, or persons performing similar functions, and effected by the company’s board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

          Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that

-71-


the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

          In our opinion, management’s assessment that the Company maintained effective internal control over financial reporting as of December 31, 2006, is fairly stated, in all material respects, based on the criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2006, based on the criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.

          We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated financial statements and financial statement schedule as of and for the year ended December 31, 2006 of the Company and our report dated March 20, 2007 expressed an unqualified opinion on those financial statements and financial statement schedule and included explanatory paragraphs which indicate that (1) the Company changed its method of accounting for stock based compensations to adopt the provisions of Statement of Financial Accounting Standard No. 123(R), Share-Based Payment, (2) changed its method of accounting for pension and other postretirement benefits to adopt the provisions of Statement of Financial Accounting Standard No. 158, Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans and (3) classified the operations of the Noma wire and cable assembly business as discontinued operations in accordance with Statement of Financial Accounting Standard No. 144, Accounting for Impairment or Disposal of Long-Lived Assets.

/s/ Deloitte & Touche LLP
Parsippany, New Jersey
March 20, 2007

-72-


Changes in Internal Control Over Financial Reporting

          There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART III

Item 10. Directors and Executive Officers of the Registrant.

          Directors. For information relating to the Company’s Directors, see the information under the caption “Election of Directors” in the Company’s definitive 2006 Proxy Statement to be filed with the Securities and Exchange Commission pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended, within 120 days after the fiscal year ended December 31, 2006 (the “Proxy Statement”), which is hereby incorporated by reference.

          Executive Officers. For information relating to the Company’s executive officers, see the information contained under the caption “Executive Officers and Key Employees” in Part I of this report.

          Compliance with Section 16(a) of the Exchange Act. For information relating to the compliance of the directors and officers of the Company, as well as any holder of ten percent or more of any registered class of the equity securities of the Company with Section 16(a) of the Exchange Act, see the information under the caption “Section 16(a) Beneficial Ownership Reporting Compliance” in the Company’s Proxy Statement, which is hereby incorporated by reference.

Item 11. Executive Compensation.

          Executive Compensation. For information relating to the compensation of the Company’s executives, see the information under the caption “Executive Compensation” in the Company’s Proxy Statement, which is hereby incorporated by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management.

          Security Ownership of Certain Beneficial Owners. For information relating to the beneficial ownership of more than five percent of the Company’s Common Stock, see the information under the caption “Security Ownership of Management and Certain Beneficial Owners” in the Company’s Proxy Statement, which is hereby incorporated by reference.

          Security Ownership of Management. For information relating to the beneficial ownership of the Company’s Common Stock by Management, see the information under the caption “Security Ownership of Management and Certain Beneficial Owners” in the Company’s Proxy Statement, which is hereby incorporated by reference.

          Securities Authorized for Issuance Under Equity Compensation Plans. For certain information relating to equity compensation plans, see the information under the caption “Equity Compensation Plan Information” in the Company’s Proxy Statement, which is hereby incorporated by reference.

-73-


Item 13. Certain Relationships and Related Transactions.

          Certain Relationships and Related Transactions. For information relating to certain relationships and related transactions of the Company, see the information under the caption “Certain Relationships and Related Transactions” in the Company’s Proxy Statement, which is hereby incorporated by reference.

Item 14. Principal Accounting Fees and Services

          Principal Accountant Fees and Services. For information relating to the principal accountant fees and services, see the information under the caption “Principal Accountant Fees and Services” in the Company’s Proxy Statement, which is hereby incorporated by reference.

PART IV

Item 15. Exhibits and Financial Statement Schedules.

Financial Statements

See Item 8.

Financial Statement Schedules

See Index to Financial Statement Schedule on page 79.

List of Exhibits

 

 

 

Exhibit No.

 

Description


 


2.1

 

Joint Plan of Reorganization Under Chapter 11, Title 11, United States Code of GenTek Inc., et al., and Noma Company, Debtors, dated August 28, 2003, as filed with the United States Bankruptcy Court for the District of Delaware on August 28, 2003 (incorporated by reference to Exhibit 2.1 of the Registrant’s Form 8-K, filed with the Commission on October 21, 2003).

 

 

 

2.2

 

First Modification to Joint Plan of Reorganization Under Chapter 11, Title 11, United States Code of GenTek Inc., et al., and Noma Company, Debtors, dated October 3, 2003 as filed with the United States Bankruptcy Court for the District of Delaware on October 3, 2003 (incorporated by reference to Exhibit 2.2 of the Registrant’s Form 8-K, filed with the Commission on October 21, 2003).

 

 

 

2.3

 

Order confirming Joint Plan of Reorganization Under Chapter 11, Title 11, United States Code of GenTek Inc., et al., and Noma Company, Debtors, as Modified, as entered by the United States Bankruptcy Court for the District of Delaware on October 7, 2003 (incorporated by reference to Exhibit 2.3 of the Registrant’s Form 8-K, filed with the Commission on October 21, 2003).

 

 

 

3.1

 

Third Amended and Restated Certificate of Incorporation of GenTek Inc., effective as of May 9, 2006 (incorporated by reference to the Registrant’s Form 10-Q, dated March 31, 2006, as filed with the Securities and Exchange Commission).

-74-



 

 

 

3.2  

 

Amended and Restated By-Laws of GenTek Inc., effective as of March 9, 2006 (incorporated by reference to the Registrant’s Form 8-K/A, dated March 9, 2006, as filed with the Securities and Exchange Commission).

 

 

 

4.1  

 

GenTek Inc. Tranche B Warrant Agreement, dated as of November 10, 2003 (incorporated by reference to the Registrant’s Form 8-A to amend its Form 10, dated November 10, 2003, as filed with the Securities and Exchange Commission).

 

 

 

4.2  

 

GenTek Inc. Tranche C Warrant Agreement, dated as of November 10, 2003 (incorporated by reference to the Registrant’s Form 8-A to amend its Form 10, dated November 10, 2003, as filed with the Securities and Exchange Commission).

 

 

 

10.1

 

Form of Registration Rights Agreement by and among the Company and the holders named therein dated as of November 10, 2003 (incorporated by reference to the Registrant’s Form 8-A to amend its Form 10, dated November 10, 2003, as filed with the Securities and Exchange Commission).

 

 

 

10.2

 

GenTek Inc. 2003 Management and Directors Incentive Plan (incorporated by reference to the Registrant’s Form 10-Q dated September 30, 2003, as filed with the Securities and Exchange Commission).

 

 

 

10.3

 

GenTek Key Employee Retention Plan (incorporated by reference to Exhibit 10.14 to the Registrant’s Form 10-K/A dated April 30, 2003, as filed with the Securities and Exchange Commission).

 

 

 

10.4

 

Form of Indemnification Agreement (incorporated by reference to the Registrant’s Form 10-K dated December 31, 2003, as filed with the Securities and Exchange Commission).

 

 

 

10.5

 

GenTek Performance Plan (incorporated by reference to the Exhibit 10.3 to the Registrant’s Amendment No. 2 to Form 10, dated April 8, 1999, as filed with the Securities and Exchange Commission).

 

 

 

10.6

 

Tax Sharing Agreement between GenTek Inc. and the General Chemical Group Inc. (incorporated by reference to the Exhibit 10.6 to the Registrant’s Amendment No. 2 to Form 10, dated April 8, 1999, as filed with the Securities and Exchange Commission).

 

 

 

10.7

 

Share Purchase Agreement by and among ADC Telecommunications Inc., Krone International Holding Inc., Krone Digital Communications Inc., GenTek Holding Corporation, and GenTek Inc., dated March 25, 2004 (incorporated by reference to Exhibit 10.14 of the Registrant’s Form 10-Q for the period ended March 31, 2004, as filed with the Securities and Exchange Commission).

 

 

 

10.8

 

Form of Director Restricted Stock Agreement (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

10.9

 

Form of Emergence Shares Restricted Stock Agreement (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange Commission).

-75-



 

 

 

10.10

 

Form of Restricted Stock Agreement (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

10.11

 

Form of Stock Option Agreement (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

10.12

 

Form of Performance Cash Award Agreement (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

10.13

 

Retention Agreement with Matthew R. Friel (incorporated by reference to the Registrant’s Form 10-Q dated September 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

10.14

 

Form of Letter Agreement and Term Sheet with Matthew R. Friel (incorporated by reference to the Registrant’s Form 10-Q dated September 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

10.15

 

Master Settlement Agreement, dated April 30, 2004, among GenTek Holding Corporation, General Chemical LLC, and Honeywell International Inc. (incorporated by reference to the Registrant’s Form 10-Q dated September 30, 2004, as filed with the Securities and Exchange Commission).

 

 

 

10.16

 

First Lien Credit and Guaranty Agreement among GenTek, Inc., GenTek Holding LLC, as borrower, the other guarantors party thereto, the lenders party thereto from time to time, Goldman Sachs Credit Partners L.P., as joint lead arranger, General Electric Capital Corporation, as co-administrative agent, and Bank of America, N.A., as co-administrative agent and collateral agent, dated February 28, 2005 (incorporated by reference to the Registrant’s Form 10-K dated December 31, 2005, as filed with the Securities and Exchange Commission).

 

 

 

10.17

 

Second Lien Credit and Guaranty Agreement among GenTek, Inc., GenTek Holding LLC, as borrower, the other guarantors party thereto, the lenders party thereto from time to time, Goldman Sachs Credit Partners L.P., as joint lead arranger, sole bookrunner, syndication agent, administrative agent and as collateral agent, Bank of America Securities LLC, as joint lead arranger and Bank of America, N.A., as documentation agent, dated February 28, 2005 (incorporated by reference to the Registrant’s Form 10-K dated December 31, 2005, as filed with the Securities and Exchange Commission).

 

 

 

10.18

 

Employment Agreement with William E. Redmond, Jr., dated May 23, 2005 (incorporated by reference to the Registrant’s Form 10-Q dated September 30, 2005, as filed with the Securities and Exchange Commission).

 

 

 

10.19

 

Employment agreement with Andrew Hines, dated September 21, 2005 (incorporated by reference to the Registrant’s Form 10-Q dated September 30, 2005, as filed with the Securities and Exchange Commission).

 

 

 

10.20

 

Employment agreement with Maximo Vargas, dated September 22, 2005 (incorporated by reference to the Registrant’s Form 10-Q dated September 30, 2005, as filed with the Securities and Exchange Commission).

-76-



 

 

 

10.21

 

Asset Purchase Agreement dated April 3, 2006 between Noma Company and Southwire Canada Company (incorporated by reference to the Registrant’s Form 8-K dated April 3, 2006, as filed with the Securities and Exchange Commission).

 

 

 

10.22

 

First Amendment to First Lien Credit and Guaranty Agreement and Pledge and Security Agreement dated April 26, 2006 (incorporated by reference to the Registrant’s Form 8-K dated April 26, 2006, as filed with the Securities and Exchange Commission).

 

 

 

10.23

 

First Amendment to Second Lien Credit and Guaranty Agreement dated April 26, 2006 (incorporated by reference to the Registrant’s Form 8-K dated April 26, 2006, as filed with the Securities and Exchange Commission).

 

 

 

10.24

 

Asset Purchase Agreement dated June 30, 2006 between Defiance, Inc., Precision Engine Products Corp. and Stanadyne Corporation (incorporated by reference to the Registrant’s Form 8-K dated June 30, 2006, as filed with the Securities and Exchange Commission).

 

 

 

10.25

 

Second Amendment to First Lien Credit and Guaranty Agreement dated July 14, 2006 (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2006, as filed with the Securities and Exchange Commission).

 

 

 

10.26

 

Second Amendment to Second Lien Credit and Guaranty Agreement dated July 14, 2006 (incorporated by reference to the Registrant’s Form 10-Q dated June 30, 2006, as filed with the Securities and Exchange Commission).

 

 

 

10.27

 

Letter Agreement with James Imbriaco, dated July 27, 2006 (incorporated by reference to the Registrant’s Form 8-K dated August 4, 2006, as filed with the Securities and Exchange Commission).

 

 

 

10.28

 

Asset Purchase Agreement dated December 22, 2006 between Electrical Components International, Inc., Noma Holding Inc. and GenTek Inc. (incorporated by reference to the Registrant’s Form 8-K dated December 22, 2006, as filed with the Securities and Exchange Commission).

 

 

 

10.29

 

Third Amendment to First Lien Credit and Guaranty Agreement and Waiver dated March 19, 2007.

 

 

 

21   

 

Subsidiaries of the Registrant.

 

 

 

23   

 

Consent of Independent Registered Public Accounting Firm.

 

 

 

31.1

 

GenTek Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2

 

Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32   

 

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.

-77-


SIGNATURES

          Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 20th day of March, 2006.

 

 

 

 

GENTEK INC.

 

 

By: 

/s/ William E. Redmond, Jr.

 

 


 

 

Name: William E. Redmond, Jr.
Title:   President and Chief Executive Officer

          Pursuant to the requirements of the Securities Exchange Act of 1934, this Registration Statement has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

 

 

 

 

Signature

 

Title

 

Date


 


 


 

 

 

 

 

Principal executive officer:

 

 

 

 

 

 

 

 

 

/s/ William E. Redmond, Jr.

 

President and Chief Executive Officer

 

March 20, 2007


 

 

 

 

William E. Redmond, Jr.

 

 

 

 

 

 

 

 

 

Principal financial and accounting officer:

 

 

 

 

 

 

 

 

 

/s/ Thomas B. Testa

 

Vice President and Chief Financial Officer

 

March 20, 2007


 

 

 

 

Thomas B. Testa

 

 

 

 

 

 

 

 

 

Directors:

 

 

 

 

 

 

 

 

 

/s/ John G. Johnson, Jr.

 

Chairman and Director

 

March 20, 2007


 

 

 

 

John G. Johnson, Jr.

 

 

 

 

 

 

 

 

 

/s/ Henry L. Druker

 

Director

 

March 20, 2007


 

 

 

 

Henry L. Druker

 

 

 

 

 

 

 

 

 

/s/ Kathleen R. Flaherty

 

Director

 

March 20, 2007


 

 

 

 

Kathleen R. Flaherty

 

 

 

 

 

 

 

 

 

/s/ John F. McGovern

 

Director

 

March 20, 2007


 

 

 

 

John F. McGovern

 

 

 

 

 

 

 

 

 

/s/ William E. Redmond, Jr.

 

Director

 

March 20, 2007


 

 

 

 

William E. Redmond, Jr.

 

 

 

 

 

 

 

 

 

 

 

Director

 

 


 

 

 

 

Richard A. Rubin

 

 

 

 

-78-


GENTEK INC.
INDEX TO FINANCIAL STATEMENT SCHEDULE

 

 

Schedule II — Valuation and Qualifying Accounts

80

Schedules required by Article 12 of Regulation S-X, other than those listed above, are omitted because of the absence of the conditions under which they are required or because the required information is included in the consolidated financial statements or notes thereto.

-79-


GENTEK INC.
Valuation and Qualifying Accounts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at
Beginning of
Period

 

Additions
Charged
To Income

 

Deductions
From Reserves

 

Other*

 

Balance at
End of Period

 

 

 


 


 


 


 


 

 

 

(In thousands)

 

Year ended December 31, 2006
Allowance for doubtful accounts

 

$

4,048

 

$

412

 

$

(692

)

$

685

 

$

4,453

 

Year ended December 31, 2005
Allowance for doubtful accounts

 

$

6,109

 

$

720

 

$

(2,505

)

$

(276

)

$

4,048

 

Year ended December 31, 2004
Allowance for doubtful accounts

 

$

6,550

 

$

1,244

 

$

(1,829

)

$

144

 

$

6,109

 


 

 

*

Primarily foreign exchange and acquisitions

-80-


GRAPHIC 2 c47397001.jpg GRAPHIC begin 644 c47397001.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^X`#D%D M;V)E`&3``````?_;`(0`!@0$!`4$!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`, M#`P,#`P0#`X/$`\.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-#`T8$!`8 M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\? M'Q\?'Q\?'Q\?_\``$0@!5@((`P$1``(1`0,1`?_$`+P``0`"`P$!```````` M```````$!0(#!@$'`0$``P$!`0```````````````0(#!00&$```!0$$!@4& M"P4$"`8#`0```0(#!`41$A0&(1/3E!4',2)25%5!T3)3=#518;%RDK(C,Y.S M%G&!0N,DD:%B<])#@S1$)1<(@L)CU)56P:+$)A$!``$"`@<%!@4#!0$````` M``$1`C$#(4&1T1(3!%%QH10%\(&QP3)"8>'Q(I)2@M)BHN(C)`;_V@`,`P$` M`A$#$0`_`.XF0@B M5URML25U("FI7*O.#588EIHK4"(N7"=IS"7F%<'**_#MTF`^V5QZ:Q2I,B&XAI^.VMTC<0;B3N)-5TR)2.FSX0&EN-7UMI5Q%DKQ M$=F%/RE_F@,L)7_$6=U/:@&$K_B+.ZGM0#"5_P`19W4]J`82O^(L[J>U`,)7 M_$6=U/:@&$K_`(BSNI[4`PE?\19W4]J`82O^(L[J>U`,)7_$6=U/:@&$K_B+ M.ZGM0#"5_P`19W4]J`82O^(L[J>U`,)7_$6=U/:@&$K_`(BSNI[4`PE?\19W M4]J`82O^(L[J>U`,)7_$6=U/:@&$K_B+.ZGM0#"5_P`19W4]J`82O^(L[J>U M`,)7_$6=U/:@&$K_`(BSNI[4`PE?\19W4]J`82O^(L[J>U`,)7_$6=U/:@&$ MK_B+.ZGM0#"5_P`19W4]J`82O^(L[J>U`,)7_$6=U/:@&$K_`(BSNI[4`PE? M\19W4]J`82O^(L[J>U`,)7_$6=U/:@&$K_B+.ZGM0#"5_P`19W4]J`82O^(L M[J>U`,)7_$6=U/:@&$K_`(BSNI[4`PE?\19W4]J`82O^(L[J>U`,)7_$6=U/ M:@&$K_B+.ZGM0#"5_P`19W4]J`82O^(L[J>U`,)7_$6=U/:@&$K_`(BSNI[4 M`PE?\19W4]J`82O^(L[J>U`,)7_$6=U/:@&$K_B+.ZGM0#"5_P`19W4]J`82 MO^(L[J>U`,)7_$6=U/:@&$K_`(BSNI[4`PE?\19W4]J`82O^(L[J>U`,)7_$ M6=U/:@&$K_B+.ZGM0#"5_P`19W4]J`CU']00X$F64]APX[2W;AQC(E7$FJRT MG?+8`N@```0:_P"XJC[*]^6H!+8^X;^:7R`,P``````````````````````` M``````````````````````````````````````````````````````!7YA]P MU'V9[ZA@+````$&O^XJC[*]^6H!+8^X;^:7R`,P````````````````````` M````````````````````````````````````````````````````````!7YA M]PU'V9[ZA@+````$&O\`N*H^RO?EJ`2V/N&_FE\@#,`````````````````` M```````````````````````````````````````````````````````````` M5^8?<-1]F>^H8"P```!!K_N*H^RO?EJ`2V/N&_FE\@#,```````````````` M``````````````````````````````````````````````````````?/NR`..PO5R]SE[(`X["]7+W.7L@#CL+UR`..PO5R]SE[(` MX["]7+W.7L@#CL+UR`..PO5R]SE[(`X["]7+W.7L@#CL+UR`.. MPO5R]SE[(`X["]7+W.7L@#CL+UR`..PO5R]SE[(`X["]7+W.7L@#CL+ MUR`..PO5R]SE[(`X["]7+W.7L@#CL+UR`..PO5R]SE[(`X["]7 M+W.7L@#CL+UR`..PO5R]SE[(`X["]7+W.7L@#CL+UR`..PO5R] MSE[(`X["]7+W.7L@#CL+UR`..PO5R]SE[(`X["]7+W.7L@#CL+UR`..PO5R]SE[(`X["]7+W.7L@#CL+UR`..PO5R]SE[(`X["]7+W.7L M@#CL+UR`..PO5R]SE[(`X["]7+W.7L@#CL+UR`..PO5R]SE[(` MX["]7+W.7L@#CL+UR`..PO5R]SE[(`X["]7+W.7L@#CL+UR`.. MPO5R]SE[(`X["]7+W.7L@#CL+UR`..PO5R]SE[(!IFYIHT&&_-F*D1X MD9M3TA]V)*2A#:"O*4I1MV$1$0#D,N+:S#5%9NS#!D&A17R`..PO5R]SE[(`X M["]7+W.7L@#CL+UR`0:]6H:Z)4$$W*(U1W2(U1)22M-!EI,VR(OVF`R M/(V2C96P=!I^H/K=.D!);ROEIJ3(E-4J(W)END M_*>2PV2W72)1$XXHBM4K[16D_A/X0&F/DK)\;!X>AP&>'+4[`U<9E.H<69&I M;5B>HI1I*TR^`!+K_N*H^RO?EJ`2V/N&_FE\@#,````````````````````` M```````````````````````````````````````````````!PCJBSWF%49%C MF3*#(2^H8 M"P```!!K_N*H^RO?EJ`2V/N&_FE\@#,````````````````````````````` M``````````````````````````````````````'(YQJM2G3FN MJ-4:(CX?!)1)4Y:?0^_I;8+X;R^A`#HZ32J=2*;&IE.83&@Q$$TPP@K"2DOE M,^DS/29Z0$L```````%?F'W#4?9GOJ&`L````0:_[BJ/LKWY:@$MC[AOYI?( M`S`````````````````````````````````````````````````````````` M````````%)F[,I4*G(4PSC*O.NEN$RVVN/)0I"UJ; M0C7)6VDV"6IY!(4[=)5XKMH"]K_N*H^RO?EJ`2V/N&_FE\@#,``````````` M`````````````````````````````````````````````````````!PJTEGK M,!MF1.9,H4@R<*WJ5&I,*+186A<>(LM.FQ;I666-Z0[H```````````%?F'W M#4?9GOJ&`X2H\HZG58I-A*_L#;N MW3M-1*-1F8;*7R>P"*E'.L*?ASX4JEMDMC[9N'.D/RG[SNLL<>-V3U7+I$1% MI09G:`ALE3GHCE9N1-6EY%/>C/QDLEKE:D[T-)+,[]ZT["2` M^@9GC-R,OU!#AK(BCO*+5K6V=I-J\J#2=GQ`/&*!3S9;ZTGT2_XN5\'^8`SX M!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4 M_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[ M4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U) MWN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[ ME;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6 MT`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M` M#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X M!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4 M_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[ M4G>Y6T`.`4_M2=[E;0!Q^:V%5"K,Y.R_)DLSI#9/URHMS)%^GP%'=M21K46O MD6*0T1]'67_#I#J8&4:'3X3$&"V_'AQ4):CL-RI*4(0DK"2DB<`;^`4_M2=[ ME;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6 MT`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`0:]0X**)/6E4B\F.ZHK94E1 M6D@STD;AD?[P%^```"#7_<51]E>_+4`EL?<-_-+Y`&8````````````````` M`````````````````````````````````````````````HLX9GX%3V\,PBA)))#:/X4$1`+T````````````!7YA]PU'V9[ZA@+````$&O^ MXJC[*]^6H!+8^X;^:7R`,P`````````````````````````````````````` M``````````````````````$2K5:G4>F2JI4GTQ8$)M3TF0OT4(05IGHM,_V% MI,!SF4*549]0=SA7HYQJK,;5&ID!1VX*G&N^A"B*TM>]8E;Q_-1T)TAUP``` M```````````K\P^X:C[,]]0P%@```"#7_<51]E>_+4`EL?<-_-+Y`&8````` M```````````````````````````````````````````````````````#A6C/ M/.8B>,E'D^@R#)E*DVM5.H-'9K-/I1XCA=318MTKQ'8@K0[H```````````` M```%?F'W#4?9GOJ&`L````0:_P"XJC[*]^6H!+8^X;^:7R`,P``````````` M````````````````````````````````````````````````<9FRIS:U5?T5 M1'E-/K0A[,51:-250H+AF1-MK26B3)))I;TVI3>7Y$VAU=-IT"F0(]/I["(L M&(VEF-':*ZA#:"L2E)%Y"(!(```````````````!7YA]PU'V9[ZA@/BU6KF: MG(4UVFSLPE!-V3A;\>2GXK`&+$G,&I;_H(_HI_XI?P?Y`#9B

'QMZ7L`# M$Y@\/C;TO8`&)S!X?&WI>P`,3F#P^-O2]@`8G,'A\;>E[``Q.8/#XV]+V`!B M

'QMZ7L`#$Y@\/C;TO8`&)S!X?&WI>P`,3F#P^-O2]@`8G,'A\;>E[``Q. M8/#XV]+V`!B

'QMZ7L`#$Y@\/C;TO8`&)S!X?&WI>P`,3F#P^-O2]@`8G, M'A\;>E[``Q.8/#XV]+V`!B

'QMZ7L`#$Y@\/C;TO8`&)S!X?&WI>P`,3F# MP^-O2]@`8G,'A\;>E[``Q.8/#XV]+V`!B

'QMZ7L`#$Y@\/C;TO8`&)S!X M?&WI>P`,3F#P^-O2]@`8G,'A\;>E[``Q.8/#XV]+V`!B

'QMZ7L`#$Y@\/ MC;TO8`&)S!X?&WI>P`,3F#P^-O2]@`8G,'A\;>E[``Q.8/#XV]+V`!B

'Q MMZ7L`#$Y@\/C;TO8`&)S!X?&WI>P`,3F#P^-O2]@`8G,'A\;>E[``Q.8/#XV M]+V`!B

'QMZ7L`#$Y@\/C;TO8`*3-.;:]1X\=B-3(TJM5)THU)@%+4:G'3 MTJ<46I(R993]HZKR)+X3(`RG0:UEZF'&U#4^?(<5)J=3>E+ULJ2NR^ZHM3U2 MT$E""T)21)+H`7>)S!X?&WI>P`,3F#P^-O2]@`8G,'A\;>E[``Q.8/#XV]+V M`!B

'QMZ7L`#$Y@\/C;TO8`&)S!X?&WI>P`,3F#P^-O2]@`8G,'A\;>E[` M`Q.8/#XV]+V`!B

'QMZ7L`#$Y@\/C;TO8`&)S!X?&WI>P`0*[(KIT2>2X, M=*#CNWE%)49D5P[3(M25O]H#H````0:_[BJ/LKWY:@$MC[AOYI?(`S`````` M```````````````````````````````````````````````````0JW6:=1*3 M+JU2>)B#";4\^Z>FQ*2Z"(M*E'T)26DST$`Y[)M'J4N8]F_,#.JK,]!M4^$H MBMI].49+1&.S_7+,B6^?:L27500#K@`````````````````!7YA]PU'V9[ZA M@+````$&O^XJC[*]^6H!+8^X;^:7R`,P```````````````````````````` M````````````````````````````'#03_7&8&ZH=OZ2H,@SI5U1&BH3VC4A< ME5EMYB,JU+7:5TW+0ZR#!AP(3$&$PB-#C(2U'CM))"$-H*Q*4I+01$0#>``````` M````````````"OS#[AJ/LSWU#`6````(-?\`<51]E>_+4`EL?<-_-+Y`&8`` M``````````````````````````````````````````````````"%/K=&IZ5* MGSXT-*;+QOO(:(KW1;?,NGR`/G>=N?\`DND2H=#H52B5;,=67AH!-.I=B,/K M632%3'6U'<3>5Z*>L=GDZ0';Y2RO%RY2CB-NJE2Y#JY53GN%8Y*EO:77EZ3L MO'H2GH2DB26@@%T`````````````````````K\P^X:C[,]]0P'(U/G#1X6)+ M`R"5%JJZ.Z<`XO2N^L?BH\X M!Q>E=]8_%1YP#B]*[ZQ^*CS@'%Z5WUC\5'G`.+TKOK'XJ/.`<7I7?6/Q4><` MXO2N^L?BH\X!Q>E=]8_%1YP#B]*[ZQ^*CS@'%Z5WUC\5'G`.+TKOK'XJ/.`< M7I7?6/Q4><`XO2N^L?BH\X!Q>E=]8_%1YP#B]*[ZQ^*CS@'%Z5WUC\5'G`.+ MTKOK'XJ/.`<7I7?6/Q4><`XO2N^L?BH\X!Q>E=]8_%1YP#B]*[ZQ^*CS@'%Z M5WUC\5'G`.+TKOK'XJ/.`<7I7?6/Q4><`XO2N^L?BH\X!Q>E=]8_%1YP#B]* M[ZQ^*CS@'%J59;C&+/\`,1YP'I52F'T2V3_8XCS@,5UBD(MOSHZ;.FUU!?\` MY`4=0YH\MZ>UK9F:*6TBPS+^K949D1V'8E*C,^GR"W#(KSYS]42* M[I@PY<. M_4,M0&[_`%32J3,5JS_:N&5XO[#$_M_$8E`S<^1E,S_'8M2:?^708C)VVVDH ML4Y.TV:#\@K(]7E2%(42Y^>*O)41H49-SH\-%J2L/JPVX^A7E(S_`&"`5R_Y M:.K2Y,<5/6B]8<`XO2N^L?BH\X!Q>E=]8_%1YP#B]*[ZQ^*CS@'%Z5WUC\5' MG`.+TKOK'XJ/.`<7I7?6/Q4><`XM2[+V,8NEY=8BSY0%16.862*.I**C6XC+ MJSNH9)PG'5*(K;I-MWEF>GHL&L9-\Z:-K>GS)BM)IX(*N8T:0E?"J7,FF5I( M<=U,)HU$=FE4MQI=GQD@Q/*B,;HCQ^">3$?5=;'C\*N8S?4.9=6CQ%4Y4*E7 M5+-QF)4T+=L,BLUJEI81^Y-ND=;TG-Z3+F[G:>RMOZNYZ'G=#EW7>8_=%(I6 MVOPJ[^BU..W1X+<^*:=U M=#B=7=9.;?-GT<4T[JZ$WB]*[ZQ^*CSC%YSB]*[ZQ^*CS@'%Z5WUC\5'G`.+ MTKOK'XJ/.`@5^J4Q5#J"4S&%*5&=)*2<09F9H/06D!"JG+R@5%%00ZN6RBJR M52JBF/)=9)XUQD0UMK)!D2FU,M)3=/HZ2L/2`C0>5648*II1FGD,3FUQWHIN MJ-E,5Y;KCL9M!^@RXX^I2DI\MGP$`C1>3F38\IB79+=DM.MO/O.R7%JE&PMI MQA,FW[U+*XS9H(^BS]H#I\Q--.4&HI<0E9%&>,B41&5NK5IT@-S%.I^H;_IF MO1+^!/P?L`9\.I_=6OH)\P!PZG]U:^@GS`'#J?W5KZ"?,`<.I_=6OH)\P!PZ MG]U:^@GS`'#J?W5KZ"?,`<.I_=6OH)\P!PZG]U:^@GS`'#J?W5KZ"?,`<.I_ M=6OH)\P!PZG]U:^@GS`'#J?W5KZ"?,`<.I_=6OH)\P!PZG]U:^@GS`'#J?W5 MKZ"?,`<.I_=6OH)\P!PZG]U:^@GS`'#J?W5KZ"?,`<.I_=6OH)\P!PZG]U:^ M@GS`'#J?W5KZ"?,`<.I_=6OH)\P!PZG]U:^@GS`'#J?W5KZ"?,`<.I_=6OH) M\P!PZG]U:^@GS`'#J?W5KZ"?,`B51W+=)A.3JHJ'!A-?>29.J:;3;T6K7801 M%1S!YGD5@B3D[+93V5]%8J*#I\`B,K24B^VJ0^7P:MJZ?;(6X>T'02S>NLLDGJ6'?MM,S+3>BND=E_P!'\ENE M_7E/J2C1JUG,J$QPEE;:5Y!.I;T?-$\A5]Q*E6_':''/:+Z+1:/$:U46!'CM6F>K::0A-I])V)(B%1N.#"/ICMG^U" M?,`QX=3^ZM?03Y@#AU/[JU]!/F`.'4_NK7T$^8`X=3^ZM?03Y@#AU/[JU]!/ MF`.'4_NK7T$^8`X=3^ZM?03Y@#AU/[JU]!/F`.'4_NK7T$^8`X=3^ZM?03Y@ M#AU/[JU]!/F`.'4_NK7T$^8!75*I9/IAV5&1`AJ/027U,MJ.VPM!*L/^(A>W M+NNPBJ]F5==],3*G+.>6)-WA%(F5@U6DE42`M+6@K?OI"6&;#T6'?\HOR)C& M8CW^TM/+S'U3%O?/RBLLG59OE7DP#+C&Z9[HW[A.3\QRD_P#,:XW&-1&2VJ3"88(K;?1I3T%Z*"Z`Y]VK M1W:#S-^JEO=$1^;H(E%H\-DF(D"/'93Z+332$)+01="2(N@AE==,XZ65UTW8 MS5LX=3^[-?03YA"IPZG]U:^@GS`'#J?W5KZ"?,`<.I_=6OH)\P!PZG]U:^@G MS`'#J?W5KZ"?,`<.I_=6OH)\P"!7X$!-"J"DQFB449TR,D)M(R0?Q`+<```$ M&O\`N*H^RO?EJ`2V/N&_FE\@#,````````````````````````````````!S M6:^8V3LK?9U:HMHF*2:FX#7VLE9%Y2:1:HB_Q*L3\)B8MF1P<^-`G1`E4>F.G,;J4;)U5KM5*Q3=;S3 M)C-*01F1EJFS4\MBS2=C<9']X3=(ZG#;)!.MQTI;0A]=VQU:;I MJ2HRMZ34'4.3N:=,MUU,IN8F$D1:R"\NG23L/2>HDZ]DSL_]FU`C*?=,K3Z'I*KI:+/]2'%EQA$SWSNWIXLJ,(F>^?E&]XK($*4V:*S M5*E5R79K$/RELM*,O_2BX=O^X.=,81$>[?5'F)CZ8MCW;ZK2F96RW2S)5.I< M6*Y823=;:03AD7:79>5^\Q2[,NNQF5+\V^[&9E:"C,``````'&9VYN9)R:MA M%7FI4MY2FU-1E-O/-K)!J;2MA*]=]JI-Q)D@RO>D:2T@.MA2%R83$E;#D9;S M:'%1GKNL;-:2,T+N&M-Y-MAV*,OC`;@````%?F'W#4?9GOJ&`L````0:_P"X MJC[*]^6H!+8^X;^:7R`,P`````````````````````````!@\\RPTIUYQ+32 M"M6XLR2DB^,ST`.:D\S\@LR,,BM,3970<:GWYSQ:;-+<1+RR_L`1GL_U)QI3 MM,RK5'F4=9R5.)BF,(01$9J5BW$/$16Z?LO(8#D5J#O#H=J"T*)LW3MT71;A[1;T;E]S#GJ4]G?.LE]M1G92:*E%/8 M2D^A*Y+:&Y*]'9-`B1<4;D_RQHZU.P\MPC?6=YR3);Q3RE6DJ\IV0;JS.\5M MIGTZ1`ZUEAAAI+3+:6FD%8E"")*2(M!$1%H`5]2S1ENF6E4:K$AF5MJ7WVVU M:"M/0I1'T&+VY=UV$3*]F5==A$RK3Y@Y><4I$!,RI.)Z$PHCZQTFXJDG'E7$D9I MOK=#&#DG MFU3)QJIV:3T=!)=,3;=9&-M??^2;;\N,;9 MG^[\D>!G!U$Q'',XS*)>58J'5Z2S3BZY'=2B2Z@V5?%=<5T"T9ED3]/C*UN; MEQ/T1/OEU=/R_.F,JD(SC4)T60@R;<8P!((E%9>;6U'Z2Z2.T1&;$?;'CO1; MG6Q]EO\`N_R;(N2'&=:3F8ZU)2XBY8[)05W_`!)-MILR/]X1G4^VW8F.HI]M MNQDWD*EE%=BO3ZK);=L)9O5.8:M!VZ%)=29?N#G3V6[(W(\Q=31%O\;=S%OE MQE5,=R.MN6^RZ9&M#\^:]T$9:+[RK.GR!'47Q%-&R-R8ZJ^(I%-ENX_Z:9#. M,F*Y18[["%7TH?)3UBK++;7#4=M@>8S*4J>:S:4XIH@2.3V17)S$MB%@RCFD MTQ8UQMA1H5>Z[=T[;W0?PD/=D>L9^5E3EQ2;9KCCI=+IO7NHR7]P>_P#2S+,A"2K+U0KQEZ15.=(>:5;9Z49*VXWD]4`G)Y=9 M"2I@T9>IZ,,3J64HC-)21/HU;G5))$9J1U3,_(`O(,*+`A1X,1LF8L5M#,=H MK3)#;:22A)6VGH25@#<`````K\P^X:C[,]]0P%@```"#7_<51]E>_+4`EL?< M-_-+Y`&8```````````````````*VHYFRW3/>56AP;3(BQ,AIK2KH+KJ3T@* M%WFYR\M4B+66ISMQ2T(@MOS;;IF1V85MZVPRTV:2`RI.J M3D!M"9:F'XJ6T25*4E2+TAQ@]58DC2Y=M.WT"L,!UJ)?-:>2%-P*10VU'UBD MOOU%XD_&VRF(W;^QT_V_"&1Y-S/,295?.$Y25>DS3&8]/;\F@E7'Y!='D>\H M"LK.3.4="2FH9G0U+=5=)#U;D/5%UU2+"(FVY*WC6KXD(\O1I$Q$S@,7,WU8 MV$1Z!28N6*98245/,-V$DBO6?8TY"FWUZ3T:Q36GX1>VROX]RUMEUV$55*#R M!/>Q&8*W+SS.9,G$Q&V'7X*%D1KM9@Q$'',M'5-TW%>2]:-)RKXU:$LTO+$W4)(DM+?.-"9(B5=]%QW6I*S27V?0*\NW7='C* M>3;&-T>ZL_EXL<9S%E)-1-T:DI--J=:\_.61F1:%$A,1.@[2T*^`*9<=L[(W MHIE1_5.R-[%=(KCC9*J><7&DEH7@68D5!VWBZ72DK(^L70OI(.9;&%NV9_)/ M-LC"S;,SN:'LLY%4V956JNU!"U6V3JFZM%MJ5:$:U+9:46Z$_P!P<^Z,*1W1 M!YFZ,*1W1'ZIU.:Y;4PBX>5(B&D[24T<9"K;++;Q:;;-`I=F778S,L[LV^[& M9E:?J;+?BL/>&O\`2%&:##S]D^;F1[+<6J,/5AB.B6N.A9&1M.*-)75%U5&5 MFDB.TB,C\H#H".W270``````/%H0M)H6DE)/0:5%:1_N,!RTSE?DE]XY,6`= M)FG>/&4EUVG.VK](U*BJ:O&?^(C`:498SW3"_P"49K.>TE)DB)7(K'D85XK/@02S`;(/-' M)$E],5^H\*G*42"@U9MVG/FI5ID1-RTLFJVS1=M`=4E25))23)23Z#+20#T` M`1:C5:73(RI52F,0HR/3?D.(:;*WX5+-)$`YS_JIDMY9M4R4]6GB(CN4F+(G M%89D1'K&&UM$6GI-?R`-:LVYWFI3P;)S[9+M^WK,N/"016%8JXPE2@%X``` M``````````K\P^X:C[,]]0P$]2T)TJ41:;-)V:3`"6DS,B,C-/I$1]'[0'A. MM'=L6D[VA.DM-GP`(=?]Q5'V5[\M0"6Q]PW\TOD`9@````````-,J;"B(UDJ M0VPBTBONK2@K3Z"M49`.8J/-OE?3C4F9FJEH6DK3;3+:<7TV:$(4I1G;Y"(! MSLG_`+D>4J%FU"J;U4?Z]QF%$D.&LVRM42%*0A!_%U@$4^?Y2C1P7)68:@AQ M)+0ZJ(II"D&5IF@TZVTTV=8CL,*E6MSFGS2D$:XN1U062:0Z3TQT[-)]=)Z_ M`I29$>B\HM(01%4!>;N M-/29-Z?@$^7S*5I*T=+FTKPRG4C+V2($1$J+7W]03EU"J1EZ&V=TR-1(5JZ> M^Y81Z25:0>7OI7YP>5OI6GC&]=JAY>69K<6;[6A1V%Y3^(=CU3T6WI;;9XZ\4]FZKO>L__/V]%;;=S*\4TTQ3X5=O M67*4_-X?3:!'GU5NPN&,5*?4Y39F96D^4=28L?RZ7I*2T#D\%D:YGW4]MC@S M&5&NZ[NBGS^3;2.1E;K2CDYH;I]$9<(R*'2\0]*NF1$5^0^\ZAM9?X+Y%VC$ M<>7&%M>^=U$1F90^[`DSI39_9R94R2IU)6F=V\A M;9FG3988SNOKJB%+LRNB(B.[VJZ`N4?+'0:LL4Y:RL^TY5?_4J5NC/^B`V1^4W+ M&,\EYG*M*0ZCT5%$9T6E9Y4@)JL@9$45BLN4LR^`X4?_`$`&"N77+Y16*RQ2 M3+XX,8__`"`,FN7V063,V@`_1.88I?\KSE5&BOWC;FHB3 MD66VFFUQE+MGD^\Z/CT@/$Q.;,,NK4:+5TI(K$O19,!:M!F=KC;TM):;"T-] M`#T\R0RE(L,^BT_[@$B!S0Y>3G4LL9A@I?7Z+#[R6'3ZUW[M[5KTF6C0 M`Z./)C26DNQW4/-**U+C:B4DR/RD96D`V``#3+A0YC"H\QAN2PKTFGD)6@_V MI41D`Y9WE7E1M2W*.4K+SZU*4;E'DNPT6K](SCI,XQVV?Q-F`Y3,&4^=+=34 MU1Q#=#BO2]']7+1BY%I=!ZZ0; MKG_[`.E0A*$DA!$E*2L2DBL(B+R$0#T``````````````````5^8?<-1]F>^ MH8#Y3FKEEF1]->1%IQ56+4*K-EQ&),E*U).72&HK,O\`J%&7]/)2NZDSM0D[ M4%T$`\RSRZSQ3$Y@9=:NRZC3IE-75FWFR5,ER94I]FH.W5$X6I;=0CK?:%;8 MDKI6@*FG\J,XMUMF:W1F:?!5^9XAK.)6:+'-PKKAM9=CHO$6 MFP[L@K2%>=/;.U7G7_U3M3F,F?ISFCYC3H`8'RQK3-ITS.=7IZM-U).G,05MA$1(GJEZ"(M!`) MI9?YFQ6SPN;8LY9),DE4J6@[5&=MIJB/1-!%H+J@(*'N>,5)8N/0JD5I$I4) MR1%79I-1DW(2ZG1H(OM-)_``\5G#.,?WC0JK&(B,U+9A1IR-"2,[N%ENN'TV M%U+3^`!53^=F6Z=6:51ZA678,VK*4A")E*D1-3=3:1O%(4TJZM742:245[XK M3`7#_,G*[%NOSI2V;++=8VE%EO1Z3I`,XO,7*TJS#YYHR[UI%UF2Z.GI?(!M M7GW+2%&A>>Z$E1=*5.QB,OW'(`;(V=:#*=U47.U%?=L-6K:*XVA6CX=#P#?=JWB\;\`MJ`R0Q6EVW* MHPJSINQ[?D=`9X.O^),[M_-`,'7_`!)G=OYH!@Z_XDSNW\T!IDE5(K6ME5B, MPU>2C6.L$A-YQ1(0FU3I%:I2B(B\I@-V#K_B3.[?S0#!U_Q)G=OYH!@Z_P") M,[M_-`,'7_$F=V_F@&#K_B3.[?S0$"NQ*X5$GFNH-*04=TU)*-89E<.TK=8= M@#H0```0:_[BJ/LKWY:@$MC[AOYI?(`S```````````````````````````` M``````````````````````````'.5SESDBO5F/6ZQ1V)M5B$V4:8Z2C6V32S M6B[IT75&9@.B-*3Z2(P'AM-'TH2?[B`17J)1GG#=>@1W'%>DM;2%*.S1I,R` M:SR]0#Z:9$/_`&#?^B`B/Y'R5(MU^7Z:[:=X[\-A6GX=*.D!@G(.1$^CEREI M_9"CE_Y`$%?*3EEJHS2 M+;.BVZ16@(SO)_EJXM*U4%@E(]$T*<19IM_A60#>GE=D=#:VVX#C27/2U4J6 MV>DK+;4.D9'\9`(W_2#(WJ:A_P#+57_W0#E>9/(!O,M"BTC+U>F4%AJ3B927 MI$ZH(=4DBU?4?E6)-"BO$9`/J5'C3XM)A1JA**=/88;;ES21JR>=0@B6Y^H8"P```!!K_`+BJ/LKWY:@$MC[AOYI?(`S` M```````````````````````````````````````````````````````````` M`````````````````%?F'W#4?9GOJ&`L````0:_[BJ/LKWY:@$MC[AOYI?(` MS``````````````````````````````````````````````````````````` M```````````````````%?F'W#4?9GOJ&`L````0:_P"XJC[*]^6H!+8^X;^: M7R`,P``````````````````````````````````````````````````````` M``````````````````````!7YA]PU'V9[ZA@.:YH9MJ^6J?"E4\V4-&X\[47 M'=2IPHL>.X\O4-//Q=8Y:DM"3/1;H`<)YYTFD$M;J2,DN*59::B)1D1GIT@,&H:O*9`/:_[BJ/LKWY:@$MC[AOYI?(`S``````````````````````` M```````````````````````````````````````````````````````%?F'W M#4?9GOJ&`L````0:_P"XJC[*]^6H!+8^X;^:7R`,P``````````````````` M``````````````````````````````````````````````````````````!7 MYA]PU'V9[ZA@+````$&O^XJC[*]^6H!+8^X;^:7R`,P````````````````` M```````````````````````````````````````````````````````````` M!7YA]PU'V9[ZA@+````$&O\`N*H^RO?EJ`2V/N&_FE\@#,`````````````` M```````````````````````````````````````````````````````````` M````5^8?<-1]F>^H8"P```!!K_N*H^RO?EJ`2V/N&_FE\@#,```````````` M```````````````````````````````````````````````````````````` M``````5^8?<-1]F>^H8"P`1)U.*6[%<.0^QA7"=)##AMIF-5.G/PG5K;2\A2+[:UH,KR33;U%(,^GHM`:$9>IZ4)3?DG=(BMQ`4_M2=[E;0` MX!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.` M4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`&IO+ M<1+[SBGY2VW+NK:.5)(D72L.P];Y>D!MX!3^U)WN5M`#@%/[4G>Y6T`.`4_M M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G M>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`:E9;AG);=)^432$+2IG% M2;%*4:32HSUO\-T_[0&W@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4 MG>Y6T`.`4_M2=[E;0`X!3^U)WN5M`#@%/[4G>Y6T`.`4_M2=[E;0`X!3^U)W MN5M`#@%/[4G>Y6T`.`4_M2=[E;0!J?RW$<4T;;\IHFW"6X12I)WTD1ECDY)0;J%()9R9*R*\5EMTW+#_`&&`MP`````` M``%-G-FJ/Y2K#=)?>C5-4-[!O1B2IXG209I)LE$HKRC*PM%OP:0'`RF^8V(A M)9?J"T3\LL15H4E26XM1>D1F7'E+21+UR6W''#-:C-)).RS2`SK,+F$W$SL;44DU.&I#A'>4D]6:C/5D22`=T```````#Q9*4A24JN*,C)*[+;#^&P MP'R.6K,T!%"C/.YAEU*+)F.OU!")*XZHS%16M)/MQV]6Z]*90EIM*RU:&U&H MKMA6AY28F=T9@BP\16TOOTB0FL3']:J,Q+<89=:=C&[?B+NN&MM*"3K"5>O= M0B(!6OGGA[+=)543S"Q42IU.IS2HN,ZDU4/73*A.2PE;JR96\E))LZ[B+JBL MML"O?3S'UZU3'M5#1K4Q&'#O.72-2E)(CO6V& M$1UG/93Z1-:E5E^6NIQD:I34AN.[3XZVHLAQULKK3#CZ6UR#*0FRZJQ!$O2` MWO'G*)3GVJB==J35/?JDAU46^U)F$N:EB"RE;"4FE"FUK6>J+J-E>+R`.6J# M?-=IHT0)-;ESDH+[8D3FXW##AN&^ALG4H4>B.HF8?'I>5B4I9(F2;UA6JMZW6ND`^P```````` M`/GV>?U!&S+BT.5=^@'0YQ/PJ2E1N%*3(BZDF3;2:M>ZE3B4F9]5-XTW=)@. M5G(SE*RU*,Y%(PNE M-Y]7/J+$E^IHCU%JB*)Y))/!I2F0]441S8017[K*4*.Q1FM:?)=(!RQ*SVXT MR]3OU$R;SBETB#**HJU$G6PD-)J3KA$I:5LH><<*TV$&I2;3,B`:6#YD%%)3 MBLP&AHH[KL5YF>X4WJW$&;!&7]H??T6W2M*P["M*V MVS]X#T```````')9_CYA6[EMZCR);:&*S$.HQXOHNQ5*-+NO,B-6J0G296D7 MP@."IJ\QRE2FR_4T:BFXN4ZAPI_$$L,-X=!$Z\2?M)3KYOFRP9W$-E9USL`; MHCO,N/3LO3$%4WW&H5<:=A.)=NN.DX::<\^3MKY&X1I-"7EFI*2T]:TP$.;' MS*S/D,(E9H51HDAB'532FH+ERR0:S6F\M6@B485B$D!?@`````````````` M```````````````````````````````````````````````````````````` M`````````````````HFZ9!G5BJ*EM$\;:V4-WC5U4ZE*K"T_"9@,:K"R?28I M2JDAJ+'-1()QPU$5Y7073\0O9EW732(J3+A6Q*1>_(OMBLQ2"L.>//V5:8VZO--(9I:R:BO,,Q91SG3.62E): M<;2AE2'$I3>497D6="[=`Q2V+Y@9#F0I[U`@%.?A1I,U!2M?#CR&824+DZE\ MVW2-;9/(T&GI5^T!KJ_,7(E$;8:;=?=DDD^OJR8CK6CJ]; M1VK0%&K.].:BZV1EV*V\^S#DPHZ9RW7-5.?;:1B&VV%.H4E+R%GJD.ITW;UO M2%B55AM+O'KDW;Q)\MMFBT+')%1R] MFB+K#I!0GSB09Z6C<-TC8J,<`_3 M5"[HC^U7G`<]6ZOD"DTZ1-<;1(P]A*CLF9N&9J)%A$I22T6_".ATWIF=FWQ; M$4KKG!U>D]&ZC/S(LB.'BUSAA5HR]F+E]6J?C4LE#3?4WJI!V+ZI$=O44LK- M/PC3J_2,[)OX:<72=TC/\`;S)B8FDN/=;,32<4Q6>>5B54E-Q9 M\:)A4$R9=L4F4A+C1G;T&:5EU?2^+08A"(WS.Y.+C1Y).?9R7UL-VMNWB)HT M$MU2?2)!&ZFW1;IZ-!V!NR]F2FU_*QK)1HR9F M>GN3Z5$6J*VZJ.I;S;K)ZULBUB"2NP[6U'<5\"B,ND@%Q^FJ%W1']JO.`?IJ MA=T1_:KS@.0J^=.45*ILNH29L8VH;2W7$(4HUJN%;<01F5JE'U4EY3`843// M*"KTB'5&)D9MF8TAY+3BE$XB\5IH<(C41+0?545O2`UU#,M!@9L51I-%:8@) ML-%1DR%,:\CC'(-<8G$$PZE/H*+7DLCM.Y=*T!RL7F]EV71:;46,OQ6W:AQ` MR8D3G$7"IZ4*N'<8<!S/R/(R_!J;M%=3)E%#?** MU,-@KSSI(2DKIR#NZ.M=\GD"RC9IHL>@)S#F"@(IM(DQ69T%UF24IQ;3ZK$I M=;L:-M9)4E1V7D:;+][083LLYJY;9DJ?#J4RM;BD..,/.,NMLO$REI3I-+58 M2E-E);O%\?[0$#+^>N7U654B7#3'3"FNQ8QI6;QR&6F'GTR2)-AH2M,1ZPC[ M/Q@--"YDH5-?`6_T[1)&%JU67*)MQI28R9+CJ(ZBZ[327$DK[0EG_"A5@"([S"Y9,DV M3E/GI?6I*%QL#*-UI3BFT,DZ@B.[KE2&B;[5XK/+8&#',KE,^25ML23;<0V; M+F%D77'GF4OMQD6%:I]3:R,F^D!F]S%Y41W$IEL2(J"2LY#S\60AMAQO7WF' ME&5B'?Z-VQ'2=FCI(!@QS(Y62E$W"BR)+UPU.(;CO*)I1K4VVVZI-J4*<<3= M3Y#M(!/RQFC(N82?9B4]QF?$A-SI<5]*V]63K:7"0:S^"\6FS3TE:`J:5S/Y M8S(D5;\%^/+E-LZN.EEYU+DIYN.O"QW$D1/.)QC7016V_ML#70^:O*^H1&52 MHBX4YQIUYZ$27'5-$T:U*0HTDD[Y,M&Z:;-!:.G0`[NAP\JUNDQJK`B7H4Q. MLC..)<;-;9F=UPDJL.ZLNLD_*DR,!._35"[HC^U7G`:9M&RS"B.RY3#;,9A) MK==4:K$I+I,[#`<7F+F/R=H$9J7-D-+B+6;;CS%]PVU7%+1:@COG?--TKJ3T M]-A:0%E1,R\LZJQ!4A34:7.2V:(#ZC)Y"W2*QI9)4I)+(SL.Q72`YNJ-(DN,RG]3)3'2K4J9TMN7KZ5L*>T6$97C(@&M?,C+YS*? M'C4"/)7+AT^8ZPU--R1>GR5QU,QT--.(=6P;9J7>6C1\&D!;9@S90*#F9^FU M*AIC4F,WK5U1YUQLW4IC+D.*BMFV;;VKU=U2">)RWH09%:`R9S_RQ=C39&#E M-MT]*U2#>BOM$1MNM-.))3EU-Y!R6C5IT$JT_+8%*WS0RI/K+-,H5`343GH9 M52I"I!LH=-\HZBUMJ%FTE*9*C,^L?4L(C-0"YJ&=,CT%MAK-5.*E5%U$E:X[ M*SF-DF+K#,TNMW;U]#)J(KA**TB623,!(D9FR@JA(J-.I+C\MZHL4AJGRDN0 MUIER30:">-PE&A&K=2Y>)*NKT$9Z`$1.;\O0*LFEYER\NDODT3KTAE:IL9LU M2'F$&IUE/40YJ+R#625:;#21D`TL\T.4T@VD1(LJ4\X9$;+$5]Q:#6XTRW?N MVV:QR0VE/QJ^([`L(V;^7TB2PPU!?>5+)#C"&(TIUQ#2FVE*T@+^A9HY<5RH0:?3X[B MY=087*C-J9>3:PTI3;KBE'U22VZC5JT^D966VD8"_K67Z.S1I[K49*'&XSRD M+(U$9*)LS(RT])`+\!1QY;[-9JR6X3TDC<9,UM&R1$>I3H^T<;/^X!-XE,\* ME?2B[U%Y_IZ/WV6:;`'0R:DO# M.XJE/X:XK7ZU435ZNSK7[S]EVSIM`?+6JER9P97*54;/Z3!6JEXK5VN87A]K M^(U/IW<-U++?(`M8=2Y67'CY`%BU+RF[3*05+A2H\) M-5=72E,&TII4E.O.4V@E.J3J5MZ]*C+[,BMNGT`**)4N4NH=PM*J=ER/AKBI M>MU.++#\.^WUFIQ-VS"=3T?)8`ZB+4LMW8%ZE5'782=@\>I>*PM]O&7L4_KK M+VK]/XKN@!'R#*RXT[,7EZ',?0]%IJV6SU24LT["DF`VT;CI&INXE:K;3.\: MK=.@!U_$IGA4KZ47;@'$IGA4KZ47;@*_,%2@<'D\@:==S^/_NKQTU]C7U'S/,_]'%S*:\:*ZNU+)^MG\6I3^NQ%/Q=JF]9B M+Y8&YQ>JU-MW[>[=`3K/`6J5Z=C]NNUS]S%7=?\`??;7 M;WDM`:JE4N3VLJ_$:4K_`'IGC&M4FYB,5+U6LM?N68C$]'5Z;=%@"NH]1Y+8 M^-PRE53BFO7X9KBUV MH4SJ]?J6[WIO^G\`Z;B4SPJ5]*+MP#B4SPJ5]*+MP'.G:`ILTU+E?QN7^HJ5)Q-[^OUJE8'78-=W777\'B,)>N7OM+ MMEG\(#1DBI/(_35*F<;ULNW7*=UVOU;6+UF+?^]U>JOW^M9=`66IKOA8:RZ_<_P!Y^']_5M`44.IZ--X!#EU+D1PAW%4J5P_[+4WU2+=5>=U>!^WOX>]K/ M]W^S_N`;N6W@L`I>MP5U=S_I3_$>IQ#7 MJ_H=9A5ZK7_;X+7X:VY?^TNV7?X0$6E5+E'JFL+2I=[61K,2IW$:S&1<+K<0 M_KO]XPUR_P#PW?X`'/4V3R);EU1W"RWXSZ&5-1W=8F.PE,-M*$1%&Z252%-$ M2TW#-[387P`+U=2Y+\(3B:4OA^O+68Q6G$7)MN(U[]_6V8J]K>M>MO=:Z`F4 MRILM^K8`RRA4N6?&5<#I4WBO#NI MBE.ZSA]UJW4XQ_T;-5>N:>BT!4G4N1_#HMVE/8;7*P&J4YK<1J8?W%Q_6ZW5 MX6YJ` M^A93J5*X!%_3E*D<%^TP5Q3.KN:Q5NJUC_W5ZW5W>I=LN=6P!;\2F>%2OI1= MN`<2F>%2OI1=N`I,QU++>)IWZBI2=;?>X;CE0KM_4JUUS6/W;VIO6_X;?C`3 MZ-4F.$0N%4J1PS4MX*XJ-QU*FZ_7.X:Q4 MB[B,8WKN&7'[FNQ=R_@^M>Z?*`M^6]2YNU3^%Q&&O:NW[2RR[_" M`QKM2Y28!7$Z5(P^*7Z"E7\3K(E^[JG[]Z_AO1_T@%7`J7(;`,X&E.ZG"L87 M4J=U^IOQ MQF(/[+57>M9=N:+`&F%4N4>#5JZ4[J;S6*Q*OM+^+?NXK7OZR_B=;?UNGMZ+ M`&J@U+E)?B\/I4W77(^$Q2G]9J\;&PUW%/WKF*P]SR?!U;0&NIU+DW>BXNE2 M+]I:K5*ZE_P"X^YO:S[.V[;I`4U'J7_;Y_6<*I4W6:E6)U2INNU-D M>]=^WUEVYJ?0_A^*T!ULJI EX-10.29 3 c47397_ex10-29.htm

Exhibit 10.29

THIRD AMENDMENT TO FIRST LIEN
CREDIT AND GUARANTY AGREEMENT
AND WAIVER

          THIS THIRD AMENDMENT TO FIRST LIEN CREDIT AND GUARANTY AGREEMENT AND WAIVER dated as of March 19, 2007 (the “Agreement”) is entered into among GENTEK INC., a Delaware corporation (Holdings”), GENTEK HOLDING, LLC, a Delaware limited liability company (the “Borrower”), certain Subsidiaries of the Borrower, as Guarantors, the Lenders party hereto, Bank of America, N.A. (“BOFA”), as Collateral Agent and Co-Administrative Agent and General Electric Capital Corporation, as Co-Administrative Agent. All capitalized terms used herein and not otherwise defined herein shall have the meanings given to such terms in the Credit Agreement (as defined below).

RECITALS

          WHEREAS, Holdings, the Borrower, the Guarantors, the Lenders, Goldman Sachs Credit Partners L.P., as Joint Lead Arranger, Sole Bookrunner and Syndication Agent, Banc of America Securities LLC, as Joint Lead Arranger, General Electric Capital Corporation, as Co-Administrative Agent and Bank of America, N.A., as Collateral Agent and Co-Administrative Agent entered into that certain First Lien Credit and Guaranty Agreement dated as of February 28, 2005 (as amended or modified from time to time, the Credit Agreement”);

          WHEREAS, Noma Holding Inc. (the “Seller”) sold certain assets (the “Transferred Assets”) to Electrical Components International, Inc. (the “Purchaser”) pursuant to that certain Asset Purchase Agreement dated as of December 22, 2006 among the Purchaser, the Seller and Holdings;

          WHEREAS, the Borrower has requested that the Lenders permit the Borrower to prepay the Second Lien Term Loans in full with the Net Asset Sale Proceeds received from the sale of the Transferred Assets and the proceeds of the Term B Loans (as defined below);

          WHEREAS, the Borrower has also requested that the Lenders amend the Credit Agreement as set forth below;

          NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

          1.           Waiver. Subject to the other terms and conditions of this Agreement, notwithstanding the terms of Section 2.14(a) of the Credit Agreement and Section 6.5 of the Credit Agreement, the Lenders hereby agree that (a) the Borrower shall not be required to prepay the Loans with the Net Asset Sale Proceeds from the sale of the Transferred Assets and (b) the Borrower may prepay the Second Lien Term Loans with the proceeds of the Term B Loan; provided that the Borrower uses the Net Asset Sale Proceeds from the sale of the Transferred Assets and the proceeds of the Term B Loan to repay the Second Lien Term Loans in full on the Third Amendment Effective Date. The above waivers shall not modify or affect the Credit Parties’ obligations to comply fully with the terms of Section 2.14(a), Section 6.5 or any other duty, term, condition or covenant contained in the Credit Agreement or any other Credit Document in the future. This waiver is limited solely to the specific waivers identified in this Section 1, and nothing contained in this Agreement shall be deemed to constitute a waiver of any other rights or remedies that the Co-Administrative Agents or any Lender may have under the Credit Agreement or any other Credit Document or under applicable law.


          2.           Amendments. The Credit Agreement is hereby amended as follows:

          (a)           The following definitions are hereby added to Section 1.1 of the Credit Agreement in the appropriate alphabetical order and shall read as follows:

          “Excepted Asset Sales” means those Asset Sales described on Schedule 1.1(d) hereto.

          “Term B Loan” means a Term B Loan made by a Lender to Borrower pursuant to Section 2.1(c) .

          Term B Loan Commitment” means the commitment of a Lender to make or otherwise fund a Term B Loan and “Term B Term Loan Commitments” means such commitments of all Lenders in the aggregate. The amount of each Lender’s Term B Loan Commitment, if any, is set forth on Appendix A-3 or in the applicable Assignment Agreement, subject to any adjustment or reduction pursuant to the terms and conditions hereof. The aggregate amount of the Term B Loan Commitments as of the Third Amendment Effective Date is $50,000,000.

          “Term B Loan Exposure” means, with respect to any Lender, as of any date of determination, the outstanding principal amount of the Term B Loans of such Lender; provided, at any time prior to the making of the Term B Loans, the Term B Loan Exposure of any Lender shall be equal to such Lender’s Term B Loan Commitment.

          “Term B Loan Installment” as defined in Section 2.12(b) .

          “Term B Loan Installment Date” as defined in Section 2.12(b) .

          “Term B Loan Maturity Date” means the earlier of (i) February 28, 2011, and (ii) the date that all Term B Loans shall become due and payable in full hereunder, whether by acceleration or otherwise.

          “Term B Loan Note” means a promissory note in the form of Exhibit B-4, as it may be amended, supplemented or otherwise modified from time to time.

          “Third Amendment Effective Date” means March 19, 2007.

          (b)           Part (i) of the definition of “Applicable Margin” in Section 1.1 of the Credit Agreement is hereby amended to read as follows:

(i) with respect to Term Loans and Term B Loans that are (a) Eurodollar Rate Loans, 2.25% per annum and (b) Base Rate Loans, 1.25% per annum; provided, that in the event the Loans are rated B1 or better by Moody’s then the Applicable Margin shall be (a) 2.00% per annum with respect to Eurodollar Rate Loans and (b) 1.00% per annum with respect to Base Rate Loans;

          (c)           The definition of “Class” in Section 1.1 of the Credit Agreement is hereby amended to read as follows:

          “Class” means (i) with respect to Lenders, each of the following classes of Lenders: (a) Lenders having Term Loan Exposure, (b) Lenders having Term B Loan

2


Exposure and (c) Lenders having Revolving Exposure (including Swing Line Lender), and (ii) with respect to Loans, each of the following classes of Loans: (a) Term Loans, (b) Term B Loans and (c) Revolving Loans (including Swing Line Loans).

          (d)           The definition of “Commitment” in Section 1.1 of the Credit Agreement is hereby amended to read as follows:

          “Commitment” means any Revolving Commitment, Term Loan Commitment or Term B Loan Commitment.

          (e)           The second parenthetical in the definition of “Consolidated Excess Cash Flow” in Section 1.1 of the Credit Agreement is hereby amended to read as follows:

(excluding (i) repayments of Revolving Loans or Swing Line Loans except to the extent the Revolving Commitments are permanently reduced in connection with such repayments and (ii) repurchases of Term Loans and Term B Loans made pursuant to Section 2.13(c))

          (f)           Part (c) of the definition of “Interest Period” in Section 1.1 of the Credit Agreement is hereby amended to read as follows:

(c)(i) no Interest Period with respect to any portion of the Term Loans shall extend beyond the Term Loan Maturity Date and (ii) no Interest Period with respect to any portion of the Term B Loans shall extend beyond the Term B Loan Maturity Date;

          (g)           The definition of “Loan” in Section 1.1 of the Credit Agreement is hereby amended to read as follows:

          “Loan” means a Term Loan, a Term B Loan, a Revolving Loan and a Swing Line Loan.

          (h)           The definition of “Pro Rata Share” in Section 1.1 of the Credit Agreement is hereby amended to read as follows:

          “Pro Rata Share” means (i) with respect to all payments, computations and other matters relating to the Term Loan of any Lender, the percentage obtained by dividing (a) the Term Loan Exposure of that Lender by (b) the aggregate Term Loan Exposure of all Lenders; (ii) with respect to all payments, computations and other matters relating to the Term B Loan of any Lender, the percentage obtained by dividing (a) the Term B Loan Exposure of that Lender by (b) the aggregate Term B Loan Exposure of all Lenders and (iii) with respect to all payments, computations and other matters relating to the Revolving Commitment or Revolving Loans of any Lender or any Letters of Credit issued or participations purchased therein by any Lender or any participations in any Swing Line Loans purchased by any Lender, the percentage obtained by dividing (a) the Revolving Exposure of that Lender by (b) the aggregate Revolving Exposure of all Lenders. For all other purposes with respect to each Lender, “Pro Rata Share” means the percentage obtained by dividing (A) an amount equal to the sum of the Term Loan Exposure, Term B Loan Exposure and the Revolving Exposure of that Lender, by (B) an amount equal to the sum of the aggregate Term Loan Exposure, Term B Loan Exposure and the aggregate Revolving Exposure of all Lenders.

3


          (i)           The definition of “Requisite Class Lenders” in Section 1.1 of the Credit Agreement is hereby amended to read as follows:

          “Requisite Class Lenders” means, at any time of determination, (i) for the Class of Lenders having Term Loan Exposure, Lenders holding more than 50% of the aggregate Term Loan Exposure of all Lenders; (ii) for the Class of Lenders having Term B Loan Exposure, Lenders holding more than 50% of the aggregate Term B Loan Exposure of all Lenders; and (iii) for the Class of Lenders having Revolving Exposure, Lenders holding more than 50% of the aggregate Revolving Exposure of all Lenders.

                    (j)           The definition of “Requisite Lenders” in Section 1.1 of the Credit Agreement is hereby amended to read as follows:

          “Requisite Lenders” means one or more Lenders having or holding Term Loan Exposure, Term B Loan Exposure and/or Revolving Exposure and representing more than 50% of the sum of (i) the aggregate Term Loan Exposure of all Lenders, (ii) the aggregate Term B Loan Exposure of all Lenders and (iii) the aggregate Revolving Exposure of all Lenders.

                    (k)           The definition of “Type of Loan” in Section 1.1 of the Credit Agreement is hereby amended to read as follows:

          “Type of Loan” means (i) with respect to either Term Loans, Term B Loans or Revolving Loans, a Base Rate Loan or a Eurodollar Rate Loan, and (ii) with respect to Swing Line Loans, a Base Rate Loan.

                    (l)           New Sections 2.1(c) and (d) are hereby added to the Credit Agreement to read as follows:

          (c)           Term B Loan Commitments. Subject to the terms and conditions hereof, each Lender severally agrees to make, on the Third Amendment Effective Date, a Term B Loan to the Borrower in an amount equal to such Lender’s Term B Loan Commitment. Borrower may make only one borrowing under the Term B Loan Commitment which shall be on the Third Amendment Effective Date. Any amount borrowed under this Section 2.1(c) and subsequently repaid or prepaid may not be reborrowed. Subject to Sections 2.13(a) and 2.14, all amounts owed hereunder with respect to the Term B Loans shall be paid in full no later than the Term B Loan Maturity Date. Each Lender’s Term B Loan Commitment shall terminate immediately and without further action on the Third Amendment Effective Date after giving effect to the funding of such Lender’s Term B Loan Commitment on such date. The Term B Loans may consist of Eurodollar Rate Loans or Base Rate Loans, as further provided herein.

          (d)           Borrowing Mechanics for Term B Loans. Borrower shall deliver to BOFA a fully executed Funding Notice (y) three Business Days prior to the Third Amendment Effective Date in the case of Term B Loans which are Eurodollar Rate Loans and (z) one Business Day prior to the Third Amendment Effective Date in the case of Term B Loans which are Base Rate Loans. Promptly upon receipt by BOFA of such notice, BOFA shall notify each Lender of the proposed borrowing. Each Lender shall make its Term B Loan available to BOFA in immediately available funds by wire transfer of same day funds in Dollars, at the Principal Office designated by BOFA. BOFA shall make the proceeds of the Term B Loan available to the Borrower on the Third

4


Amendment Effective Date by causing an amount of same day funds in Dollars equal to the proceeds of the Term B Loan to be credited to the account of the Borrower at the Principal Office designated by BOFA or to such other account as may be designated in writing to BOFA by the Borrower.

                    (m)           Section 2.5(a) of the Credit Agreement is hereby amended to read as follows:

          (a)           Pro Rata Shares. All Loans shall be made, and all participations purchased, by Lenders simultaneously and proportionately to their respective Pro Rata Shares, it being understood that no Lender shall be responsible for any default by any other Lender in such other Lender’s obligation to make a Loan requested hereunder or purchase a participation required hereby nor shall any Term Loan Commitment, Term B Loan Commitment or any Revolving Commitment of any Lender be increased or decreased as a result of a default by any other Lender in such other Lender’s obligation to make a Loan requested hereunder or purchase a participation required hereby.

                    (n)           The last sentence of Section 2.5(b) of the Credit Agreement is hereby amended to read as follows:

Nothing in this Section 2.5(b) shall be deemed to relieve any Lender from its obligation to fulfill its Term Loan Commitments, Term B Loan Commitments and Revolving Commitments hereunder or to prejudice any rights that the Borrower may have against any Lender as a result of any default by such Lender hereunder.

                    (o)           The following sentence is hereby added at the end of Section 2.6 of the Credit Agreement:

The proceeds of the Term B Loans shall be applied by the Borrower to repay the Second Lien Term Loans on the Third Amendment Effective Date.

                    (p)           Section 2.7(c) of the Credit Agreement is hereby amended to read as follows:

          (c)           Notes. If so requested by any Lender by written notice to the Borrower (with a copy to Administrative Agents) at least two Business Days prior to the Closing Date, or at any time thereafter, the Borrower shall execute and deliver to such Lender (and/or, if applicable and if so specified in such notice, to any Person who is an assignee of such Lender pursuant to Section 10.6) on the Closing Date (or, if such notice is delivered after the Closing Date, promptly after Borrower’s receipt of such notice) a Note or Notes to evidence such Lender’s Term Loan, Term B Loan, Revolving Loan or Swing Line Loan, as the case may be.

                    (q)           Clause (i) in Section 2.8(a) of the Credit Agreement is hereby amended to read as follows:

          (i)           in the case of Term Loans, Term B Loans and Revolving Loans:

                    (r)           The first sentence of Section 2.8(c) of the Credit Agreement is hereby amended to read as follows:

          (c)           In connection with Eurodollar Rate Loans there shall be no more than (i) five (5) Interest Periods outstanding at any time with respect to Revolving Loans, (ii)

5


five (5) Interest Periods outstanding at any time with respect to the Term Loans and (iii) five (5) Interest Periods outstanding at any time with respect to the Term B Loans.

                    (s)           Subclauses (ii) and (iii) of Section 2.8(e) of the Credit Agreement are hereby amended to read as follows:

(ii) with respect to Term Loans and Term B Loans, shall accrue on a daily basis on and to the March 31st, June 30th, September 30th and December 31st most recently ended prior to such payment date and shall be payable in arrears on each Interest Payment Date; (iii) shall accrue on a daily basis and shall be payable in arrears upon any prepayment of Term Loans or Term B Loans, whether voluntary or mandatory, to the extent accrued on the amount being prepaid;.

                    (t)           The language preceding the proviso in Section 2.9(a)(i) of the Credit Agreement is hereby amended to read as follows:

          (i)           to convert at any time all or any part of any Term Loan, Term B Loan or Revolving Loan equal to $500,000 and integral multiples of $100,000 in excess of that amount from one Type of Loan to another Type of Loan;

                    (u)           A new Section 2.12(b) is hereby added to the Credit Agreement following Section 2.12(a) to read as follows:

          (b)           Scheduled Installments for Term B Loans. The principal amounts of the Term B Loans shall be repaid in consecutive quarterly installments (each, a “Term B Loan Installment”) in the aggregate amounts set forth below on the four quarterly scheduled Interest Payment Dates applicable to Term B Loans (each, a “Term B Loan Installment Date”), commencing June 30, 2007:

Fiscal Quarter Term B Loan Installments
June 30, 2007 $125,000
September 30, 2007 $125,000
December 31, 2007 $125,000
March 31, 2008 $125,000
June 30, 2008 $125,000
September 30, 2008 $125,000
December 31, 2008 $125,000
March 31, 2009 $125,000
June 30, 2009 $125,000
September 30, 2009 $125,000
December 31, 2009 $125,000
March 31, 2010 $125,000
June 30, 2010 $12,125,000
September 30, 2010 $12,125,000
December 31, 2010 $12,125,000
Term B Loan Maturity Date $12,125,000

Notwithstanding the foregoing, (x) such Term B Loan Installments shall be reduced in connection with any voluntary or mandatory prepayments of the Term B Loans, as the case may be, in accordance with Sections 2.13, 2.14 and 2.15, as applicable; and (y) the

6


Term B Loans, together with all other amounts owed hereunder with respect thereto, shall, in any event, be paid in full no later than the Term B Loan Maturity Date.

                    (v)           The second parenthetical in Section 2.13 of the Credit Agreement is hereby amended to read as follows:

(and Administrative Agents will promptly transmit such telephonic or original notice for Term Loans, Term B Loans or Revolving Loans, as the case may be, by telefacsimile or telephone to each Lender)

                    (w)           Section 2.13(c) of the Credit Agreement is hereby amended to read as follows:

                                (c)           Certain Permitted Term Loan and Term B Loan Repurchases.

          Notwithstanding anything to the contrary contained in this Section 2.13 or any other provision of this Agreement, so long as (i) there is no Default, (ii) there is no Event of Default and (iii) no Default or Event of Default would result therefrom, Borrower may repurchase outstanding Term Loans and Term B Loans on the following basis:

          (i)           Borrower may repurchase all or any portion of the Term Loans and the Term B Loans of one or more Lenders pursuant to an Assignment Agreement, between Borrower and such Lender or Lenders in an aggregate principal amount not to exceed (y) 10% of the initial aggregate principal amount of Term Loans and Term B Loans with respect to all such repurchases pursuant to this clause (i) and (z) $10,000,000 in any Fiscal Year; provided that, with respect to such repurchases, Borrower shall simultaneously provide a copy of such Assignment Agreement and any other agreements between Borrower and such Lender with respect to such repurchase to Administrative Agents;

          (ii)          In addition, Borrower may make one or more offers (each, an “Offer”) to repurchase all or any portion of the Term Loans and the Term B Loans (such Term Loans and Term B Loans, the “Offer Loans”) of Lenders, provided, (A) Borrower delivers a notice of such Offer to Administrative Agents and all Lenders no later than noon (New York City time) at least five Business Days in advance of a proposed consummation date of such Offer indicating (1) the last date on which such Offer may be accepted, (2) the maximum dollar amount of the Offer, (3) the repurchase price per dollar of principal amount of such Offer Loans at which Borrower is willing to repurchase the Offer Loans and (4) the instructions, consistent with this Section 2.13(c) with respect to the Offer (which shall be reasonably acceptable to Borrower and Administrative Agents), that a Lender must follow in order to have its Offer Loans repurchased; (B) the maximum dollar amount of the Offer shall be no less than an aggregate $1,000,000; (C) Borrower shall hold the Offer open for a minimum period of two Business Days; (D) a Lender who elects to participate in the Offer may choose to tender all or part of such Lender’s Offer Loans; and (E) the Offer shall be made to Lenders holding the Offer Loans on a pro rata basis in accordance with their Pro Rata Shares; provided, further that, if any Lender elects not to

7


participate in the Offer, either in whole or in part, the amount of such Lender’s Offer Loans not being tendered shall be excluded in calculating the pro rata amount applicable to the balance of such Offer Loans;

          (iii)           With respect to all repurchases made by Borrower pursuant to this Section 2.13(c), (A) Borrower shall pay all accrued and unpaid interest, if any, on the repurchased Term Loans and Term B Loans to the date of repurchase of such Term Loans and Term B Loans (B) Borrower shall have provided to all Lenders all information that, together with any previously provided information, would satisfy the requirements of Rule 10b-5 of the Exchange Act with respect to an offer by Borrower to repurchase securities registered under the Securities Act of 1933 (whether or not such securities are outstanding) as if such offer was being made as of the date of such repurchase of Term Loans and Term B Loans from a Lender and (C) such repurchases shall not be deemed to be voluntary prepayments pursuant to this Section 2.13, Section 2.15 or 2.16 hereunder except that the amount of the Loans so repurchased shall be repurchased between the Term Loans and the Term B Loans and applied on a pro rata basis in each case to reduce the scheduled remaining Installments of principal on such Term Loan and the remaining Term B Loan Installments of principal on such Term B Loan, as applicable; and

          (iv)          Following repurchase by Borrower pursuant to this Section 2.13(c), the Term Loans and Term B Loans so repurchased shall be deemed cancelled for all purposes and no longer outstanding (and may not be resold by Borrower), for all purposes of this Agreement and all other Credit Documents, including, but not limited to (A) the making of, or the application of, any payments to the Lenders under this Agreement or any other Credit Document, (B) the making of any request, demand, authorization, direction, notice, consent or waiver under this Agreement or any other Credit Document or (C) the determination of Requisite Lenders, or for any similar or related purpose, under this Agreement or any other Credit Document. Any payment made by Borrower in connection with a repurchase permitted by this Section 2.13(c) shall not be subject to the provisions of either Section 2.16(a) or Section 2.17. Failure by Borrower to make any payment to a Lender required by an agreement permitted by this Section 2.13(c) shall not constitute an Event of Default under Section 8.1(a).

Notwithstanding any of the provisions set forth in this Agreement to the contrary, Borrower, the Lenders and Agents hereby agree that nothing in this Agreement shall be understood to mean or suggest that the Term Loans or the Term B Loans constitute “securities” for purposes of either the Securities Act or the Exchange Act.

                    (x)            Section 2.14(a) of the Credit Agreement is hereby amended to read as follows:

          (a)           Asset Sales. No later than the third Business Day following the date of receipt by any Credit Party of any Net Asset Sale Proceeds (other than any Net Asset Sale

8


Proceeds received from any Excepted Asset Sale), the Borrower shall prepay the Loans and/or the Revolving Commitments shall be permanently reduced as set forth in Section 2.15(b) in an aggregate amount equal to such Net Asset Sale Proceeds; provided, so long as no Default or Event of Default shall have occurred and be continuing, Borrower shall have the option, directly or through one or more of its Subsidiaries, to invest Net Asset Sale Proceeds (in an aggregate amount not to exceed $20,000,000 of such proceeds received by the Credit Parties in any Fiscal Year) within three hundred sixty-five days of receipt thereof in long-term assets of the general type used in the business of Borrower and its Subsidiaries and Permitted Acquisitions; provided further, pending any such investment such Net Asset Sale Proceeds shall be applied to prepay Revolving Loans to the extent outstanding (without a reduction in Revolving Commitments) and provided further, that any such Net Asset Sale Proceeds not so reinvested within 365 days of receipt thereof shall be applied to prepay the Loans as set forth herein.

                    (y)           The first parenthetical in Section 2.14(c) of the Credit Agreement is hereby amended to read as follows:

(other than pursuant to (i) any employee stock or stock option compensation plan and (ii) the exercise of warrants payable in cash in an amount not to exceed $10,000,000 in any Fiscal Year and $30,000,000 in the aggregate from the Closing Date through the applicable date of determination)

                    (z)           Section 2.14(e) of the Credit Agreement is hereby amended to read as follows:

          (e)           Consolidated Excess Cash Flow. In the event that there shall be Consolidated Excess Cash Flow for any Fiscal Year (commencing with the Fiscal Year ending December 31, 2006), the Borrower shall, no later than ninety days after the end of such Fiscal Year, prepay the Loans and/or the Revolving Commitments shall be permanently reduced as set forth in Section 2.15(b) in an aggregate amount equal to the sum of (i) 50% of such Consolidated Excess Cash Flow minus (ii) any voluntary repurchases of the Term Loans or the Term B Loans made by the Borrower pursuant to the terms hereof; provided, on any date that the Leverage Ratio (determined for any such period by reference to the most recent Compliance Certificate delivered pursuant to Section 5.1(d) calculating the Leverage Ratio) shall be 3.50:1.00 or less, the Borrower shall not be required to make the prepayments and/or reductions otherwise required hereby.

          (aa)           The third clause following the “:”in Section 2.15(a) of the Credit Agreement and the last sentence of Section 2.15(a) of the Credit Agreement are each hereby amended to read as follows:

           third, to prepay the Term Loans and the Term B Loans, on a pro rata basis (in accordance with the outstanding principal amounts thereof).

          Any prepayment of any Term Loan pursuant to Section 2.13(a) shall be further applied on a pro rata basis to reduce the scheduled remaining Installments of principal on such Term Loan, and any prepayment of any Term B Loan pursuant to Section 2.13(a) shall be further applied on a pro rata basis to reduce the scheduled remaining Term B Installments of principal on such Term B Loan.

9


          (bb)         The first clause following the “:” in Section 2.15(b) of the Credit Agreement is hereby amended to read as follows:

          first, to prepay Term Loans and Term B Loans, on a pro rata basis (in accordance with the respective outstanding principal amounts thereof) and shall be further applied on a pro rata basis to the remaining scheduled Installments of principal of the Term Loans and remaining scheduled Term B Loan Installments of principal of the Term B Loans;

                    (cc)         The language preceding the “:” in Section 3.2(a) is hereby amended to read as follows:

          (a)           Conditions Precedent. The obligation of each Lender to make any Loan, or Issuing Bank to issue any Letter of Credit, on any Credit Date, including the Closing Date, the Term Loan Funding Date and the Third Amendment Effective Date, are subject to the satisfaction, or waiver in accordance with Section 10.5, of the following conditions precedent:

          (dd)         Section 3.2(a)(vi) of the Credit Agreement is hereby amended to read as follows:

                                          (a)           [Intentionally omitted.]

                    (ee)         Section 5.1(a) of the Credit Agreement is hereby amended to read as follows:

                                          (a)           [Intentionally omitted.]

                            (ff)          Section 6.1(o) of the Credit Agreement is hereby amended to read as follows:

          (o)           other Indebtedness of Holdings and its Subsidiaries in an aggregate amount not to exceed at any time $25,000,000; and

                    (gg)         Section 6.2(p) of the Credit Agreement is hereby amended to read as follows:

          (p)           other Liens securing Indebtedness in an aggregate amount not to exceed $25,000,000 at any time outstanding.

          (hh)         The “.”at the end of Section 6.5(d) of the Credit Agreement is replaced with a “; and” and the following new clause (e) is hereby added at the end of Section 6.5 of the Credit Agreement to read as follows:

          (e)           Holdings may repurchase shares of its Capital Stock; provided that (i) no Default or Event of Default exists immediately prior to and after giving effect to any such repurchase and (ii) the aggregate amount of all such repurchases of Capital Stock by Holdings pursuant to this Section 6.5(e) from the Third Amendment Effective Date through the remaining term of this Agreement shall not exceed $100,000,000; provided that Holdings may make additional repurchases of its Capital Stock in excess of the threshold established in clause (ii) above if the Borrower delivers a revised Compliance Certificate demonstrating that the Leverage Ratio calculated on a pro forma basis after giving effect to such repurchase (as if such repurchase had occurred in the beginning of the period set forth in such Compliance Certificate) is at least .50 less than the ratio required to be maintained by Section 6.8(b) .

10


          (ii)           Sections 6.8(a), (b) and (c) of the Credit Agreement are each hereby amended to read as follows:

          (a)           Interest Coverage Ratio. Holdings shall not permit the Interest Coverage Ratio as of the last day of any Fiscal Quarter, beginning with the Fiscal Quarter ending December 31, 2006, to be less than the correlative ratio indicated:

Fiscal Quarter Interest Coverage Ratio
December 31, 2006 2.75:1.00
March 31, 2007 2.75:1.00
June 30, 2007 2.75:1.00
September 30, 2007 2.75:1.00
December 31, 2007 and each fiscal 3.00:1.00
Quarter ending thereafter  

          (b)           Leverage Ratio. Holdings shall not permit the Leverage Ratio as of the last day of any Fiscal Quarter, beginning with the Fiscal Quarter ending December 31, 2006 to exceed the correlative ratio indicated:

Fiscal Quarter Leverage Ratio
December 31, 2006 4.00:1.00
March 31, 2007 4.00:1.00
June 30, 2007 4.00:1.00
September 30, 2007 4.00:1.00
December 31, 2007 and each fiscal 3.50:1.00
Quarter ending thereafter  

          (c)           Maximum Consolidated Capital Expenditures. Holdings shall not, and shall not permit its Subsidiaries to, make or incur Consolidated Capital Expenditures, in any Fiscal Year indicated below, in an aggregate amount for Holdings and its Subsidiaries in excess of the corresponding amount set forth below opposite such Fiscal Year (other than those funded with (i) the Net Asset Sale Proceeds of any Asset Sale (including without limitation the Net Asset Sale Proceeds of any Excepted Asset Sale) that are not required to be used to prepay the Loans pursuant to Section 2.14(a) or (ii) insurance proceeds); provided, such amount for any Fiscal Year shall be increased by an amount equal to the excess, if any, (but in no event more than $15,000,000) of such amount for the previous Fiscal Year (as adjusted in accordance with this proviso) over the actual amount of such Consolidated Capital Expenditures for such previous Fiscal Year:

Fiscal Year Consolidated Capital
  Expenditures
2005 $43,800,000
2006 $36,900,000
2007 $44,000,000
2008 $42,000,000
2009 $33,000,000

                    (jj)          Clause (3) of Section 6.9(b) of the Credit Agreement is hereby amended to read

11


             as follows:

(3) the Net Asset Sale Proceeds thereof (other than any Net Asset Sale Proceeds received from any Excepted Asset Sale) shall be applied as required by Section 2.14(a) and

                    (kk)         Section 6.9(d) of the Credit Agreement is hereby amended to read as follows:

          (d)           Permitted Acquisitions, the non-equity consideration for which constitutes (i) less than $40,000,000 in the aggregate in any Fiscal Year; and (ii) less than $100,000,000 in the aggregate from the Third Amendment Effective Date to the date of determination; provided, that the non-equity consideration of any Permitted Acquisition may exceed the limitations set forth in clauses (i) and (ii) of this Section 6.9(d), if the Borrower delivers a revised Compliance Certificate demonstrating that the Leverage Ratio calculated on a pro forma basis in accordance with Section 6.9(d) after giving effect to such Permitted Acquisition (as if such Permitted Acquisition had occurred in the beginning of the period set forth in such Compliance Certificate) is at least .50 less than the ratio required to be maintained by Section 6.8(b) (it being understood and agreed that (x) any Cash proceeds received by Holdings from a capital contribution, or the issuance of Capital Stock, and used as consideration to make a Permitted Acquisition within 90 days of receipt of such Cash proceeds shall be considered equity consideration (and not cash consideration counting toward the baskets above) for purposes of this Section 6.9(d) and (y) any proceeds of a Revolving Loan borrowing and/or Cash used to fund in whole or in part a Permitted Acquisition shall be considered equity consideration (and not cash consideration counting toward the baskets above) for purposes of this Section 6.9(d) so long as such Revolving Loan and/or Cash is immediately repaid or replenished in full with Cash proceeds received by Holdings from a capital contribution, or the issuance of Capital Stock within 90 days of the date of the consummation of such Permitted Acquisition);

                    (ll)          Section 6.11 of the Credit Agreement is hereby amended to read as follows:

                           6.11      [Intentionally omitted.]

                    (mm)      Clause (B) of Section 10.6(c)(ii) of the Credit Agreement is hereby amended to read as follows:

(B) $1,000,000 as of the Trade Date (or such lesser amount as may be agreed to by Borrower and Administrative Agents or as shall constitute the aggregate amount of the Term Loan or the Term B Loan of the assigning Lender) with respect to the assignment of Term Loans and Term B Loans;

                    (nn)       Section 10.6(d) of the Credit Agreement is hereby amended to read as follows:

          (d)           Mechanics. Assignments of Term Loans and Term B Loans by Lenders may be made via an electronic settlement system acceptable to Administrative Agents as designated in writing from time to time to the Lenders by Administrative Agents (the “Settlement Service”). Each such assignment shall be effected by the assigning Lender and proposed assignee pursuant to the procedures then in effect under the Settlement Service, which procedures shall be consistent with the other provisions of this Section 10.6. Each assignor Lender and proposed assignee shall comply with the requirements of the Settlement Service in connection with effecting any transfer of Loans

12


pursuant to the Settlement Service. Administrative Agents’ and Borrower’s consent shall be deemed to have been granted, with regard to any Lender set forth on a list of preapproved lenders agreed to in advance between Borrower and GSCP, pursuant to Section 10.6(c)(ii) with respect to any transfer effected through the Settlement Service. Subject to the other requirements of this Section 10.6, assignments and assumptions of Term Loans and Term B Loans may also be effected by manual execution and delivery to the Administrative Agents of an Assignment Agreement with, in the case of an assignment pursuant to Section 10.6(c)(ii), the prior written consent of each of Borrower and Administrative Agents (such consent not to be (x) unreasonably withheld or delayed or (y) in the case of Borrower, required at any time an Event of Default shall have occurred and then be continuing). Initially, assignments and assumptions of Term Loans and Term B Loans shall be effected by such manual execution until Administrative Agents notify Lenders to the contrary. Assignments and assumptions of Revolving Loans and Revolving Commitments shall only be effected by manual execution and delivery to the Administrative Agents of an Assignment Agreement. Assignments made pursuant to the foregoing provision shall be effective as of the Assignment Effective Date. In connection with all assignments there shall be delivered to Administrative Agents such forms, certificates or other evidence, if any, with respect to United States federal income tax withholding matters as the assignee under such Assignment Agreement may be required to deliver pursuant to Section 2.20(c) . Notwithstanding anything herein or in any Assignment Agreement to the contrary and (i) unless notice to the contrary is delivered to the Lenders from the Administrative Agents or (ii) so long as no Default or Event of Default has occurred and is continuing, payment to the assignor by the assignee in respect of the settlement of an assignment of any Term Loan or Term B Loan (but not any Revolving Loan or Revolving Commitment) shall include such compensation to the assignor as may be agreed upon by the assignor and the assignee with respect to all unpaid interest which has accrued on such Term Loan or Term B Loan to but excluding the Assignment Effective Date. On and after the applicable Assignment Effective Date, the applicable assignee shall be entitled to receive all interest paid or payable with respect to the assigned Term Loan or Term B Loan, whether such interest accrued before or after the applicable Assignment Effective Date.

          (oo)         A new Appendix A-3 is hereby added to the Credit Agreement to read as provided on Appendix A-3 attached hereto.

          (pp)         A new Schedule 1.1(d) is hereby added to the Credit Agreement to read as provided on Schedule 1.1(d) attached hereto.

          (qq)         Exhibit A-1 to the Credit Agreement is hereby amended to read as provided on Exhibit A-1 attached hereto.

          (rr)           Exhibit A-2 to the Credit Agreement is hereby amended to read as provided on Exhibit A-2 attached hereto.

          (ss)          A new Exhibit B-4 is hereby added to the Credit Agreement to read as provided on Exhibit B-4 attached hereto.

          3.           Conditions Precedent. This Agreement shall be effective upon satisfaction of the following conditions precedent:

13


          (a)           Receipt by BOFA of counterparts of this Agreement duly executed by the Borrower, the Guarantors and the Requisite Lenders; and

          (b)           Receipt by BOFA of a certificate of an Authorized Officer of the Borrower, in form and substance reasonably satisfactory to BOFA, (i) certifying that the Organizational Documents of each Credit Party delivered on the Closing Date have not been amended, supplemented or otherwise modified since the Closing Date except as otherwise disclosed in a public filing or to BOFA directly, and remain in full force and effect as of the Third Amendment Effective Date, (ii) attaching resolutions of each Credit Party approving and adopting this Agreement, the transactions contemplated herein and authorizing the execution and delivery of this Agreement and any documents, agreements or certificates related thereto and certifying that such resolutions have not been amended, supplemented or otherwise modified and remain in full force and effect as of the Third Amendment Effective Date and (iii) certifying that Holdings and its Subsidiaries (after giving effect to this Agreement and the incurrence of Indebtedness related hereto) are Solvent on a consolidated basis.

          (c)           Receipt by the BOFA of favorable opinions of legal counsel to the Credit Parties, addressed to BOFA and each Lender, dated as of the Third Amendment Effective Date, in form and substance satisfactory to BOFA.

          (d)           Receipt by BOFA of a payoff letter from Goldman Sachs Credit Partners L.P., in its capacity as administrative agent under the Second Lien Credit Agreement, containing the payoff amount for the Second Lien Term Loans and other agreements reasonably satisfactory to BOFA and the Borrower.

4.           Miscellaneous.

          (a)           The Credit Agreement, and the obligations of the Credit Parties thereunder and under the other Credit Documents, are hereby ratified and confirmed and shall remain in full force and effect according to their terms.

          (b)           Each Guarantor (i) acknowledges and consents to all of the terms and conditions of this Agreement, (ii) affirms all of its obligations under the Credit Documents and (iii) agrees that this Agreement and all documents executed in connection herewith do not operate to reduce or discharge its obligations under the Credit Agreement or the other Credit Documents.

          (c)           The Borrower and the Guarantors hereby represent and warrant as follows:

          (i)           Each Credit Party has taken all necessary action to authorize the execution, delivery and performance of this Agreement.

          (ii)          This Agreement has been duly executed and delivered by the Credit Parties and constitutes each of the Credit Parties’ legal, valid and binding obligations, enforceable in accordance with its terms, except as such enforceability may be limited by Debtor Relief Laws and general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law).

          (iii)         No consent, approval, authorization or order of, or filing, registration or qualification with, any court or governmental authority or third party is required in connection with the execution, delivery or performance by any Credit Party of this Agreement.

14


          (d)           This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be an original, but all of which shall constitute one and the same instrument. Delivery of an executed counterpart of this Agreement by telecopy shall be effective as an original and shall constitute a representation that an executed original shall be delivered.

          (e)           THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.

15


          Each of the parties hereto has caused a counterpart of this Agreement to be duly executed and delivered as of the date first above written.

BORROWER: GENTEK HOLDING, LLC
 
  By:           s/WILLIAM E. REDMOND, Jr
  Name: WILLIAM E. REDMOND, Jr
  Title: President and Chief Executive Officer
 
GUARANTORS: GENTEK INC.
 
  By:           s/WILLIAM E. REDMOND, Jr
  Name: WILLIAM E. REDMOND, Jr
  Title:    President and Chief Executive Officer
 
 
BALCRANK PRODUCTS INC.
 
BINDERLINE DRAFTLINE, INC.
  DEFIANCE, INC.
 
DEFIANCE KINEMATICS INC.
  DEFIANCE PRECISION PRODUCTS, INC.
  DEFIANCE PRECISION PRODUCTS MANAGEMENT LLC
  DEFIANCE PRECISION PRODUCTS MANUFACTURING LLC
  DEFIANCE TESTING & ENGINEERING SERVICES, INC.
  FINI ENTERPRISE, INC.
  GENERAL CHEMICAL LLC
  GENERAL CHEMICAL PERFORMANCE PRODUCTS LLC
  GENERAL CHEMICAL WEST LLC
  GENTEK TECHNOLOGIES MARKETING INC.
  HY-FORM PRODUCTS, INC.
  PRINTING DEVELOPMENTS, INC.
  REHEIS, INC.
 
TOLEDO TECHNOLOGIES INC.
  TOLEDO TECHNOLOGIES MANAGEMENT LLC
  TOLEDO TECHNOLOGIES MANUFACTURING LLC
  VIGILANT NETWORKS LLC
 
 
  By:      s/James Imbriaco                                        
  Name:  James Imbriaco
  Title: Secretary

GENTEK HOLDING, LLC
THIRD AMENDMENT TO FIRST LIEN CREDIT
AND GUARANTY AGREEMENT AND WAIVER


  BANK OF AMERICA, N.A., as Collateral Agent and
  Co-Administrative Agent
   
   
  By:__________________________________
  Name:
  Title:
   
  BANK OF AMERICA, N.A., as a Lender
   
   
  By:__________________________________
  Name:
  Title:
   
   
  GENERAL ELECTRIC CAPITAL CORPORATION,
  as Co-Administrative Agent and a Lender
   
   
  By:__________________________________
  Name:
  Title:

GENTEK HOLDING, LLC
THIRD AMENDMENT TO FIRST LIEN CREDIT
AND GUARANTY AGREEMENT AND WAIVER


LENDERS: [Insert name of applicable Lender]
 
 
 
By:__________________________________
  Name:
  Title:

GENTEK HOLDING, LLC
THIRD AMENDMENT TO FIRST LIEN CREDIT
AND GUARANTY AGREEMENT AND WAIVER


EX-21 4 c47397_ex21.htm

EXHIBIT 21

SUBSIDIARIES OF THE COMPANY

 

 

 

Name

 

Formation

 

 

Jurisdiction

 

 

 

GenTek Financial Services Ltd.

 

Barbados

GenTek Holding, LLC

 

Delaware

General Chemical Performance Products LLC

 

Delaware

Fini Enterprises, Inc.

 

Texas

General Chemical LLC

 

Delaware

Inmobiliara GenTek, S.A. de C.V.

 

Mexico

General Chemical West LLC

 

Delaware

Waterside Urban Renewal Corporation

 

New Jersey

General Chemical Canada Holdings Inc.

 

Delaware

General Chemical Performance Products Ltd.

 

Ontario

Reheis, Inc.

 

Delaware

Reheis Holdings Inc.

 

Delaware

Ilminster Company

 

Ireland

Reheis Ireland

 

Ireland

Alembic Manufacturing Ltd.

 

United Kingdom

GenTek Technologies Marketing Inc.

 

Delaware

Balcrank Products Inc.

 

Delaware

GT Technologies Europe GmbH

 

Germany

Defiance, Inc.

 

Delaware

Defiance Precision Products Inc.

 

Ohio

Defiance Precision Products Management LLC

 

Delaware

Defiance Precision Products Manufacturing LLC

 

Delaware

Defiance Testing & Engineering Services, Inc.

 

Michigan

Binderline Draftline, Inc.

 

Michigan

Defiance Kinematics Inc.

 

Delaware

DTA Development, LLC

 

Michigan

Hy-Form Products, Inc.

 

Michigan

Toledo Technologies Inc.

 

Delaware

Toledo Technologies Management LLC

 

Delaware

Toledo Technologies Manufacturing LLC

 

Delaware

1279597 Ontario Inc.

 

Ontario

Sandco Automotive Ltd.

 

Ontario

Noma Holding Inc.

 

Delaware

Noma Corporation

 

Delaware

Noma Technologies Limited Partnership

 

Massachusetts

Noma Delaware Inc.

 

Delaware

Noma Company

 

Nova Scotia

Printing Developments, Inc.

 

Delaware

Vigilant Networks LLC

 

Delaware

Vigilant Networks Canada Inc.

 

Ontario



EX-31.1 5 c47397_ex31-1.htm

Exhibit 31.1

CERTIFICATION

I, William E. Redmond, Jr., certify that:

 

 

 

1.

I have reviewed this annual report on Form 10-K of GenTek Inc.;

 

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

 

4.

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

 

5.

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


 

 

 

Date   March 20, 2007

/s/ 

William E. Redmond, Jr.

 

 


 

 

William E. Redmond, Jr.

 

 

President and Chief Executive Officer



EX-31.2 6 c47397_ex31-2.htm

Exhibit 31.2

CERTIFICATION

I, Thomas B. Testa, certify that:

 

 

 

1.

I have reviewed this annual report on Form 10-K of GenTek Inc.;

 

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

 

4.

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

 

5.

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

 

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


 

 

 

Date   March 20, 2007

/s/ 

Thomas B. Testa

 

 


 

 

Thomas B. Testa

 

 

Vice President and Chief Financial Officer



EX-32 7 c47397_ex32.htm

Exhibit 32

Certification of CEO and CFO Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report on Form 10-K of GenTek Inc. (the “Company”) for the year ended December 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), William E. Redmond, Jr., as Chief Executive Officer of the Company, and Thomas B. Testa, as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

          (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

          (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

/s/ 

William E. Redmond, Jr.

 

 


 

 

William E. Redmond, Jr.

 

 

Chief Executive Officer

 

 

March 20, 2007

 

 

 

 

/s/ 

Thomas B. Testa

 

 


 

 

Thomas B. Testa

 

 

Chief Financial Officer

 

 

March 20, 2007

 

This certification accompanies the Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 has been provided to GenTek Inc. and will be retained by GenTek Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


-----END PRIVACY-ENHANCED MESSAGE-----